Obama will Stammzellenforschung lockern - Schubkraft für CBAI - 500 Beiträge pro Seite (Seite 6)
eröffnet am 11.11.08 17:29:48 von
neuester Beitrag 10.11.15 18:47:43 von
neuester Beitrag 10.11.15 18:47:43 von
Beiträge: 7.844
ID: 1.146.013
ID: 1.146.013
Aufrufe heute: 1
Gesamt: 459.496
Gesamt: 459.496
Aktive User: 0
ISIN: US12482D1037 · WKN: A2JM3A
0,0078
USD
+4,00 %
+0,0003 USD
Letzter Kurs 01.07.20 Nasdaq OTC
Werte aus der Branche Gesundheitswesen
Wertpapier | Kurs | Perf. % |
---|---|---|
2,0500 | +112,88 | |
4,9400 | +40,34 | |
2,8200 | +31,78 | |
2,3700 | +18,50 | |
0,6000 | +17,62 |
Wertpapier | Kurs | Perf. % |
---|---|---|
2,0190 | -12,45 | |
0,7500 | -12,79 | |
27,53 | -15,29 | |
7,31 | -25,39 | |
2,0500 | -28,32 |
So die 8 muss in Sichtweite kommen.....wird sie wohl auch...dann in D mal die 6
ich behaupte mal wir basteln ein wEHHH
Antwort auf Beitrag Nr.: 38.552.158 von Jamster83 am 11.12.09 15:59:06Ich denke auch das wird nochmals nach oben laufen...aber ist halt auch Freitag...und wir wissen ja was die Amis da machen
Antwort auf Beitrag Nr.: 38.552.293 von Expertchen007 am 11.12.09 16:14:26alles verkaufen damit sich mutti paar neue schuhe kaufen kann;I)
Antwort auf Beitrag Nr.: 38.552.304 von Jamster83 am 11.12.09 16:15:35hi expertchen
habe mir auch eine schnitte ins depot gelegt. danke für den tipp!
lg,
freybel
habe mir auch eine schnitte ins depot gelegt. danke für den tipp!
lg,
freybel
Antwort auf Beitrag Nr.: 38.552.393 von freybel am 11.12.09 16:25:19good luck.....2010 reden wir mal drüber wie es gelaufen ist...paar hunderter setzen und gut ist....wo haste es gelesen.???..bei Cel- sci ?????
Antwort auf Beitrag Nr.: 38.552.501 von Expertchen007 am 11.12.09 16:35:53
ja genau!
dann habe ich ein bisschen nachgeforscht.... dann leider gezögert, sonst wäre es noch günstiger gegangen....
lg,
freybel
ja genau!
dann habe ich ein bisschen nachgeforscht.... dann leider gezögert, sonst wäre es noch günstiger gegangen....
lg,
freybel
Antwort auf Beitrag Nr.: 38.552.786 von freybel am 11.12.09 17:05:48Dann kennste ja auch diese Story.....das war ein Hammer ( leider ohne mich )....VERMILLION INC.NEW
Local-Id:
ISIN: US92407M2061
Symbol: VRMLQ
Local-Id:
ISIN: US92407M2061
Symbol: VRMLQ
Antwort auf Beitrag Nr.: 38.552.158 von Jamster83 am 11.12.09 15:59:06Da ist das " wEEEEE "
Antwort auf Beitrag Nr.: 38.552.831 von Expertchen007 am 11.12.09 17:10:18ich auch nicht!
hammerstory!
hammerstory!
Antwort auf Beitrag Nr.: 38.552.831 von Expertchen007 am 11.12.09 17:10:18leck fett ...... wo haste DEN Chart ausgegraben ..... sind die auch an der OTC?
Antwort auf Beitrag Nr.: 38.552.916 von Tom06 am 11.12.09 17:18:50Tja das musste mal nachlesen ab 14.09.09......sind danach von 0,002 US$...bis heute 19,50 US$ gestiegen......passiert aber wohl nur alle 100 Börsenjahre sowas......
Antwort auf Beitrag Nr.: 38.552.958 von Expertchen007 am 11.12.09 17:21:39tze und da willste nur 20000% haben *fg, wer da mit bei war hat garantiert voll abgespritzt wo die so gestiegen ist
Antwort auf Beitrag Nr.: 38.553.194 von Jamster83 am 11.12.09 17:47:11Da war die Hose bestimmt ordentlich nass...soweit ich aber noch weiß...war in D keiner dabei den ich kennen würde......Handel war seinerzeit nur in USA OTC......dort gibts wohl paar neue Millionäre seitdem.....ist halt Biotech....eine richtige Meldung und alles ist anders......gibt aber auch andere Beispiele...wo eine Meldung alles zerlegt hat....
Antwort auf Beitrag Nr.: 38.552.855 von Expertchen007 am 11.12.09 17:13:34hi all,
wo es zuckt , bist du dabei , sei gegrüßt .
wo es zuckt , bist du dabei , sei gegrüßt .
Antwort auf Beitrag Nr.: 38.553.256 von Expertchen007 am 11.12.09 17:53:38ja leider wie immer hop oder top.
aber mal ehrlich die warscheinlichkeit mal ein euro mit aktien zu machen ist besser als lotto zuspielen( da verliere ich nur hrr)
aber mal ehrlich die warscheinlichkeit mal ein euro mit aktien zu machen ist besser als lotto zuspielen( da verliere ich nur hrr)
Antwort auf Beitrag Nr.: 38.553.316 von jarek_1 am 11.12.09 17:59:57Na klar...muss ja meine Brötchen verdienen...bin aber schon länger investiert....haste noch nicht genug von Neomedia.....das wird doch nix dort....schau ich mir schon ne ganze Weile an....auf gehts hau hier rein...kann eine Chance in 2010 werden....weil mal was neues
Antwort auf Beitrag Nr.: 38.553.346 von Jamster83 am 11.12.09 18:03:53Lotto Chance 1 : 140 000 000...Börse dürfte etwas besser abschneiden...nur Jahresende da kann nix verdient werden....so ab Mitte Januar geht das Spiel dann von vorne los....jetzt kann man nur den Grundstock legen
Antwort auf Beitrag Nr.: 38.553.436 von Expertchen007 am 11.12.09 18:15:05der meinung bin ich auch,naja und zu neomedia, ich vermute mal da sollte man bisle zeit mitbringen so 1-2 jährchen noch. aber solange da nicht irgend welche daten kommen sieht es eh mau aus, wie überall halt
Ich denke das wird heut ne Nullnummer.
Nichts desto trotz war das diese Woche der Anfang der Erfolgsstory!
Die Zukunft von Cord Blood ist meiner Ansicht nach gesichert. Bin ebenfalls der Meinung vieler Anderen hier, das die Ära Anfang 2010 so richtig beginnt. Vorher sollte man aber unbedingt investiert sein, billiger kommt man nicht mehr ran.
Schönes Wochenende
Cleffy
Nichts desto trotz war das diese Woche der Anfang der Erfolgsstory!
Die Zukunft von Cord Blood ist meiner Ansicht nach gesichert. Bin ebenfalls der Meinung vieler Anderen hier, das die Ära Anfang 2010 so richtig beginnt. Vorher sollte man aber unbedingt investiert sein, billiger kommt man nicht mehr ran.
Schönes Wochenende
Cleffy
Antwort auf Beitrag Nr.: 38.554.228 von Cleffy am 11.12.09 19:55:34na dann hoffen wir mal und halten uns an der nabelschnur...!
Für einen Freitag aber ein schöner SK
Wo soll das nur hinführen?
Glück auf!
Wo soll das nur hinführen?
Glück auf!
Antwort auf Beitrag Nr.: 38.553.418 von Expertchen007 am 11.12.09 18:13:02bin bei beiden investiert und glaube auch an beide Unternehmen ...... bin gespannt was hier und dort noch so geht
zur kenntnis genommem
Published: December 11,2009Send to a friend
Cord Blood America to Open "State of the Art" Cryogenic Lab in Las Vegas
By Traci Hogg
Cord Blood America (CBAI.OB) opens its state of the art cryogenic lab in Las Vegas next month. This is big news for the cord blood storage industry as the lab has the potential to be one of the largest, if not the largest, banking lab in the US.
Cord Blood America is the parent company of CorCell Companies, Inc., which was the first licensed private cord blood bank in the USA. CorCell has been dedicated to cord blood preservation since 1995.
Since 2006, Cord Blood America has merged several cord blood banks into CorCell - most notably, Cord Partners of Los Angeles, CA, CORD of Long Island, NY, and CureSource of Charleston. Today, CBAI safeguards cord blood stem cells for over 20,000 customers.
CorCell is an industry leader in private cord blood banking services. It processes and stores your baby's cord blood under FDA cord blood requirements using Good Manufacturing Practice Standards (cGMP), a higher processing standard than that of many other cord blood banks. This means your baby's cord blood will not only be viable for current therapies, but will meet the standards of future therapies that are currently being researched and developed today.
Their program credentials include:
Experience in private family cord blood banking since 1995.
Licensed, accredited and FDA registered lab facility that is a leader in cellular engineering.
Safe, reliable, easy-to-use collection procedure.
History of cord blood collections nationwide and internationally.
Successful track record of cord blood transplants,
First Known autologous transplant worldwide for childhood leukemia.
Discounts through health insurance.
I wish I had learned about cord blood banking in time to make use of it. I was pregnant with twin boys, one of which had a serious heart defect and sadly, he passed away. Years have passed and we now have two beautiful boys. It would have certainly relieved our concerns if we had cord blood stored for our children, but we were not counseled about it, and it is too late for our family. But I'd encourage others to take the opportunity to protect your baby's future and store their cord blood. This one simple, painless step can make all the difference if it is ever needed. Medical advancements are happening quickly, making what was once incurable... curable.
Here is one recent example of how cord blood reversed Cerebral Palsy in a Colorado child:
www.fox2548.com
Cord Blood America is one of those penny stocks that will allow you to sleep at night. They have always been current with SEC filings and Matthew Schissler, CEO, keeps investors up-to-date with interviews and PR's. They have been paying down debt in 2009 and are on their way to becoming cash flow positive. A recent press release from the company states, "Our 2010 business strategy involves a shift in focus to acquiring more assets, organic growth and diversification and increase of our revenue streams."
With stem cell advances in the news almost daily, and the new lab opening in just over a month, the possibilities are endless. More and more new parents will start storing their baby's cord blood and protecting their future health.
Disclosure: Writer is Long CBAI.OB
http://newsblaze.com/story/20091211153708trho.nb/topstory.ht…
Published: December 11,2009Send to a friend
Cord Blood America to Open "State of the Art" Cryogenic Lab in Las Vegas
By Traci Hogg
Cord Blood America (CBAI.OB) opens its state of the art cryogenic lab in Las Vegas next month. This is big news for the cord blood storage industry as the lab has the potential to be one of the largest, if not the largest, banking lab in the US.
Cord Blood America is the parent company of CorCell Companies, Inc., which was the first licensed private cord blood bank in the USA. CorCell has been dedicated to cord blood preservation since 1995.
Since 2006, Cord Blood America has merged several cord blood banks into CorCell - most notably, Cord Partners of Los Angeles, CA, CORD of Long Island, NY, and CureSource of Charleston. Today, CBAI safeguards cord blood stem cells for over 20,000 customers.
CorCell is an industry leader in private cord blood banking services. It processes and stores your baby's cord blood under FDA cord blood requirements using Good Manufacturing Practice Standards (cGMP), a higher processing standard than that of many other cord blood banks. This means your baby's cord blood will not only be viable for current therapies, but will meet the standards of future therapies that are currently being researched and developed today.
Their program credentials include:
Experience in private family cord blood banking since 1995.
Licensed, accredited and FDA registered lab facility that is a leader in cellular engineering.
Safe, reliable, easy-to-use collection procedure.
History of cord blood collections nationwide and internationally.
Successful track record of cord blood transplants,
First Known autologous transplant worldwide for childhood leukemia.
Discounts through health insurance.
I wish I had learned about cord blood banking in time to make use of it. I was pregnant with twin boys, one of which had a serious heart defect and sadly, he passed away. Years have passed and we now have two beautiful boys. It would have certainly relieved our concerns if we had cord blood stored for our children, but we were not counseled about it, and it is too late for our family. But I'd encourage others to take the opportunity to protect your baby's future and store their cord blood. This one simple, painless step can make all the difference if it is ever needed. Medical advancements are happening quickly, making what was once incurable... curable.
Here is one recent example of how cord blood reversed Cerebral Palsy in a Colorado child:
www.fox2548.com
Cord Blood America is one of those penny stocks that will allow you to sleep at night. They have always been current with SEC filings and Matthew Schissler, CEO, keeps investors up-to-date with interviews and PR's. They have been paying down debt in 2009 and are on their way to becoming cash flow positive. A recent press release from the company states, "Our 2010 business strategy involves a shift in focus to acquiring more assets, organic growth and diversification and increase of our revenue streams."
With stem cell advances in the news almost daily, and the new lab opening in just over a month, the possibilities are endless. More and more new parents will start storing their baby's cord blood and protecting their future health.
Disclosure: Writer is Long CBAI.OB
http://newsblaze.com/story/20091211153708trho.nb/topstory.ht…
Antwort auf Beitrag Nr.: 38.555.229 von Skrollein am 11.12.09 22:15:07immer nach norden
war ja ein schöner kampf um die 0,007 sk 0,0071 dann doch erreicht, gewinnmitnahmen und trotzdem positiver sk
Antwort auf Beitrag Nr.: 38.556.127 von CLICKTO am 12.12.09 10:47:15sehr schöner Verlauf..........hast BM
Sollte es wirklich wahr werden, dass ich hier mit CBAI und auch mit Motion Network gleich auf 2 Perlen im Hot-Stock-Bereich gestoßen bin
Bin gespannt auf die nächsten Wochen
Glück auf!
Bin gespannt auf die nächsten Wochen
Glück auf!
Antwort auf Beitrag Nr.: 38.560.016 von Skrollein am 13.12.09 22:25:27Kann passieren das es so kommt....
Antwort auf Beitrag Nr.: 38.561.471 von Expertchen007 am 14.12.09 10:54:15weshalb bist Du eher der Meinung, dass es ab Mitte Januar hoch geht?
etwa weil dann der neue Gebäudekomplex in Betrieb genommen wird?
bin schon investiert, aber könnte noch´n bischen nachlegen
etwa weil dann der neue Gebäudekomplex in Betrieb genommen wird?
bin schon investiert, aber könnte noch´n bischen nachlegen
Antwort auf Beitrag Nr.: 38.562.220 von Tom06 am 14.12.09 12:44:36Geanau das ist ein wesentlicher Grund für mich...denn ab dann kann auch Umsatz gemacht werden.....
in Berlin 2 K zu 0,006 € gelaufen...macht wohl einer Witzchen...bisschen Kursmanipulation - aber sieht nett aus ...
in Berlin 2 K zu 0,006 € gelaufen...macht wohl einer Witzchen...bisschen Kursmanipulation - aber sieht nett aus ...
CBAI; A good Stem Cell play for the long
Dec 13, 2009 08:26 PM GMT
Cord Blood America is a holdings company with several subsidiaries including CorCell which already has stem cell collection facilities in all 50 cont states as well as other international locations. With approximately 20,000 customers already and a recent strategic alliance with blue cross/blue shield, this company is already well established in a market that is about to be booming. Recent news is Jan 2010 CorCell is opening possibly the largest cryogenic stem cell lab in America which will increase the capacity for customer base and also saves internal costs they had been incurring outsourcing long-term storage with other companies. This company has really paid down its debt this year and furthermore is looking at turning a potential profit as soon as next year(2010). Also worth mentioning is that the company is pretty good with PR keeping positive press releases on the regular.
I would suspect and hope for a R/S somewhere in the area of 5:1 to bring their share count down to a reasonable number and perhaps to assist with meeting requirements for getting them out of the OTC market.
Rough guesstimate;
1 year target = .10
3 year target = $7 (With R/S)
5 year target = $18
I do not think this is unreasonable and in fact may be conservative. Without a question there are going to be some huge plays on Stem Cell technology over the next decade and I believe that with CBAI’s diversification and sector wide market they could be one of the big stem cell plays of tomorrow.
Author is long on CBAI and similar biotech stocks such as GERN, ACTC, CTIC & HLCS
http://www.socialpicks.com/ideas/show/264894
Dec 13, 2009 08:26 PM GMT
Cord Blood America is a holdings company with several subsidiaries including CorCell which already has stem cell collection facilities in all 50 cont states as well as other international locations. With approximately 20,000 customers already and a recent strategic alliance with blue cross/blue shield, this company is already well established in a market that is about to be booming. Recent news is Jan 2010 CorCell is opening possibly the largest cryogenic stem cell lab in America which will increase the capacity for customer base and also saves internal costs they had been incurring outsourcing long-term storage with other companies. This company has really paid down its debt this year and furthermore is looking at turning a potential profit as soon as next year(2010). Also worth mentioning is that the company is pretty good with PR keeping positive press releases on the regular.
I would suspect and hope for a R/S somewhere in the area of 5:1 to bring their share count down to a reasonable number and perhaps to assist with meeting requirements for getting them out of the OTC market.
Rough guesstimate;
1 year target = .10
3 year target = $7 (With R/S)
5 year target = $18
I do not think this is unreasonable and in fact may be conservative. Without a question there are going to be some huge plays on Stem Cell technology over the next decade and I believe that with CBAI’s diversification and sector wide market they could be one of the big stem cell plays of tomorrow.
Author is long on CBAI and similar biotech stocks such as GERN, ACTC, CTIC & HLCS
http://www.socialpicks.com/ideas/show/264894
Heut kommt die 0,008 US$ in Sichtweite...eventuell wird die auch mal geknackt...ist ja jede Menge Luft nach oben noch drin.....
Antwort auf Beitrag Nr.: 38.563.082 von Expertchen007 am 14.12.09 15:04:52Weshalb könnte ein Unternehmen einen R/S durchführen?
Welche Vorteile ergeben sich dadurch bzw. welche Motivation steckt dahinter?
Der Wert bleibt ja im Verhältnis gleich.
Welche Vorteile ergeben sich dadurch bzw. welche Motivation steckt dahinter?
Der Wert bleibt ja im Verhältnis gleich.
Antwort auf Beitrag Nr.: 38.563.303 von Tom06 am 14.12.09 15:31:55Im Regalfall dient es der Kapitalbeschaffung in anderen Fällen ist es eine Kosmetik für instu. Anlegen - je nachdem....bei einem neuen Unternehmen wie Cord...kann es sehr von Vorteil sein...aber ist alles Zukuntfsmusik...wenn es mal 0,10 US$ vor R/S sind...dann waren es bereits rund 1800 % plus bis dahin....ist ja auch schon mal was
Antwort auf Beitrag Nr.: 38.563.392 von Expertchen007 am 14.12.09 15:40:10bei 0,10 bis 0,30 wäre es auch wohl richtig einen rs durchzuführen nur meine meinung
Antwort auf Beitrag Nr.: 38.563.455 von CLICKTO am 14.12.09 15:45:40Aber absolut richtig...bis dahin ist aber noch " bisschen Zeit " .....obwohl das auch mal schnell gehen kann...dann ärgert es mich allerdings doch keine 5 Mio. Anteile zu haben...aber alles geht halt nicht
Na heute läuft das Volumen aber schön gleichmässig rein....SK sollte die 0,008 US$ + sein
Antwort auf Beitrag Nr.: 38.563.525 von Expertchen007 am 14.12.09 15:54:07bis jetzt läufts gut und mal sehen was die amis aus den ganzen news machen, viele sind ja überzeugt von cbai , ich auch
und durch die 8
Antwort auf Beitrag Nr.: 38.563.644 von CLICKTO am 14.12.09 16:04:59Hmmmm....überleg gerade was anderes zu verkaufen um weiter Cord zu erhöhen....keine einfache Entscheidung...immerhin rund 85 % mehr als letzte Woche zahlen in USA
Antwort auf Beitrag Nr.: 38.563.670 von Expertchen007 am 14.12.09 16:07:22wär nicht wagt, gewinnt auch nichts ,habe auch umgeschichtet
Antwort auf Beitrag Nr.: 38.563.688 von CLICKTO am 14.12.09 16:10:01wohl war...allerdings würde mir ein anderer Wert erst mal 5 K Verlust reinhauen....na ja wieder die 26,8 % zurück...dann könnt ich allerdings rund 2 Mio Anteile aufstocken...heiße Geschichte
0,0082 US$ = 0,0056 €......
Umsätze sind jetzt um einiges geringer als beim letzten Anstieg auf 0,01$.
Erwarte nun schnell die 0,018 vom Beginn des Jahres 09.
Erwarte nun schnell die 0,018 vom Beginn des Jahres 09.
Antwort auf Beitrag Nr.: 38.563.714 von Digedanium am 14.12.09 16:13:02Das wäre ein Zwischenziel mal wieder....
lange wird sich das Bid mit 0,005 € wohl in D nicht mehr halten können
Stuttgart Rt
Geld Brief
Taxe 0,005 0,006
Stückzahl 475.000 Stk. 1.660.000 Stk.
Taxierungszeitpunkt 14.12.2009 16:21:07 Uhr
akt./rel. Spread 0,001 20,000%
Kursdaten
Börsenplatz Stuttgart
Last 0,006bB 1.000.000 Stk.
Geld Brief
Taxe 0,005 0,006
Stückzahl 475.000 Stk. 1.660.000 Stk.
Taxierungszeitpunkt 14.12.2009 16:21:07 Uhr
akt./rel. Spread 0,001 20,000%
Kursdaten
Börsenplatz Stuttgart
Last 0,006bB 1.000.000 Stk.
nun gehts aber echt flott voran
Antwort auf Beitrag Nr.: 38.564.006 von Expertchen007 am 14.12.09 16:45:55schöner verlauf,trotz gewinnmitnahmen , der kurs steigt weiterund wenn die verkäufer panik kriegen ,kaufen sie sie teurer zurück
wegen mir darf der Wert ruhig noch mal richtig zurückkommen...wenigstens bis ich alle Einkäufe erledigt habt...aber ob er es tut ist die andere Frage
Antwort auf Beitrag Nr.: 38.564.099 von Expertchen007 am 14.12.09 16:54:45ja schwere entscheidung , nachkaufen oder warten , ach scheisse ich hole mir noch welche, bevor es teurer wird
kommt der 0,007 € Step heute schon ??? Etwas zu hoch noch...aber wegen mir
Taxe 0,005 0,007
Stückzahl 475.000 Stk. 122.057 Stk.
Taxierungszeitpunkt 14.12.2009 17:16:15 Uhr
akt./rel. Spread 0,002 40,000%
Kursdaten
Börsenplatz Stuttgart
Last 0,006 910.990 Stk.
Kurszeit 14.12.2009 17:15:54 Uhr
Taxe 0,005 0,007
Stückzahl 475.000 Stk. 122.057 Stk.
Taxierungszeitpunkt 14.12.2009 17:16:15 Uhr
akt./rel. Spread 0,002 40,000%
Kursdaten
Börsenplatz Stuttgart
Last 0,006 910.990 Stk.
Kurszeit 14.12.2009 17:15:54 Uhr
Antwort auf Beitrag Nr.: 38.564.251 von CLICKTO am 14.12.09 17:12:44würde es aufsplitten..falls er doch zurückkommt....denke diese Woche " könnte " es nochmal billiger werden...in USA ist es ja nicht wie hier das die auch mal über die Möglichkeit eines Kurses von 0,10 US$..Diskutieren...nein...dort ist gleich mal die 18 US$ das Thema...USA halt
-ansonsten ist die 0,0085 US$ eine Hürde..ok..wenn die fällt sag ich auch nächster Step ist 0,010 US$..aber fällt die wirklich ????
-ansonsten ist die 0,0085 US$ eine Hürde..ok..wenn die fällt sag ich auch nächster Step ist 0,010 US$..aber fällt die wirklich ????
Antwort auf Beitrag Nr.: 38.564.335 von Expertchen007 am 14.12.09 17:23:32ja ich splitte auch meistens, und halte etwa 20 des einsatzes zurück um evt zu verbilligen und wenn er steigt umso besser dann habe ich noch 20% frei für einen anderen wert , die 85 sind schwer zu knacken aber vieleicht klappts ja auch , bei den amis weiss mann /frau nie , diese amis
Antwort auf Beitrag Nr.: 38.564.335 von Expertchen007 am 14.12.09 17:23:32klar fällt die 0,0085 ,ist reine zeitsache
Antwort auf Beitrag Nr.: 38.564.447 von CLICKTO am 14.12.09 17:34:23...das schon...aber Frage ist wieviel Zeit die brauch...wie gesagt..mir wäre es aus Eigennutz auch Recht wenns erst mal einen steilen Bogen nach unten geht....in 2010 möcht ich das aber dann nicht mehr sehen...jetzt schon....
Antwort auf Beitrag Nr.: 38.564.505 von Expertchen007 am 14.12.09 17:39:53 ist blöde wenn man billig kaufen will, und der kurs macht nicht mit vieleicht klappt es ja noch
knapp 100 Millionen !!! Anteile in USA gehandelt....sauber
Antwort auf Beitrag Nr.: 38.564.541 von CLICKTO am 14.12.09 17:43:06stimmt !!!!!....0,0085 US$ wieder...nun wirds wieder heikel werden.....
Antwort auf Beitrag Nr.: 38.564.587 von Expertchen007 am 14.12.09 17:47:18dann könnten heute ja um die 200 mill gehandelt werden
nun ist es passiert - die 0,0085 ist erst mal gefallen,....bin ja gespannt was aus der Prognose nun wird
Antwort auf Beitrag Nr.: 38.564.600 von Expertchen007 am 14.12.09 17:48:45sauber
Antwort auf Beitrag Nr.: 38.564.655 von Expertchen007 am 14.12.09 17:55:12prognossen hin oder her ich warte erstmal auf die richtigen zocker hier ...... paar sind ja schon da
Antwort auf Beitrag Nr.: 38.564.689 von Expertchen007 am 14.12.09 17:58:19sieht gut aus und zieht an
Antwort auf Beitrag Nr.: 38.564.696 von CLICKTO am 14.12.09 17:59:49ja...wird wohl auch in Richtung 0,010 US$ bereits heute gehen...kommen immer mehr Käufer rein
Antwort auf Beitrag Nr.: 38.564.728 von Expertchen007 am 14.12.09 18:03:17haste noch zugekauft ?
Antwort auf Beitrag Nr.: 38.564.743 von CLICKTO am 14.12.09 18:04:55Nein noch nicht....wenns bis 0,10 mal wirklich gehen sollte ist noch Zeit....oder bzw. wenns dann dort ist hat sich das ganze auch gelohnt...kann man so oder so sehen....erst mal dabei sein ist wichtiger....
Antwort auf Beitrag Nr.: 38.564.765 von Expertchen007 am 14.12.09 18:07:12haste auch recht, ( nicht zu gierig werden ) machen schon die verkäufer die teurer nachkaufen, auf jeden fall sollte man investiert sein ,bevor das labor eröffnet ,die tage sind gezählt !!!! 18 januar 2010 bis dahin ist wenig zeit, aber viel fantasie siehe usa
Haua jetzt gehts wohl in die Richtung mit einer " 0 " weniger hinterm Komma...
Antwort auf Beitrag Nr.: 38.564.830 von Expertchen007 am 14.12.09 18:14:38wäre nicht schlecht ,dann kommt stimmung auf, und kaufpanik hoffe ich
kleine verschaufpause und dann angriff die 2te auf die neun
Antwort auf Beitrag Nr.: 38.564.869 von CLICKTO am 14.12.09 18:19:13
ist das aufregend! bin noch nicht mal eine woche dabei und schon dieser run!
freybel
ist das aufregend! bin noch nicht mal eine woche dabei und schon dieser run!
freybel
ist schon weichnachten
das sieht ja super aus,
das ist erst der anfang!
wir werden nächstes jahr uns im 10cent bereich bewegen hoffentlich
stammzellen wird in den nächsten jahren boomen.
das wird das medizinboom des jahrhunderts
und wir hoffen das cord blood zu einem gigant wird
das sieht ja super aus,
das ist erst der anfang!
wir werden nächstes jahr uns im 10cent bereich bewegen hoffentlich
stammzellen wird in den nächsten jahren boomen.
das wird das medizinboom des jahrhunderts
und wir hoffen das cord blood zu einem gigant wird
9 durch
Antwort auf Beitrag Nr.: 38.564.995 von CLICKTO am 14.12.09 18:36:05und ich dachte die brauchen 3 - 5 anläufe
und noch keine weitere news in sichtweite ,die müssten noch was bringen wie schulden weiter abgebaut oder ganz getillt
die will nicht aufhören zu steigen...nicht zu glauben..SK 0,008 + US$ hätte auch gereicht....
Stuttgart fällt wohl bald die 0,007 € dann
Stuttgart fällt wohl bald die 0,007 € dann
wie gesagt die 0,0085 US$ war dei Hürde..was danach kommt war mit Ansage
Antwort auf Beitrag Nr.: 38.565.041 von Expertchen007 am 14.12.09 18:42:03dann........ gibts die 8 oder 9 oder 10 usw
Bei mir steht sogar Stammzellenwerbung rechts im WO !!!! Vita34
in Stuttgart gabs gerade rund 700 K zu 0,006 €...sogar unter USA Pari...auch mal selten so andersherum....
Antwort auf Beitrag Nr.: 38.565.135 von Expertchen007 am 14.12.09 18:55:05Altooschanelli !!!!
Da biste mal fast den ganzen Tag nur unterwegs, setzt dich an den PC und dann das!!!
Meine Perle kullert wacker immer weiter nach oben
Gezz Bier aufm Tisch und Prost!
Glück auf!
Da biste mal fast den ganzen Tag nur unterwegs, setzt dich an den PC und dann das!!!
Meine Perle kullert wacker immer weiter nach oben
Gezz Bier aufm Tisch und Prost!
Glück auf!
Antwort auf Beitrag Nr.: 38.565.308 von Skrollein am 14.12.09 19:17:49Wo bleiben die
Antwort auf Beitrag Nr.: 38.565.411 von Scania01 am 14.12.09 19:33:05O.K. Bier und
Greif zu!
Glück auf!
Greif zu!
Glück auf!
das obere Bollingerband durchbrochen!
Mal sehen, ob der Trend anhält.....
Mal sehen, ob der Trend anhält.....
CBAI.ob: Shares of Cord Blood America have been on the move to the upside over the past few weeks after the the umbilical cord blood stem cell preservation company recently announced that it's Las Vegas corporate office and laboratory will be open for business on January 22, 2010.
Stem cell research has gained traction in both the political and commercial arenas, and purchasing a few 'night on the town' shares of a company that could be getting a head start on the storage aspect of the market could pay off pretty good over the mid to long term, while there is also some short term potential for the stock to move higher as the January 22 grand opening date approaches.
The biggest question that potential investors have when playing with the penny plays is whether or not the company is for real or not; meaning does the company actually follow through on the promises of the press releases. I followed 'Cord Blood America' for a while before buying in and I'm pretty convinced that these guys are legit; but firm dates such as the January 22nd grand opening allow us the opportunity to see if the company can follow through on its promises.
If nothing else, the stock should be hyped and pumped between now and the third week of January - I've already seen CBAI popping up in message board discussion - and that could offer investors and traders the opportunity to flip a few shares and possibly end up on house money before long.
The stock is still trading for below a penny, but has moved up recently.
Definitely a risky play, but one with some potential, in my opinion.
Disclosure: VFC is long CBAI.
Stem cell research has gained traction in both the political and commercial arenas, and purchasing a few 'night on the town' shares of a company that could be getting a head start on the storage aspect of the market could pay off pretty good over the mid to long term, while there is also some short term potential for the stock to move higher as the January 22 grand opening date approaches.
The biggest question that potential investors have when playing with the penny plays is whether or not the company is for real or not; meaning does the company actually follow through on the promises of the press releases. I followed 'Cord Blood America' for a while before buying in and I'm pretty convinced that these guys are legit; but firm dates such as the January 22nd grand opening allow us the opportunity to see if the company can follow through on its promises.
If nothing else, the stock should be hyped and pumped between now and the third week of January - I've already seen CBAI popping up in message board discussion - and that could offer investors and traders the opportunity to flip a few shares and possibly end up on house money before long.
The stock is still trading for below a penny, but has moved up recently.
Definitely a risky play, but one with some potential, in my opinion.
Disclosure: VFC is long CBAI.
guten morgen
sind ja gestern fast 300 mii umgesetzt worden da haben sich einige fett eingekauft
Antwort auf Beitrag Nr.: 38.567.419 von CLICKTO am 15.12.09 08:49:51der kampf um die 0,009 hat gehalten , bin gespannt was noch kommt
Antwort auf Beitrag Nr.: 38.567.430 von CLICKTO am 15.12.09 08:52:06guten morgen @all!
stuttg. und berlin taxen 0,005 dafür kaufe ich noch welche sofort
Antwort auf Beitrag Nr.: 38.567.445 von CLICKTO am 15.12.09 08:55:08diese blöde Taxerei geht mir echt auf den Keks ..... wenn die wenigstens zu diesem Preis dann auch welche ausgeben würden
oh keiner da ? bei diesen umsätzen , und bei diesen zukunftsaussichten .
na wird sich wohl bald ändern, die ruhe wird vorbei sein , spätestens wenn das pennyland erreicht ist .
na wird sich wohl bald ändern, die ruhe wird vorbei sein , spätestens wenn das pennyland erreicht ist .
0,004 hallo mm was soll das? dafür verkauft keiner
Antwort auf Beitrag Nr.: 38.567.656 von Tom06 am 15.12.09 09:32:46ja das ist schon blöde, und man kriegt nichts zu diesem kurs
gibt kaum einer was ab zu 0,006
Antwort auf Beitrag Nr.: 38.568.695 von CLICKTO am 15.12.09 11:55:43ich hab in der Vergangenheit meine Anteile in USA gekauft....denke da wird man nicht so veräppelt wie hier vom Broker in Berlin
Antwort auf Beitrag Nr.: 38.567.707 von CLICKTO am 15.12.09 09:39:40Hallo all,
heute kleiner Rücksetzer......könnte sein...kommt drauf an was an News nachkommt
heute kleiner Rücksetzer......könnte sein...kommt drauf an was an News nachkommt
Antwort auf Beitrag Nr.: 38.568.909 von Expertchen007 am 15.12.09 12:26:26wir werden sehen was passiert gewinne werden wohl mitgenommen ,mal schauen was die da gegensetzten bis januar ist alles möglich ,je nach news lage ,aber bis jetzt ist es ok. die fast 300 mill von gestern, da möchten auch einige noch im plus landen bzw ca 60 % von dennen . nur meine meinung
Antwort auf Beitrag Nr.: 38.568.909 von Expertchen007 am 15.12.09 12:26:26will ja kein schwarzmaler sehn aber ich denke ende der woche wird es wieder auf den normalen ß,006 cent dümpeln... sieht mir irgend wie nach zock aus.... denke wenn wirklich finazstatus zusehn ist wird das hier intressant.
Antwort auf Beitrag Nr.: 38.570.695 von Jamster83 am 15.12.09 15:57:34Rücksetzer - ja..!!!aber 0,006 US$ glaub ich nicht das es klappt.....
Gibt es noch das Berliner Orderbuch/Markttiefe/Level II. Finde auf deren Seite nichts mehr.
Antwort auf Beitrag Nr.: 38.570.839 von enuxx am 15.12.09 16:10:59Gibts nicht mehr. Hab da angerufen. Naja, Berlin-Börse ist eh Müll.
Antwort auf Beitrag Nr.: 38.570.900 von enuxx am 15.12.09 16:16:48Stimmt - gibts schon ne Weile nicht mehr...warum allerdings kann ich Dir auch nicht sagen...geht eh zumeist über Stuttgart
Heut geht nix....und wer eh nicht vorhat zu verkaufen..dem kanns egal sein.....mir solls recht sein...etwas tiefer noch und ich nehm eine Portion auf
Antwort auf Beitrag Nr.: 38.571.912 von Expertchen007 am 15.12.09 18:11:00gap muss wohl noch geschlossen werden (o,oo72)
sind noch mehr GAPs offen
wird jedoch langfristig alte Höhen
erreichen
schönen Abend
li
wird jedoch langfristig alte Höhen
erreichen
schönen Abend
li
hört sich nicht schlecht an
Cord Blood Stem Cells
A Global Market OverviewProduct Code INX00004
Publication Date October 2009
Publisher Industry Experts
Product Type Report
Pages 230
Buy this product or for assistance call +44 20 7060 7474
PDF £2,660.00$4319 | €2970FAX Order above formats by FAXSummary
Umbilical cord and placenta, once considered medical waste are emerged to be a valuable source of stem cells. The cord blood stem cells show the potential to treat the fatal diseases such as leukemia, cardiac attacks and debilitating diseases including Alzheimer's and Parkinson's. Cord blood stem cells are also widely used in therapies such as blood disorders, bone and tissue engineering, dermatology.
Cord blood stem cell technologies analyzed in this study include Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant. The report is also analyses the global market for stem cell therapeutic areas comprising Neurology, Oncology, Cardiology, Cartilage, Blood Disorders, Diabetes, Dermatology and Other.
Global cord blood stem cells market for 2010 is estimated at about US$4.5 billion. The market is further projected to register a robust CAGR of 27.3% during the period 2006-2015 to reach US$15 billion by 2015. The study includes 129 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the global market value in USD by geographic regions and the product segments.
The report analyses the cord blood stem cells market for global and the regional markets including North America, Europe, Asia-Pacific and Rest of World. The regional markets further analyzed for 21 independent countries across Europe - The United Kingdom, Germany, France, Spain, Russia, Sweden, Switzerland and Rest of Europe; North America - the United States, Canada and Mexico; Asia-Pacific - India, China, Japan, Australia, South Korea, Hong Kong, Singapore and Rest of Asia-Pacific; Rest of World - Brazil, Columbia, Argentina and Israel.
This study profiles 47 key global players and 63 major players across North America - 33; Europe - 10; Asia-Pacific - 15; and Rest of World - 5. The report also provides the listing of the companies engaged in collection, processing and banking of cord blood stem cells. This list also includes the companies engaged in the treatment of deadly diseases using CB stem cells. The global list covers the addresses, contact numbers and the website addresses of 219 private and 75 public cord blood banks.
Major Global Market Players
weiter siehe link
http://www.reportbuyer.com/pharma_healthcare/biotechnology/c…
Cord Blood Stem Cells
A Global Market OverviewProduct Code INX00004
Publication Date October 2009
Publisher Industry Experts
Product Type Report
Pages 230
Buy this product or for assistance call +44 20 7060 7474
PDF £2,660.00$4319 | €2970FAX Order above formats by FAXSummary
Umbilical cord and placenta, once considered medical waste are emerged to be a valuable source of stem cells. The cord blood stem cells show the potential to treat the fatal diseases such as leukemia, cardiac attacks and debilitating diseases including Alzheimer's and Parkinson's. Cord blood stem cells are also widely used in therapies such as blood disorders, bone and tissue engineering, dermatology.
Cord blood stem cell technologies analyzed in this study include Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant. The report is also analyses the global market for stem cell therapeutic areas comprising Neurology, Oncology, Cardiology, Cartilage, Blood Disorders, Diabetes, Dermatology and Other.
Global cord blood stem cells market for 2010 is estimated at about US$4.5 billion. The market is further projected to register a robust CAGR of 27.3% during the period 2006-2015 to reach US$15 billion by 2015. The study includes 129 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the global market value in USD by geographic regions and the product segments.
The report analyses the cord blood stem cells market for global and the regional markets including North America, Europe, Asia-Pacific and Rest of World. The regional markets further analyzed for 21 independent countries across Europe - The United Kingdom, Germany, France, Spain, Russia, Sweden, Switzerland and Rest of Europe; North America - the United States, Canada and Mexico; Asia-Pacific - India, China, Japan, Australia, South Korea, Hong Kong, Singapore and Rest of Asia-Pacific; Rest of World - Brazil, Columbia, Argentina and Israel.
This study profiles 47 key global players and 63 major players across North America - 33; Europe - 10; Asia-Pacific - 15; and Rest of World - 5. The report also provides the listing of the companies engaged in collection, processing and banking of cord blood stem cells. This list also includes the companies engaged in the treatment of deadly diseases using CB stem cells. The global list covers the addresses, contact numbers and the website addresses of 219 private and 75 public cord blood banks.
Major Global Market Players
weiter siehe link
http://www.reportbuyer.com/pharma_healthcare/biotechnology/c…
Antwort auf Beitrag Nr.: 38.572.466 von CLICKTO am 15.12.09 19:14:04Immer mit der Ruhe.....das sind jezt eh nur Kurse die alle vor der Fertigung sind....wenn diese mal läuft und dann so im September 2010 die Zahlen kommen nach und den ersten 2 Quartalen - dann sieht es ja hoffentlich anders aus.....sollte es Cord schaffen sich zu etablieren innerhalb der Branche - " kann " was großes anstehen - sehe dem erst mal relaxt entgegen - alles Zukunftsmusik -wer dabei sein will darf das gerne tun/ - wer der Story nicht traut - einfach nicht kaufen
Nach der gestrigen Korrektur ( die wichtig war )...erwarte ich im SK heute grün...wieviel wird uns der Markt zeigen
Antwort auf Beitrag Nr.: 38.577.269 von Expertchen007 am 16.12.09 13:05:06CT sagt was anderes aus.
http://americanbulls.com/StockPage.asp?CompanyTicker=CBAI&Ma…
http://americanbulls.com/StockPage.asp?CompanyTicker=CBAI&Ma…
Antwort auf Beitrag Nr.: 38.576.244 von Expertchen007 am 16.12.09 11:18:05bin die ruhe selbst ,habe ja gesagt alles ist möglich , aber der artikel zeigt auf gute zukunfsmusik hin bleiben
Antwort auf Beitrag Nr.: 38.577.716 von Scania01 am 16.12.09 13:59:30Mir ist beides irgenwie Recht....wenns steigt...hab ich meine Anteile...wenns fällt werde ich die Bestände erhöhen...insofern kann / darf beides passieren....wie ich sagte mich interessiert was nach dem 2.- Quartal als Kurs da steht...vorher ist alles nur ein Game
Spread in Berlin 0,003 -0,008 €
Cord Blood America Says 2009 Debt Reduction Tops $10 Million
Cord Blood America Says 2009 Debt Reduction Tops $10 Million
Dec. 16, 2009 (PR Newswire) --
Cord Blood America Says 2009 Debt Reduction Tops $10 Million
PR Newswire
LAS VEGAS, Dec. 16
LAS VEGAS, Dec. 16 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has reduced its debt by a total of $1.4 million so far in the fourth quarter of 2009 and total debt eliminated for the year now tops $10 million.
"We said going into this year that reducing debt, and subsequently strengthening our balance sheet, would be a very high priority," said Matthew Schissler, co-founder and CEO. "With more than $10 million in debt retired, we succeeded in this goal and are very pleased to make this announcement to our shareholders."
Cord Blood America recently announced a grand opening of its stem cell laboratory and headquarters in Las Vegas on January 22, 2010. "We can salute this financial achievement as we open perhaps the largest cryogenic storage facility in the U.S.," Mr. Schissler said.
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.
CONTACT:
Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com
Forward-Looking Statements
Some statements made in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as "anticipate,'' "believe,'' "expect,'' "future,'' "intend,'' "plan,'' and similar expressions to identify forward-looking statements. These statements including those related to the growth of the industry, new stem cell treatments, and the Company's performance, are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.
SOURCE Cord Blood America, Inc.
Source: PR Newswire (December 16, 2009 - 9:00 AM EST)
News by QuoteMedia
Cord Blood America Says 2009 Debt Reduction Tops $10 Million
Dec. 16, 2009 (PR Newswire) --
Cord Blood America Says 2009 Debt Reduction Tops $10 Million
PR Newswire
LAS VEGAS, Dec. 16
LAS VEGAS, Dec. 16 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has reduced its debt by a total of $1.4 million so far in the fourth quarter of 2009 and total debt eliminated for the year now tops $10 million.
"We said going into this year that reducing debt, and subsequently strengthening our balance sheet, would be a very high priority," said Matthew Schissler, co-founder and CEO. "With more than $10 million in debt retired, we succeeded in this goal and are very pleased to make this announcement to our shareholders."
Cord Blood America recently announced a grand opening of its stem cell laboratory and headquarters in Las Vegas on January 22, 2010. "We can salute this financial achievement as we open perhaps the largest cryogenic storage facility in the U.S.," Mr. Schissler said.
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.
CONTACT:
Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com
Forward-Looking Statements
Some statements made in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as "anticipate,'' "believe,'' "expect,'' "future,'' "intend,'' "plan,'' and similar expressions to identify forward-looking statements. These statements including those related to the growth of the industry, new stem cell treatments, and the Company's performance, are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.
SOURCE Cord Blood America, Inc.
Source: PR Newswire (December 16, 2009 - 9:00 AM EST)
News by QuoteMedia
Sind doch mal wieder gute NEws...wieder paar Schulden weg...aber woher kommt die Kohle..??? Fragen wir uns ja nun schon länger !!!!
Antwort auf Beitrag Nr.: 38.579.643 von Expertchen007 am 16.12.09 17:13:03naja mit irgend was müssen die ja jetzt schon geld verdienen bzw. ein sponsor haben. woher sollten die sonst in der höhe die schulden verringern.
mein persöhnliche meinung dazu ist, das ich es gut finde das sie es auch schaffen, immer ein bisschen mehr los zuwerden, wenn das nächstes jahr so weiter geht. wie ich schon erwähnt hatte wird der finanzbericht garantiert nett aussehn
mein persöhnliche meinung dazu ist, das ich es gut finde das sie es auch schaffen, immer ein bisschen mehr los zuwerden, wenn das nächstes jahr so weiter geht. wie ich schon erwähnt hatte wird der finanzbericht garantiert nett aussehn
der kurs könnte aber dadrauf reagieren
oder sucht neuen boden was meint ihr?
oder sucht neuen boden was meint ihr?
Es gibt wohl Adressen, die den Kurs einfach nicht viel weiter oben sehen wollen.
Schaut euch mal den scheiss Drückerkurs an!!!
Antwort auf Beitrag Nr.: 38.580.370 von Stimmungskanone am 16.12.09 18:21:57das glaube ich auch!!
weil hier hunderte millionen überm tisch gehen!
VOLUMEN IST JA DA
aber der kurs wird gedrückt bis die gewissen herren genug
eingesackt haben!!!
dann geht es richtig los!
ich lege nochmals welche für 0,005 eurocent nach
wenn der bei 0,0074 richtung bleiben sollte
wir werden noch viel freude mit cord haben,
jetzt wird erstmal eingesammelt
bis es richtig up geht....
weil hier hunderte millionen überm tisch gehen!
VOLUMEN IST JA DA
aber der kurs wird gedrückt bis die gewissen herren genug
eingesackt haben!!!
dann geht es richtig los!
ich lege nochmals welche für 0,005 eurocent nach
wenn der bei 0,0074 richtung bleiben sollte
wir werden noch viel freude mit cord haben,
jetzt wird erstmal eingesammelt
bis es richtig up geht....
Antwort auf Beitrag Nr.: 38.580.531 von lilie31 am 16.12.09 18:36:42Wo kaufst du eigentlich, in Deutschland oder in Amerika?
Antwort auf Beitrag Nr.: 38.580.723 von Scania01 am 16.12.09 18:56:45Bei Aldi!
Antwort auf Beitrag Nr.: 38.580.837 von Stimmungskanone am 16.12.09 19:08:37Liegt das an CBAI?
Bei 0,0075 scheint der Boden gefunden zu sein!
Antwort auf Beitrag Nr.: 38.580.531 von lilie31 am 16.12.09 18:36:42sag mir Bescheid wenns mit 0,005 € geklappt hat...da wirste warten müssen....
Immer weiter runter ! Saupack!
Antwort auf Beitrag Nr.: 38.580.903 von Stimmungskanone am 16.12.09 19:15:55Der Schein trügt!
Heute noch riesen rebound!!!!?????
Antwort auf Beitrag Nr.: 38.581.068 von Stimmungskanone am 16.12.09 19:33:41
Antwort auf Beitrag Nr.: 38.581.068 von Stimmungskanone am 16.12.09 19:33:41Darf Dir verkünden Du hast es nach rund 12 Monaten aus meiner IGNORE Liste herraus geschafft.....aber nur zur Bewährung....
passiert nicht sehr oft...das da einer rauskommt...sind aber immer noch sehr viele drin...eingesperrt sozusagen...
passiert nicht sehr oft...das da einer rauskommt...sind aber immer noch sehr viele drin...eingesperrt sozusagen...
Antwort auf Beitrag Nr.: 38.580.419 von Stimmungskanone am 16.12.09 18:26:13SEHR GUT !!
das gap bei 73 ist dicht !!
das gap bei 73 ist dicht !!
Antwort auf Beitrag Nr.: 38.581.734 von itsSHOWTIME am 16.12.09 20:43:26aus dem jahresabschluss 2008 / vita 34
Des Weiteren übernimmt die VITA 34 International AG die Garantie, dass Corcell, Inc. sämtliche Zahlungsverpflichtungen aus der Transaktion mit Cord Blood America nachkommt. Die Garantieverpflichtung endet spätestens am 31.03.2010 und ist auf einen Gesamtbetrag in Höhe von TUSD 3.770 begrenzt.
Des Weiteren übernimmt die VITA 34 International AG die Garantie, dass Corcell, Inc. sämtliche Zahlungsverpflichtungen aus der Transaktion mit Cord Blood America nachkommt. Die Garantieverpflichtung endet spätestens am 31.03.2010 und ist auf einen Gesamtbetrag in Höhe von TUSD 3.770 begrenzt.
aktueller zwischenbericht vita 34:
ir.vita34.de/download/.../vita34/.../DE000A0BL849-Q3-2009-EQ-D-00.pdf
s. insbesondere seite 19 / finanzerträge: Tilgung der ausgereichten Darlehen durch Cord Blood America ....
interessant irgendetwas scheint die beiden unternehmen auch finanziell miteinander zu verbinden.
das wäre doch mal ein knaller, wenn vita und cbai eine kooperation oder ähnliches verkünden würden ....
ir.vita34.de/download/.../vita34/.../DE000A0BL849-Q3-2009-EQ-D-00.pdf
s. insbesondere seite 19 / finanzerträge: Tilgung der ausgereichten Darlehen durch Cord Blood America ....
interessant irgendetwas scheint die beiden unternehmen auch finanziell miteinander zu verbinden.
das wäre doch mal ein knaller, wenn vita und cbai eine kooperation oder ähnliches verkünden würden ....
Antwort auf Beitrag Nr.: 38.580.723 von Scania01 am 16.12.09 18:56:45sorry scania,
ich habe dein posting heute gesehen!
IN DEUTSCHLAND!
wie kauft ihr denn, in amerika?
über cortal consors?
habe einen depo bei VOLKSBANK!
leider bieten die sowas nicht an
ich habe dein posting heute gesehen!
IN DEUTSCHLAND!
wie kauft ihr denn, in amerika?
über cortal consors?
habe einen depo bei VOLKSBANK!
leider bieten die sowas nicht an
Antwort auf Beitrag Nr.: 38.584.302 von lilie31 am 17.12.09 09:30:46
ich habe mein depot auch bei einer volksbank. da kannst du ohne probleme auch in den staaten ordern. klappt 100 %-ig - und günstig.
frag` doch noch mal deinen banker = das ist sicherlich auch bei deiner volksbank möglich !!!
ich habe mein depot auch bei einer volksbank. da kannst du ohne probleme auch in den staaten ordern. klappt 100 %-ig - und günstig.
frag` doch noch mal deinen banker = das ist sicherlich auch bei deiner volksbank möglich !!!
übrigens: wenn du heute kaufen möchtest = heute wurden schon mehrere stücke in d zu 5 gehandelt. das sind fast 10 % unter pari.
vielleicht hast du ja noch glück.
vielleicht hast du ja noch glück.
Antwort auf Beitrag Nr.: 38.584.471 von itsSHOWTIME am 17.12.09 09:46:19danke
Antwort auf Beitrag Nr.: 38.584.451 von itsSHOWTIME am 17.12.09 09:44:01ich habe mein depot auch bei einer volksbank. da kannst du ohne probleme auch in den staaten ordern. klappt 100 %-ig - und günstig.
Ja sehr günstig...nur so rund 50 Euro / Trade...sehr günstig
Cortal 19,90...oder wenn USA Depot...( cortal Partner ) ...ab 4,95 US$ / Trade
Ja sehr günstig...nur so rund 50 Euro / Trade...sehr günstig
Cortal 19,90...oder wenn USA Depot...( cortal Partner ) ...ab 4,95 US$ / Trade
Antwort auf Beitrag Nr.: 38.581.986 von itsSHOWTIME am 16.12.09 21:10:20Danke für die VITA Info...find ich ja äussert interessant....wenns so läuft...wirds richtig gut
itsallbull: Itsallbull.net Featuring Cord Blood America Inc. and Initiates Technical Analysis & Research Coverage
Thu. December 17, 2009; Posted: 04:15 AM
You too can increase your ETF trading!
See the PowerRating of CBAI now and learn how it rates on a 1-10 scale. The higher the PowerRating, the greater potential short-term gain based on historical data.
New York, NY, Dec 17, 2009 (M2 PRESSWIRE via COMTEX) -- CBAI | Quote | Chart | News | PowerRating -- Itsallbull.NET, a leading financial community forum is now featuring Cord Blood America Inc. (OTCBB: CBAI). Cord Blood America Inc. is one of the small cap companies listed in the IAB MCSC Index, which has been over performing the Dow Jones and S&P TSX indices since its inception in September of this year.
Itsallbull.net offers a full suite of quotes, graphs, company information, research reports, corporate videos and message boards. All information including the research report & technical analysis video on Cord Blood America Inc. is available FREE at the following address: http://www.itsallbull.net/boards.php?id=16922&ref=pr" target="_blank" rel="nofollow ugc noopener">http://www.itsallbull.net/boards.php?id=16922&ref=pr
LAS VEGAS, Dec 16, 2009 -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has reduced its debt by a total of $1.4 million so far in the fourth quarter of 2009 and total debt eliminated for the year now tops $10 million.
Contact Us
www.itsallbull.net/contactus.php www.itsallbull.net info@itsallbull.net
About Itsallbull.net
Itsallbull.net is an online financial community forum aimed at providing financial information to money managers, individual investors and analysts. We offer a unique information services to the investment communities by giving them the opportunity to exchange thoughts on boards of publicly traded companies moderated by IR professionals.
Information about forward-looking statements
Please be advised that statements made herein, other than historical data, constitute forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those stated or implied by such forward-looking statements. The potential risks and uncertainties include, among others, potential volatility in the company's stock price, increased competition, customer acceptance of new products and services offered by the company, and uncertainty of future revenue and profitability and fluctuations in its quarterly operating results. Please also be advised that the company's stock is not currently registered with the Securities and Exchange Commission
CONTACT: Itsallbull.net e-mail: info@itsallbull.net WWW: http://www.itsallbull.net
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
For full details for CBAI click here.
More News: Market Updates | Stock Alerts | All Trading News | Stock Index
Thu. December 17, 2009; Posted: 04:15 AM
You too can increase your ETF trading!
See the PowerRating of CBAI now and learn how it rates on a 1-10 scale. The higher the PowerRating, the greater potential short-term gain based on historical data.
New York, NY, Dec 17, 2009 (M2 PRESSWIRE via COMTEX) -- CBAI | Quote | Chart | News | PowerRating -- Itsallbull.NET, a leading financial community forum is now featuring Cord Blood America Inc. (OTCBB: CBAI). Cord Blood America Inc. is one of the small cap companies listed in the IAB MCSC Index, which has been over performing the Dow Jones and S&P TSX indices since its inception in September of this year.
Itsallbull.net offers a full suite of quotes, graphs, company information, research reports, corporate videos and message boards. All information including the research report & technical analysis video on Cord Blood America Inc. is available FREE at the following address: http://www.itsallbull.net/boards.php?id=16922&ref=pr" target="_blank" rel="nofollow ugc noopener">http://www.itsallbull.net/boards.php?id=16922&ref=pr
LAS VEGAS, Dec 16, 2009 -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has reduced its debt by a total of $1.4 million so far in the fourth quarter of 2009 and total debt eliminated for the year now tops $10 million.
Contact Us
www.itsallbull.net/contactus.php www.itsallbull.net info@itsallbull.net
About Itsallbull.net
Itsallbull.net is an online financial community forum aimed at providing financial information to money managers, individual investors and analysts. We offer a unique information services to the investment communities by giving them the opportunity to exchange thoughts on boards of publicly traded companies moderated by IR professionals.
Information about forward-looking statements
Please be advised that statements made herein, other than historical data, constitute forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those stated or implied by such forward-looking statements. The potential risks and uncertainties include, among others, potential volatility in the company's stock price, increased competition, customer acceptance of new products and services offered by the company, and uncertainty of future revenue and profitability and fluctuations in its quarterly operating results. Please also be advised that the company's stock is not currently registered with the Securities and Exchange Commission
CONTACT: Itsallbull.net e-mail: info@itsallbull.net WWW: http://www.itsallbull.net
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
For full details for CBAI click here.
More News: Market Updates | Stock Alerts | All Trading News | Stock Index
Antwort auf Beitrag Nr.: 38.585.154 von Expertchen007 am 17.12.09 10:54:03selber ordern - für`s internet freischalten lassen !!
und schon ist es billiger als bei cortal !!
und schon ist es billiger als bei cortal !!
Antwort auf Beitrag Nr.: 38.585.472 von itsSHOWTIME am 17.12.09 11:22:55Hatte das mal bei der Volksbank...aber billiger wars nicht..ist aber auch egal...jeder wie er denkt !!!
2010 - das Jahr von Cord Blood.......gut möglich
2010 - das Jahr von Cord Blood.......gut möglich
Mit großen Stücken hoch und mit kleinen Orders wieder runter geholt! Scheiss Drückerkolonne!
Nice....wenigstens zum einkaufen...
Antwort auf Beitrag Nr.: 38.588.733 von Expertchen007 am 17.12.09 17:11:04Einkaufen kannst du bei Lidl!
Der Kurs soll jetzt endlich mal durchstarten!
Der Kurs soll jetzt endlich mal durchstarten!
Antwort auf Beitrag Nr.: 38.588.925 von Stimmungskanone am 17.12.09 17:27:25mit dem durchstarten musste noch etwas warten, denke um den 20 januar 2010 ist es soweit, vorher wäre natürlich super ,aber sich jetzt schon mal positionen aufbauen kann nicht schaden , musst natürlich auch verluste und gewinne ertragen können
So GENTA verkauft.....auf gehts mal rüber wieder mit paar hundert K auf der 0,005 € in mein Depot
Antwort auf Beitrag Nr.: 38.588.925 von Stimmungskanone am 17.12.09 17:27:25Der Kurs soll jetzt endlich mal durchstarten
Nein bloss noch nicht....ich bin immer noch nicht fertig mit dem Kaufen der Positionen...wenn dann solls sichs mal richtig lohnen
Nein bloss noch nicht....ich bin immer noch nicht fertig mit dem Kaufen der Positionen...wenn dann solls sichs mal richtig lohnen
Antwort auf Beitrag Nr.: 38.589.651 von Expertchen007 am 17.12.09 18:45:49und ich wollte heute morgen rein bei genta ,habe es dann aber versäumt meine kauforder ek zu erhöhen und der tiefere hat nicht aussgeführt egal habe ich mehr für cbai
Antwort auf Beitrag Nr.: 38.589.782 von CLICKTO am 17.12.09 18:58:15Ja wäre ein gutes Geschäft gewesen...ich war allerdings 48 % im minus heute früh noch...bin aber fast 0/0 jetzt rausgekommen...kein Verlust ist auch ein Gewinn...somit einiges frei für Cord Blood...und das bleibt dann auch schön drin liegen bis Ende 2010...falls nix blödes passiert....
Der Kurs müsste mal deutlich unter die 0,007 US$..dann würde sich USA Kauf wieder rechnen....ist aber auch immer eine blöde Sache...mit dem Pari Kurs
Antwort auf Beitrag Nr.: 38.590.303 von Expertchen007 am 17.12.09 19:55:05ja ich weiss dein ek bei genta war so ca. 0,10 nach splitt, ich wäre auch raus an deiner stelle
Antwort auf Beitrag Nr.: 38.590.331 von CLICKTO am 17.12.09 19:58:23Ja irgendwie Glück gehabt...hätt ich gestern niemals mit gerechnet...insofern bin ich zufrieden...
Tagchen,
so RT im Moment genau 0,007 US$...somit wird nun USA wieder mal interessant ( zum Einkaufen )
so RT im Moment genau 0,007 US$...somit wird nun USA wieder mal interessant ( zum Einkaufen )
Bid in D bei 0,004 €...das wäre natürlich ein Knaller da was abzubekommen...wollen allerdings paar andere auch haben..
Hier paar Infos zu Cord Blood und das drumherum
http://www.youtube.com/results?search_query=cord+blood&searc…
und das hier noch
http://www.nationalpost.com/story.html?id=2238599
Denke die Branche wird an sich echt interessant werden....welche Firma auch immer hier der Gewinner werden sollte.....Cord Blood hat eine Chance dabei zu sein
http://www.youtube.com/results?search_query=cord+blood&searc…
und das hier noch
http://www.nationalpost.com/story.html?id=2238599
Denke die Branche wird an sich echt interessant werden....welche Firma auch immer hier der Gewinner werden sollte.....Cord Blood hat eine Chance dabei zu sein
Volumen mal wieder sehr ordentlich für sie ersten 39 Minuten im Handel
find ich recht erstaunlich. naja gucken wa mal, sind uns ja da alle einig ab wann es warscheinlich intressanter wird;9
Antwort auf Beitrag Nr.: 38.609.969 von Jamster83 am 21.12.09 16:18:46Glaub nicht das der jetzige Kurs interessant ist...ob nun 8 oder 9....sondern die ersten Zahlen in 2010...die werden wichtig...und wie weit kann Cord seine Position auf diesem Markt ausbauen...
wenn wir die 0,009us cent knacken!
dann gibt es run bis 0,015
aber wir bleiben immer bei 0,009 hängen
dann gibt es run bis 0,015
aber wir bleiben immer bei 0,009 hängen
Antwort auf Beitrag Nr.: 38.610.835 von lilie31 am 21.12.09 17:40:12Wie kommst du auf 0,015
Toller Bid-Überhang heute ! Da könnte heut noch die Post abgehen !
Handelsplatz Geld-Stk. Geld Geld-Brief Brief Brief-Stk. Spread Zeit
Stuttgart 1.112.000 0,005 € 0,006 € 885.611 20,00% 11:01:22
Berlin 1.000.000 0,005 € 0,006 € 500.000 20,00% 11:01:20
Nasdaq OTC BB 5.000 0,0071 $ 0,0086 $ 5.000 21,13%
Handelsplatz Geld-Stk. Geld Geld-Brief Brief Brief-Stk. Spread Zeit
Stuttgart 1.112.000 0,005 € 0,006 € 885.611 20,00% 11:01:22
Berlin 1.000.000 0,005 € 0,006 € 500.000 20,00% 11:01:20
Nasdaq OTC BB 5.000 0,0071 $ 0,0086 $ 5.000 21,13%
mal gucken was heute wird
Antwort auf Beitrag Nr.: 38.617.087 von Scania01 am 22.12.09 14:22:12aber sicher ich will ja milliönär werden.
Antwort auf Beitrag Nr.: 38.617.218 von Blade99 am 22.12.09 14:36:59Was für eine Vorstellungskraft.
Milionäre wollen doch alle werden.
Milionäre wollen doch alle werden.
Antwort auf Beitrag Nr.: 38.617.087 von Scania01 am 22.12.09 14:22:12naja, ich würde schon sagen das die lage anders aussieht als 2005. da ja obama die regeln bisle gelockert hat, die ab nächstes jahr das neue labor auf machen, schulden abbauen.... dazu kommt das mit der narbelschnurrblut die leute erst seit letzter zeit was hören da es vermehrt in dokus etc. kommt. also lassen wir uns überrraschen
Antwort auf Beitrag Nr.: 38.617.452 von Jamster83 am 22.12.09 14:58:18Deine Phantasien gehen etwas weiter, wie mir scheint.
Sag mal an, welche Kurse sind für dich akzeptabel.
Sag mal an, welche Kurse sind für dich akzeptabel.
Antwort auf Beitrag Nr.: 38.619.892 von Scania01 am 22.12.09 19:30:42ach ich bin da sehr bescheiden so 10-20cent wären schon sehr nett aber über mehr würde ich mich natürlich nicht beklagen
Na mal sehen, ob da heuer kurstechnisch noch etwas läuft. Meines Erachtens nach geht´s da in Sachen Kurssteigerung erst im Januar weiter !
Antwort auf Beitrag Nr.: 38.622.306 von fuerza_hercuela am 23.12.09 09:26:00Brauchst doch bloss in Berlin zu kaufen, und schon
steigt der Kurs.
http://www.ariva.de/quote/simple.m?secu=910077
steigt der Kurs.
http://www.ariva.de/quote/simple.m?secu=910077
Ordentlich Bid-Überhang!
Handelsplatz Geld-Stk. Geld Geld-Brief Brief Brief-Stk. Spread Zeit
Stuttgart 1.812.000 0,005 € 0,006 € 785.611 20,00% 09:40:41
Nasdaq OTC BB 5.000 0,0071 $ 0,0089 $ 5.000 25,35% 22.12.09
Berlin 25.000 0,004 € 0,008 € 12.500 100% 09:09:25
Handelsplatz Geld-Stk. Geld Geld-Brief Brief Brief-Stk. Spread Zeit
Stuttgart 1.812.000 0,005 € 0,006 € 785.611 20,00% 09:40:41
Nasdaq OTC BB 5.000 0,0071 $ 0,0089 $ 5.000 25,35% 22.12.09
Berlin 25.000 0,004 € 0,008 € 12.500 100% 09:09:25
da könnten ja einige ruhig mal auf der 0,005 verkaufen!
ich nehm die dinger dann!
ich nehm die dinger dann!
cbai macht uns auch ein schönes weihnachtgeschenk:
morgen abend bei einem penny ?!?!?!?
morgen abend bei einem penny ?!?!?!?
Antwort auf Beitrag Nr.: 38.623.369 von MoneyDee am 23.12.09 11:28:16Nicht so gierig, lass und teilen
Antwort auf Beitrag Nr.: 38.625.800 von itsSHOWTIME am 23.12.09 16:09:13Ist Morgen überhaupt Handel bei den Anis?
In Deutschland jeden falls nicht.
http://deutsche-boerse.com/dbag/dispatch/de/binary/gdb_conte…
In Deutschland jeden falls nicht.
http://deutsche-boerse.com/dbag/dispatch/de/binary/gdb_conte…
Antwort auf Beitrag Nr.: 38.626.316 von Scania01 am 23.12.09 16:56:14halben tag!
Antwort auf Beitrag Nr.: 38.626.734 von lilie31 am 23.12.09 17:44:52Heute und Morgen wird nicht viel passieren.
Lassen wir es ruhig angehen und uns die
Weihnachtsgans gut schmecken.
Frohes Fest
Lassen wir es ruhig angehen und uns die
Weihnachtsgans gut schmecken.
Frohes Fest
In Amiland brauchen wohl noch einige für morgen Weihnachtsgeld!
Sehe ich ähnlich, wir waren am oberen BB und da muss es mal kurz wieder runter, kurz vor Weihnachten werden schon mal Gewinne mitgenommen, aber die Aussichten sind und bleiben gut und in wenigen Tagen setzt sich der Aufwärtstrend wieder fort
ich wünsche allen cord investierten einen wunderschönes fest
mit ihren familien!
auf ein frohes 2010 mit unseren cord blood
mit ihren familien!
auf ein frohes 2010 mit unseren cord blood
Hallo Kinder,
lustig hier- wünsche FROHE WEIHNACHT ....paar 1000 -er €€€ hin oder her heute- was solls.....wer das heute ERNST nimmt....aber nein !!! muss nicht sein...dies ist kein normaler Handelstag--....und wird es nie sein
lustig hier- wünsche FROHE WEIHNACHT ....paar 1000 -er €€€ hin oder her heute- was solls.....wer das heute ERNST nimmt....aber nein !!! muss nicht sein...dies ist kein normaler Handelstag--....und wird es nie sein
schöne festtage, allen
Einer war schon mal gucken im neuen Labor in Vegas - fand ich ganz interessant.
Glück auf!
Aus dem Ami-Forum Investors-Hub:
Posted by: socali4life Date: Thursday, December 24, 2009 10:01:09 AM
In reply to: None Post # of 14175
Hello everyone,
My family and I were in Vegas for the past few days. Yesterday, before we started back to so cal, I went by CBAI.
I was just planning on looking at the outside but I decided to see if they were open. They were. The receptionist greeted me and called Matt up to the lobby area. He was very willing to speak with an investor. He gave me a nice tour of the facility including showing me the tanks (about 12 in there now, more to come) and the lab. He also showed me where the file room was, the office spaces, additional storage spaces, etc...
Those of you that will be there on the 22nd will be impressed. The facility is set up very nice. You can see the airport from the main cross st (Bruce St). Very close.
I noticed a couple things I liked. Very clean. Well organized, and not a lot of waste going around. If you remember the .com days, there was excess everything (furniture, computers, toys, games, etc..etc...). Matt and company seemed to be spending money wisely. I also liked the amount of space they have to expand.
I was able to meet some of the staff, and viewed others working hard. They all seem to be very focused on not just the opening, but the aftermath and the expectations to come with it. They were all very nice and were willing to share a few moments of what they are doing currently.
Oh, and Matt is very aware of the bashers and pumpers out there. He said something very simplistic about all those that have something bad to say. Basically...."our address is out there so come and by anytime to see us."
I left the bldg. no longer looking at this as a long term trade but a long term investment. I feel my money is very safe and will give great returns in the future.
By the way, when going south on the strip, turn right on Left on E Sunset Blvd (the sign will actually say W Sunset Blvd on the overhead), then turn right on Bruce (very small street and hard to see sign). All the way down and right on Helm
Merry Xmas
Glück auf!
Aus dem Ami-Forum Investors-Hub:
Posted by: socali4life Date: Thursday, December 24, 2009 10:01:09 AM
In reply to: None Post # of 14175
Hello everyone,
My family and I were in Vegas for the past few days. Yesterday, before we started back to so cal, I went by CBAI.
I was just planning on looking at the outside but I decided to see if they were open. They were. The receptionist greeted me and called Matt up to the lobby area. He was very willing to speak with an investor. He gave me a nice tour of the facility including showing me the tanks (about 12 in there now, more to come) and the lab. He also showed me where the file room was, the office spaces, additional storage spaces, etc...
Those of you that will be there on the 22nd will be impressed. The facility is set up very nice. You can see the airport from the main cross st (Bruce St). Very close.
I noticed a couple things I liked. Very clean. Well organized, and not a lot of waste going around. If you remember the .com days, there was excess everything (furniture, computers, toys, games, etc..etc...). Matt and company seemed to be spending money wisely. I also liked the amount of space they have to expand.
I was able to meet some of the staff, and viewed others working hard. They all seem to be very focused on not just the opening, but the aftermath and the expectations to come with it. They were all very nice and were willing to share a few moments of what they are doing currently.
Oh, and Matt is very aware of the bashers and pumpers out there. He said something very simplistic about all those that have something bad to say. Basically...."our address is out there so come and by anytime to see us."
I left the bldg. no longer looking at this as a long term trade but a long term investment. I feel my money is very safe and will give great returns in the future.
By the way, when going south on the strip, turn right on Left on E Sunset Blvd (the sign will actually say W Sunset Blvd on the overhead), then turn right on Bruce (very small street and hard to see sign). All the way down and right on Helm
Merry Xmas
Kurs entwicket sich ja - schön langsam steigend- das könnte passen in 2010
Gehe stark davon aus, dass es 2010 gut laufen wird in Sachen CBAI. Alle Vorkehrungen des Managements laufen in diese Richtung.
Denke auch das es hier 2010 abgehen wird, bis jetzt sind noch nicht viele auf Cord Blood aufmerksam geworden aber das kommt noch.
Und dann
Und dann
Wir starten ja wieder gut in den Tag kann kaum den 20.01. abwarten.
Kann nun schneller als erwartet über die 0,10 US$ gehen...dann wirds interessant
Wird wohl nicht mehr lange dauern bis Stuttgart die 0,007 € hat...
Taxe 0,006 0,007
Stückzahl 960.000 Stk. 2.760.000 Stk.
Taxierungszeitpunkt 29.12.2009 15:58:55 Uhr
Taxe 0,006 0,007
Stückzahl 960.000 Stk. 2.760.000 Stk.
Taxierungszeitpunkt 29.12.2009 15:58:55 Uhr
Antwort auf Beitrag Nr.: 38.642.249 von Expertchen007 am 29.12.09 16:10:29gegen steigende kurse hab ich natürlich nix, aber ihr wisst ja. man sollte die sau im dorf lassen bevor wir sie wieder durchtreiben
..und schon passiert
Börsenplatz Stuttgart
Last 0,007bB 320.000 Stk.
Kurszeit 29.12.2009 16:19:46 Uhr
Börsenplatz Stuttgart
Last 0,007bB 320.000 Stk.
Kurszeit 29.12.2009 16:19:46 Uhr
Antwort auf Beitrag Nr.: 38.642.320 von Jamster83 am 29.12.09 16:18:23Wir haben ja jede Menge Zeit...und 2010 ist lang
Antwort auf Beitrag Nr.: 38.625.800 von itsSHOWTIME am 23.12.09 16:09:13cbai sei verziehen - den penny sahen wir nicht schon am 24.12. - sondern erst gleich !
So nun müsste mal der Sprung über die 0,10 US$ erfolgen...passt doch alles....nur irgend jemand will das wohl noch nicht
Antwort auf Beitrag Nr.: 38.642.577 von Expertchen007 am 29.12.09 16:49:11sorry....0,010 US$ meinte ich....das andere kommt später
Antwort auf Beitrag Nr.: 38.642.547 von itsSHOWTIME am 29.12.09 16:45:55So nun bin ich gespannt was passiert..die 0,010 ist weg...nun ist der Weg frei zum nächsten Step
Stuttgart
Taxe 0,007 0,008
Stückzahl 33.041 Stk. 820.000 Stk.
Taxierungszeitpunkt 29.12.2009 16:54:43 Uhr
Taxe 0,007 0,008
Stückzahl 33.041 Stk. 820.000 Stk.
Taxierungszeitpunkt 29.12.2009 16:54:43 Uhr
Antwort auf Beitrag Nr.: 38.642.619 von Expertchen007 am 29.12.09 16:53:52Umsätze auf einmal riesig!! Toll
müsste noch ein Umsatzschwung kommen, im Augenblick abwarten.
Antwort auf Beitrag Nr.: 38.642.679 von Digedanium am 29.12.09 17:00:37naja 153mio atm ist recht nett. denke alle schleudern ihr geld jetzt rein was der nette arbeitgeber zahlte
Antwort auf Beitrag Nr.: 38.642.679 von Digedanium am 29.12.09 17:00:37Eh gut fürs Jahresende..wenn ich da andere Positionen im Depot anschaue..au weia....da hilft der Tropfen von Cord nicht wirklich viel weiter...aber wer weiß schon was so kommt
Na jetzt dreht Deutschland aber auf
Taxe 0,007 0,009
Stückzahl 992.676 Stk. 407.324 Stk.
Taxierungszeitpunkt 29.12.2009 17:06:16 Uhr
akt./rel. Spread 0,002 28,571%
Kursdaten
Börsenplatz Stuttgart
Last 0,008 1.400.000 Stk.
Kurszeit 29.12.2009 17:06:11 Uhr
Taxe 0,007 0,009
Stückzahl 992.676 Stk. 407.324 Stk.
Taxierungszeitpunkt 29.12.2009 17:06:16 Uhr
akt./rel. Spread 0,002 28,571%
Kursdaten
Börsenplatz Stuttgart
Last 0,008 1.400.000 Stk.
Kurszeit 29.12.2009 17:06:11 Uhr
Wirklich stark heute der Umsatz...muss man sagen
Antwort auf Beitrag Nr.: 38.642.802 von Expertchen007 am 29.12.09 17:14:47wenn man das schon wieder sieht fragt man sich, wieso hab ich nicht mehr damals gekauft
Antwort auf Beitrag Nr.: 38.642.821 von Jamster83 am 29.12.09 17:17:37...wem sagst Du das....
Antwort auf Beitrag Nr.: 38.642.732 von Jamster83 am 29.12.09 17:06:09stunde und bisle später und es sind schon 240mio umsatz, das jeden tag wäre nett
mal gucken ob heute noch 0,007 (G) erreicht werden !
Antwort auf Beitrag Nr.: 38.643.660 von fuerza_hercuela am 29.12.09 19:27:36Bist spät dran wir haben die 0,007 ...und hatten bereits die 0,008 €
Wow..neues TH im Moment...wird ja immer besser
könnte sogar einen 0,011 US$ SK langen...wäre natrlich stark...dann kommt die 0,009 morgen im ASK auf jeden Fall wieder mal in D
Antwort auf Beitrag Nr.: 38.643.984 von Expertchen007 am 29.12.09 20:22:38uff könnt man echt schwach werden nen sl zusetzten damit man sich richtig ärgert wenn die ein das abfischen und wegziehn
Antwort auf Beitrag Nr.: 38.643.997 von Jamster83 am 29.12.09 20:24:43Noch schlimmer wärs wenn der SL greift...und danach der Kurs nach oben schießt...was machste denn dann...ne im ernst...das ist erst der Anfang der Story
0,011 US$ und steigend...jetzt wirds langsam teuer für mich mit aufstocken...hatte gehofft es bleibt noch ne Weile unten...na ja bin dabei...passt
Was soll man jetzt sagen...SK 0,0125 oder wie ???? Kann gut möglich sein
Was soll man jetzt sagen...SK 0,0125 oder wie ???? Kann gut möglich sein
gucken wir mal wo die reise hingeht, was mich stark verwundert ist das hier heute keine nervensägen aufgetaucht sind die alles schlecht quatschen.
Was ist denn hier los?
Gutes Zöckle oder eine Schlüssige Nachricht?
Gutes Zöckle oder eine Schlüssige Nachricht?
Antwort auf Beitrag Nr.: 38.644.047 von Expertchen007 am 29.12.09 20:32:00Aufstocken ?
Machste nicht auch grad gewinn mit ADVENTRX PHARMACEUTICALS INC COM ( ANX )
Verkauf und besorg die lieber CBAI wenn die auf alte Höchsmarken schießen bist du vielleicht millionär.
Machste nicht auch grad gewinn mit ADVENTRX PHARMACEUTICALS INC COM ( ANX )
Verkauf und besorg die lieber CBAI wenn die auf alte Höchsmarken schießen bist du vielleicht millionär.
Antwort auf Beitrag Nr.: 38.644.069 von Winthorpe-der-Echte am 29.12.09 20:35:19wird sich rausstellen, und zu deiner frage news gab es vor einer weile das,dass neue labor im jan. aufgemacht wird + obama hat die spielregeln gelockert für stammzellen.
So wie ich das nun verstanden habe ist / war an der 0,0113 US$ ein Wiederstandspunkt...immerhin bereits über 350 Mio. !!!!! Anteile gehandelt heute...na wenn das nix ist..weiß ich auch nicht
Antwort auf Beitrag Nr.: 38.644.079 von Blade99 am 29.12.09 20:37:01CBAI wenn die auf alte Höchsmarken schießen bist du vielleicht millionär.
Das bin ich dann auch so !!!!!
Das bin ich dann auch so !!!!!
Antwort auf Beitrag Nr.: 38.644.100 von Expertchen007 am 29.12.09 20:40:25was war die höchstmarke?
Antwort auf Beitrag Nr.: 38.644.104 von Jamster83 am 29.12.09 20:40:541,25$
So jetzt habt ihr den Mist - alle Wiederstände gebrochen...ich sag keine Prognose !!!!
naja würde reichen um ruhig leben zukönnen
Antwort auf Beitrag Nr.: 38.644.113 von Expertchen007 am 29.12.09 20:42:10Bist du schon millionär oder hast du genausoviel anteile wich ich ?
Antwort auf Beitrag Nr.: 38.644.100 von Expertchen007 am 29.12.09 20:40:25Hallo mein Bester.
Nur nicht vergessen, dass wir fast 7 Mia. a/s haben mittlerweile.
Da ist es ein sehr langer Weg zum $$$$$...
Aber nehmen würd´ ich ihn natürlich auch.
lg, barb
Nur nicht vergessen, dass wir fast 7 Mia. a/s haben mittlerweile.
Da ist es ein sehr langer Weg zum $$$$$...
Aber nehmen würd´ ich ihn natürlich auch.
lg, barb
Antwort auf Beitrag Nr.: 38.644.104 von Jamster83 am 29.12.09 20:40:54wie der Kollege sagte...siehe 5 JAHRESCHART
Antwort auf Beitrag Nr.: 38.644.119 von Blade99 am 29.12.09 20:43:16Alles verrate ich dann auch nicht !!!!
@barbarez69 ....ein großes HALLO an Dich
@barbarez69 ....ein großes HALLO an Dich
CORD BLOOD AMERICA, INC.
1857 Helm Drive
Las Vegas, NV 89119
Via Edgar
December 29, 2009
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street N.E.
Washington D.C. 20002
Re: Cord Blood America, Inc.
Request to Withdraw Registration Statement on Form S-1 (RW)
SEC File Number: 333-162832
Ladies and Gentlemen:
Pursuant to Rule 477(a) promulgated under the Securities Act of 1933, as amended (the "Securities Act"), Cord Blood America, Inc. (the " Registrant") hereby requests immediate withdrawal of its Registration Statement on Form S-1 (File No. 333-162832), which was originally filed with the Securities and Exchange Commission (the "Commission") on November 2, 2009, along with any exhibits (the "Registration Statement"). No securities have been issued under this S-1 Registration Statement.
The Registrants believes that withdrawal of the Registration Statement is consistent with the public interest and the protection of investors. The Registrant requests, in accordance with Rule 457(p) under the Securities Act that all fees paid to the Commission in connection with the filing of the Registration Statement be credited to the Registrants’ account to be offset against the filing fee for any future registration statement or registration statements.
The Registrant confirms that no securities have been or will be distributed, issued or sold pursuant to the Registration Statement or the prospectus contained therein.
If you have any questions regarding this application for withdrawal, please contact the undersigned at 702-914-7250
Very truly yours,
By
/s/ MATTHEW SCHISSLER
Matthew Schissler
Chief Executive Officer
1857 Helm Drive
Las Vegas, NV 89119
Via Edgar
December 29, 2009
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street N.E.
Washington D.C. 20002
Re: Cord Blood America, Inc.
Request to Withdraw Registration Statement on Form S-1 (RW)
SEC File Number: 333-162832
Ladies and Gentlemen:
Pursuant to Rule 477(a) promulgated under the Securities Act of 1933, as amended (the "Securities Act"), Cord Blood America, Inc. (the " Registrant") hereby requests immediate withdrawal of its Registration Statement on Form S-1 (File No. 333-162832), which was originally filed with the Securities and Exchange Commission (the "Commission") on November 2, 2009, along with any exhibits (the "Registration Statement"). No securities have been issued under this S-1 Registration Statement.
The Registrants believes that withdrawal of the Registration Statement is consistent with the public interest and the protection of investors. The Registrant requests, in accordance with Rule 457(p) under the Securities Act that all fees paid to the Commission in connection with the filing of the Registration Statement be credited to the Registrants’ account to be offset against the filing fee for any future registration statement or registration statements.
The Registrant confirms that no securities have been or will be distributed, issued or sold pursuant to the Registration Statement or the prospectus contained therein.
If you have any questions regarding this application for withdrawal, please contact the undersigned at 702-914-7250
Very truly yours,
By
/s/ MATTHEW SCHISSLER
Matthew Schissler
Chief Executive Officer
0.0117
mh jetzt auf deutsch für mich was das sec filling bedeutet
Antwort auf Beitrag Nr.: 38.644.130 von Expertchen007 am 29.12.09 20:45:41Du hast ja die letzten Wochen sehr getrommelt für CBAI.
Ich freue mich, dass Du richtig lagst.
Jetzt gilt es, Gewinne auch mal zu realisieren.
Nur so ein Gedanke, da ich cord schon etwas länger im Depot habe...
lg, barb
Ich freue mich, dass Du richtig lagst.
Jetzt gilt es, Gewinne auch mal zu realisieren.
Nur so ein Gedanke, da ich cord schon etwas länger im Depot habe...
lg, barb
Antwort auf Beitrag Nr.: 38.644.162 von barbarez69 am 29.12.09 20:51:05Noch nicht.....wäre schade um den Termin 22.01.2010.....dann gehts in die Produktionphase...warum jetzt schon..aber hast Recht....vom Prinzip her gesehen.....die Amis träummen ja schon von ganz anderen Dimensionen...aber die sind weit...sehr weit weg
Antwort auf Beitrag Nr.: 38.644.156 von Jamster83 am 29.12.09 20:50:23S1 Filing...kann ich Dir auch nix dazu sagen muss ich mal nachschauen
neuer anlauf auf die 0.012
So hab das S1 Filing mal in USA eingestellt....hoffe die können was damit anfangen...
habs ja schon nicht mehr geglaubt
habe bei 0.011 nochmals nachgefasst
closed bei 0.0118 plus 36% vol.527,169,247
morgen gap up
morgen gap up
Möchte mal wissen welcher Idiot bei 0,006€ heute in Berlin verkauft hat.
Die hätte ich auch gerne alle genommen.
Die hätte ich auch gerne alle genommen.
Antwort auf Beitrag Nr.: 38.645.569 von Blade99 am 30.12.09 09:52:16waren ja nur 16.000
aber ich hätte sie auch genommen!
aber ich hätte sie auch genommen!
Antwort auf Beitrag Nr.: 38.645.569 von Blade99 am 30.12.09 09:52:16der mm
Also ich find 0,008 € immer noch nicht " so " teuer für eine neues Unternehmen----o.k die MK wird halt höher -
paar Zahlen aktuell - Stand heute ( bei 0,0117 US$ )
http://ih.advfn.com/p.php?pid=squote&symbol=CBAI
Market Cap
$ 53.45M
Outstanding
4,568.3M
Float
2,574.9M
http://ih.advfn.com/p.php?pid=squote&symbol=CBAI
Market Cap
$ 53.45M
Outstanding
4,568.3M
Float
2,574.9M
Cord Blood America (BB) (CBAI)
$ 0.0117 ▲0.0031 (36.05%)
Volume: 530,062,247
$ 0.0117 ▲0.0031 (36.05%)
Volume: 530,062,247
gutentag zusammen
sieht ja gut aus
ich glaube mein kursziel ist schneller erreicht als ich dachte
aber wir werden noch mehr freude haben,als wir denken
ich bleibe langfristig drinne
da ich davon ausgehe,das dieses geschäft in amerika aufgeht
meine persönliche meinung natürlich!
sieht ja gut aus
ich glaube mein kursziel ist schneller erreicht als ich dachte
aber wir werden noch mehr freude haben,als wir denken
ich bleibe langfristig drinne
da ich davon ausgehe,das dieses geschäft in amerika aufgeht
meine persönliche meinung natürlich!
Antwort auf Beitrag Nr.: 38.646.423 von lilie31 am 30.12.09 12:02:49na jetzt sind aber einige aufgestanden!
Habe meine CBAI-Papiere eben mit über 100% Gewinn abgestoßen weil ich davon ausgehe, dass die Amis vor Jahresschluss die Kursgewinne absahnen werden. Werde dann sehen, dass ich zu 0,005 € wieder einsteigen kann. Mal sehen, ob es aufgeht.
Keine Handelsaufforderung - nur meine persönliche Meinung !
Keine Handelsaufforderung - nur meine persönliche Meinung !
Antwort auf Beitrag Nr.: 38.646.581 von fuerza_hercuela am 30.12.09 12:29:22Risiko, denn ich glaube nicht, dass es hier gewaltig nach unten geht, dem Volumen und Interesse nach kann es auch nochmals etwas hoch gehen
Antwort auf Beitrag Nr.: 38.646.581 von fuerza_hercuela am 30.12.09 12:29:22Gewinne tun nicht weh....aber obs klappt ist eine andere Frage...good luck dabei
Antwort auf Beitrag Nr.: 38.646.806 von Expertchen007 am 30.12.09 12:56:08........schaun wa mal dann sehn wa schon !
Antwort auf Beitrag Nr.: 38.646.581 von fuerza_hercuela am 30.12.09 12:29:22ich glaube, es wäre sinnvoller gewesen, nur die hälfte zu verkaufen + dann nur noch mit dem gewinn weiter zu spekulieren.
warten wir es mal ab.
warten wir es mal ab.
was hat das mit dem neuen s 1 - filing auf sich ?
dilution wird gestoppt ? oder wie muss man das deuten ?
dilution wird gestoppt ? oder wie muss man das deuten ?
Antwort auf Beitrag Nr.: 38.647.232 von itsSHOWTIME am 30.12.09 14:02:40Nein gabs im November auch schon mal.....da gehts um irgenwelche Daten die geleifert werden müssen....so hab ich es verstanden...aber S1 als solches sagt mir auch nix....die amis blicken das auch nicht richtig
IN D unter PARI 0,0117 US$ = 0,0082 € ....gibts auch nicht so oft...meist ist es darüber
IN D unter PARI 0,0117 US$ = 0,0082 € ....gibts auch nicht so oft...meist ist es darüber
14 Uhr heute in D Schluß...so wie ich es weiß - keine Orderannahme mehr ????
Informationen vom Parkett
Bitte beachten Sie, dass am 30.12. (Jahresschlussbörse) der Handel um 14 Uhr endet.
Wir wünschen unseren Nutzern ein gesundes und erfolgreiches neues Jahr.
Bitte beachten Sie, dass am 30.12. (Jahresschlussbörse) der Handel um 14 Uhr endet.
Wir wünschen unseren Nutzern ein gesundes und erfolgreiches neues Jahr.
Ferttisch mit dem Handel von Aktien für heuer in der BRD !
ALLEN EINEN GUTEN RUTSCH INS JAHR 2010
ALLEN EINEN GUTEN RUTSCH INS JAHR 2010
Antwort auf Beitrag Nr.: 38.647.437 von fuerza_hercuela am 30.12.09 14:31:25Auch guten Rutsch...wohl dem der international Handeln kann....
hallo
err.heute bei den amis bei 0.012 meiner meinung
err.heute bei den amis bei 0.012 meiner meinung
Antwort auf Beitrag Nr.: 38.647.460 von oski am 30.12.09 14:34:38Hätt ich auch gerne - glaubs aber nicht.....auch dort ist Jahresende...aber im Januar dürfen wir wohl einiges erwarten
Antwort auf Beitrag Nr.: 38.647.478 von Expertchen007 am 30.12.09 14:38:1830min.vor handelschluss wurde enorm zugekauft,denke es gibt ein GAP UP
Antwort auf Beitrag Nr.: 38.647.460 von oski am 30.12.09 14:34:38Ich glaubs jetzt doch !!!!!
OTC...Wert...aber alle Indikatoren auf " BUY "...gibts selten mal...
*************************************************************
BarChart likes CBAI...No Brainer....
Composite Indicator
Trend Spotter TM Hold
Short Term Indicators
7 Day Average Directional Indicator Buy
10 - 8 Day Moving Average Hilo Channel Buy
20 Day Moving Average vs Price Buy
20 - 50 Day MACD Oscillator Buy
20 Day Bollinger Bands Buy
Short Term Indicators Average: 100% - Buy 20-Day Average Volume - 118147047
Medium Term Indicators
40 Day Commodity Channel Index Buy
50 Day Moving Average vs Price Buy
20 - 100 Day MACD Oscillator Buy
50 Day Parabolic Time/Price Buy
Medium Term Indicators Average: 100% - Buy
50-Day Average Volume - 78630281
Long Term Indicators
60 Day Commodity Channel Index Buy
100 Day Moving Average vs Price Buy
50 - 100 Day MACD Oscillator Buy
Long Term Indicators Average: 100% - Buy
100-Day Average Volume - 130316992
Overall Average: 96% - Buy
*************************************************************
BarChart likes CBAI...No Brainer....
Composite Indicator
Trend Spotter TM Hold
Short Term Indicators
7 Day Average Directional Indicator Buy
10 - 8 Day Moving Average Hilo Channel Buy
20 Day Moving Average vs Price Buy
20 - 50 Day MACD Oscillator Buy
20 Day Bollinger Bands Buy
Short Term Indicators Average: 100% - Buy 20-Day Average Volume - 118147047
Medium Term Indicators
40 Day Commodity Channel Index Buy
50 Day Moving Average vs Price Buy
20 - 100 Day MACD Oscillator Buy
50 Day Parabolic Time/Price Buy
Medium Term Indicators Average: 100% - Buy
50-Day Average Volume - 78630281
Long Term Indicators
60 Day Commodity Channel Index Buy
100 Day Moving Average vs Price Buy
50 - 100 Day MACD Oscillator Buy
Long Term Indicators Average: 100% - Buy
100-Day Average Volume - 130316992
Overall Average: 96% - Buy
Wir alle dürfen gespannt sein was nun gleich passiert....wenns fällt ( gibts Zukaufmöglichkleiten ) - wenns steigt - tja auch o.k ...wenn die Story klappt sind das eh noch keine Kurse die dann mal zu sehen sein werden... meine persönliche Meinung
Kein schlechter Start...bin mal gespannt was in 1 Std. ist...noch keine Tendenz zu sehen...obwohl es gute Käufe sind
Antwort auf Beitrag Nr.: 38.647.720 von Expertchen007 am 30.12.09 15:26:14Fällt ja wie ein Stein.
Antwort auf Beitrag Nr.: 38.647.786 von Scania01 am 30.12.09 15:39:42Wegen mir gerne....aber wenn dann nochmal richtig bis zum 22.01.2010...befürchte aber die steigt auch wieder...schade das in D gerade kein Handel ist..hätte man was zu 0,007 abzwicken können...in USA ja noch darüber
nur geduld MM's spielchen
Antwort auf Beitrag Nr.: 38.647.786 von Scania01 am 30.12.09 15:39:42Schade war nix mit billig einkaufen...na ja vielleicht gehts doch nochmal runter....so 1,5 Milliönchen würd ich noch nehmen
So mal die Orders auf 3 Positionn gesplittet...1. sitzt unter der 0,010 kanpp drunter...Rest dann tiefer
@ all,
ist morgen in Amiland auch noch Handel?
ist morgen in Amiland auch noch Handel?
Antwort auf Beitrag Nr.: 38.648.165 von Scania01 am 30.12.09 16:49:18Handel 31-12.2009
New York 19.00
NY (Treas) 20.00
New York 19.00
NY (Treas) 20.00
Antwort auf Beitrag Nr.: 38.648.231 von Stimmungskanone am 30.12.09 17:04:23Danke
0.0122 vol.267,759,404,
UP
UP
0.0127 vol.300,000,000
Habe in einem anderen Forum folgendes aufgeschnbappt !
"Es gibt da einen Makler, NITE heisst der, und der bringt die Aktien für CBAI auf den Markt, und da der fleissig verkauft, steigt die Anzahl der Aktien permanent, das ist die Verwässerung. Kann man nur sehen, wenn man OTC-Level2-Zugang hat, quasi Einblick in Bid und Ask. Habe ich leider auch nicht, aber laut den iHubbern stellt NITE da immer wieder neue Teile rein, zum Beispiel:
http://investorshub.advfn.com/boards/read_msg.aspx?message_i…
Konnte man vor Wochen auch hier schön beobachten, kaum war damals eine Position gekauft, stand im Brief schon wieder die nächste Position, und jede Posi hatte immer wieder den Wert von 10k€.!
_________________________________________________________________
Denke somit, dass wir die Tage wieder einen Rutsch erleben werden!
Meine persönliche Meinung !
"Es gibt da einen Makler, NITE heisst der, und der bringt die Aktien für CBAI auf den Markt, und da der fleissig verkauft, steigt die Anzahl der Aktien permanent, das ist die Verwässerung. Kann man nur sehen, wenn man OTC-Level2-Zugang hat, quasi Einblick in Bid und Ask. Habe ich leider auch nicht, aber laut den iHubbern stellt NITE da immer wieder neue Teile rein, zum Beispiel:
http://investorshub.advfn.com/boards/read_msg.aspx?message_i…
Konnte man vor Wochen auch hier schön beobachten, kaum war damals eine Position gekauft, stand im Brief schon wieder die nächste Position, und jede Posi hatte immer wieder den Wert von 10k€.!
_________________________________________________________________
Denke somit, dass wir die Tage wieder einen Rutsch erleben werden!
Meine persönliche Meinung !
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
———————
FORM S-8
———————
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
———————
Cord Blood America, Inc.
(Exact name of registrant as specified in its charter)
———————
Florida
65-1078768
(State or other jurisdiction
of incorporation or organization)
(I.R.S. Employer
Identification No.)
1857 Helm Drive
Las Vegas, NV 89119
(Address of Principal Executive Offices and Zip Code)
Cord Blood America, Inc. 2010 Flexible Stock Plan
(Full title of the plan)
Donald G. Davis, Esq., P.O. Box 12009, Marina del Rey, CA 90295
(Name and address of agent for service)
310-823-8300
(Telephone number, including area code, of agent for service)
CALCULATION OF REGISTRATION FEE
Title of Securities
to be Registered (1)
Amount to be
Registered (3)
Proposed Maximum
Offering Price Per
Share (2)
Proposed Maximum
Aggregate Offering
Price (2)
Amount of
Registration Fee
Common Stock
$0.0001 par value
80,000,000
Shares
$0.0117
Per Share
$936,000
$66.74
———————
(1)
This registration statement covers common stock issuable under our plan titled “Cord Blood America, Inc. 2010 Flexible Stock Plan” (the “Stock Plan”)
(2)
Estimated solely for the purpose of calculating the registration fee. Pursuant to Rule 457(c) under the Securities Act, the proposed maximum offering price per share and the proposed maximum aggregate offering price have been determined on the basis of the average of the bid and asked price as of a specified date within five business days prior to the date of filing the registration statement.
(3)
This Registration Statement registers 80,000,000 shares of the Common Stock (the “Common Stock”), par value $0.0001 per share, of Cord Blood America, Inc. (the “Company”), for future issuance under the Cord Blood America, Inc. 2010 Flexible Stock Plan. to such persons as are designated by the Company from time to time under the terms of its the Plan.
Copies to:
Donald G. Davis
Davis & Associates
P.O. Box 12009
Marina del Rey, CA 90295
(310) 823-8300
INFORMATION REQUIRED IN SECTION 10(a) PROSPECTUS
Item 1.
Plan Information.*
Item 2.
Registrant Information and Employee Plan Annual Information.*
Information required by Part I to be contained in Section 10(a) prospectus is omitted from the Registration Statement in accordance with Rule 428 under the Securities Act of 1933, and Note to Part I of Form S-8.
PART II
Item 3.
Incorporation of Documents by Reference.
The following documents filed by Cord Blood America, Inc. (the “Company”), with the Securities and Exchange Commission are incorporated by reference into this Registration Statement:
(1)
The Company’s Annual Report on Form 10-K, for the year ended December 31, 2008;
(2)
All other reports filed by the Company pursuant to Sections 13(a) or 15(d) of the Exchange Act subsequent to the filing of the Company’s Annual Report for the year ended December 31, 2008 with the Securities and Exchange Commission;
(3)
The description of the Company’s Common Stock which is contained in the Company’s Registration Statement on Form S-1, filed as amended with the Securities and Exchange Commission on August 3, 2009.
All reports and other documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which de-registers all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be a part of this Registration Statement from the date of the filing of such reports and documents.
Any statement contained in an Incorporated Document shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed Incorporated Document modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.
Item 4.
Description of Securities.
The class of securities to be offered is registered under Section 12 of the Exchange Act. Therefore, a description of the Common Stock required by Item 202 of Regulation S-K is not required.
Item 5.
Interests of Named Experts and Counsel.
Donald G. Davis, Esq., of the Law Firm of Davis & Associates, Inc., has provided legal advice to the Registrant in connection with the Company’s preparation of this Registration Statement, and has also through his professional law corporation, rendered a legal opinion attached hereto as an Exhibit, as to the validity and due issuance of the shares of the Company’s Common Stock to be issued and registered hereby. At the same time, Donald G. Davis has been issued shares of the Company’s Common Stock in the past under a prior Company Flexible Stock Plan, and additional shares will be issued to Mr. Davis in the future, in payment of retainers for future legal services to be rendered pursuant to the terms of written Agreements for Legal Services with the Company. Neither Donald G. Davis, nor the law firm of Davis & Associates has been employed on a contingent basis. Neither Mr. Davis nor Davis & Associates has or is to receive a substantial interest direct or indirect in Registrant, nor are either of them connected with Registrant other than in their role as outside special legal counsel for the Company.
Item 6.
Indemnification of Directors and Officers.
The officers and directors of the Company are indemnified as provided by Florida Statutes: Title XXXVI, Chapter 607-Corporations and the Articles and bylaws of the Company.
The Company’s Articles of Incorporation and by-laws include an indemnification provision under which the Company agreed to indemnify all directors and officers to the fullest extent permitted by the laws of the State of Florida.
Item 7.
Exemption from Registration Claimed.
Not applicable.
Item 8.
Exhibits.
Exhibit
Number
Description
4.1
Cord Blood America, Inc. 2010 Flexible Stock Plan
5.1
Opinion of Davis & Associates regarding validity of securities, with “Consent to Use”
23.1
Consent of Rose, Snyder & Jacobs, A Corporation of Certified Public Accountants,, filed herewith.
23.2
Consent of Donald G. Davis, Esq., included in the opinion filed as Exhibit 5.1 hereto.
Item 9.
Undertakings.
The Company hereby undertakes:
A.
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration:
(1)
To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;
(2)
To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement; and
(3)
To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement;
Provided however, that paragraphs (a) (1) and (2) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed by the Company pursuant to section 13 or section 15(d) of the Exchange Act that are incorporated by reference herein.
B.
That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new Registration Statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
C.
To remove from registration by means of post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
(1)
The Company hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the Company’s annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 that is incorporated by reference in the Registration Statement shall be deemed to be a new Registration Statement relating to the securities offered therein, and the offering of such securities at the time shall be deemed to be the initial bona fide offering thereof.
(2)
Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Company pursuant to the foregoing provisions, or otherwise, the Company has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Company of expenses incurred or paid by the director, officer or controlling person of the Company in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Company will, unless in the opinion of the counsel the matter has been settled by controlling precedent, submit to the appropriate jurisdiction the question of whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant, Cord Blood America, Inc., certifies that it has reasonable grounds to believe that it meets all of the requirements for filing a Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of West Hollywood, State of California, on December 30, 2009.
Cord Blood America, Inc.
December 30, 2009
By:
/s/ Matthew L. Schissler
Matthew L. Schissler
Chairman of the Board and Chief Executive Officer
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the date indicated.
Signature
Title
Date
/s/ Matthew L. Schissler
Chief Executive Officer and Director
December 30, 2009
Matthew L. Schissler
/s/ Joseph Vicente
Director
December 30, 2009
Joseph Vicente
EXHIBIT INDEX
Exhibit
Number
Description
4.1
Cord Blood America, Inc. 2010 Flexible Stock Plan
5.1
Opinion of Davis & Associates regarding validity of securities, with “Consent to Use”
23.1
Consent of Rose, Snyder & Jacobs, A Corporation of Certified Public Accountants,, filed herewith.
23.2
Consent of Donald G. Davis, Esq., included in the opinion filed as Exhibit 5.1 hereto.
EX-4.1
EXHIBIT 4.1
CORD BLOOD AMERICA, INC. 2010 FLEXIBLE STOCK PLAN
ARTICLE I
NAME AND PURPOSE
1.1
Name. The name of the Plan is the "Cord Blood America, Inc. 2010 Flexible Stock Plan."
1.2
Purpose. The Company has established the Plan to attract, retain, motivate and reward Employees and other individuals, to encourage ownership of the Company's Common Stock by Employees and other individuals, and to promote and further the best interests of the Company.
ARTICLE II
DEFINITIONS OF TERMS AND RULES OF CONSTRUCTION
2.1
General Definitions. The following words and phrases, when used in the Plan, unless otherwise specifically defined or unless the context clearly otherwise requires, shall have the following respective meanings:
A.
Agreement. The document which evidences the grant of any Benefit under the Plan and which sets forth the Benefit and the terms, conditions and provisions of, and restrictions relating to, such Benefit.
B.
Benefit. Any benefit granted to a Participant under the Plan.
C.
Board. The Board of Directors of the Company.
D.
Company. Cord Blood America, Inc., a Florida Corporation
E.
Committee. The Committee described in Section 5.1, or in the event that the Board of Directors does not appoint a Committee, then the Board of Directors.
F.
Common Stock. The Company's Common Stock, $0.0001 par value.
G.
Effective Date. The date that the Plan is adopted by the Board of Directors.
H.
Employee. Any person, consultant or professional employed by the Employer.
I.
Employer. The Company and all Subsidiaries.
J.
Exchange Act. The Securities Exchange Act of 1934, as amended.
K.
Fair Market Value. The last reported sale price, regular way, of the Shares on any day or, in case no such reported sale takes place on such day, the average of the reported closing bid and asked prices, regular way, in either case on the principal national securities exchange on which the Shares are listed or if the Shares are not listed on a national securities exchange and are listed on the NASDAQ Stock Market, the sale price determined in the same fashion or, if the Shares are not so listed on any of the foregoing, the average of the bid and asked prices on such day as furnished by dealers in the Shares in the over-the-counter market. All calculations of the current market price shall be made to the nearest cent.
L.
Option. An option to purchase Shares granted under the Plan.
M.
Other Stock Based Award. An award under the Plan that is valued in whole or in part by reference to, or is otherwise based on, Common Stock.
N.
Participant. A person who is granted a Benefit under the Plan. Benefits may be granted only to Employees, employees and owners of entities which are not Subsidiaries but which have a direct or indirect ownership interest in an Employer or in which an Employer has a direct or indirect ownership interest, persons who, and employees and owners of entities which, are customers and suppliers of an Employer, persons who, and employees and owners of entities which, render services to an Employer, and persons who, and employees and owners of entities, which have ownership or business affiliations with any persons or entity previously described.
O.
Performance Share. A Share awarded to a Participant under ARTICLE XIV of the Plan.
P.
Plan. The Cord Blood America, Inc. 2010 Flexible Stock Plan, and all amendments and supplements to it.
Q.
Restricted Stock. Shares issued under ARTICLE XIII of the Plan.
R.
Share. A share of Common Stock.
S.
Subsidiary. Any corporation in an unbroken chain of corporations beginning with the Company if, at the time of grant of an Option or other Benefit, each of the corporations, other than the last corporation in the unbroken chain, owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.
2.2
Other Definitions. In addition to the above definitions, certain words and phrases used in the Plan and any Agreement may be defined in other portions of the Plan or in such Agreement.
2.3
Conflicts in Plan. In the case of any conflict in the terms of the Plan relating to a Benefit, the provisions in the ARTICLE of the Plan which specifically permits the grant of such Benefit shall control those in a different ARTICLE.
ARTICLE III
COMMON STOCK
3.1
Number of Shares. The number of Shares which may be issued or sold or for which Options or Performance Shares may be granted under the Plan is fixed at 80,000,000 Shares. At this date there are no shares issued and outstanding under this 2010 Flexible Stock Plan. Such Shares may be authorized but unissued Shares, or Shares held in the treasury, or both.
3.2
Reusage. If an Option expires or is terminated, surrendered, or canceled without having been fully exercised, if Restricted Shares or Performance Shares are forfeited, or if any other grant results in any Shares not being issued, the Shares covered by such Option, grant of Restricted Shares, Performance Shares or other grant, as the case may be, shall again be available for use under the Plan, to the fullest extent permitted under applicable law.
3.3
Adjustments. If there is any change in the Common Stock of the Company by reason of any stock dividend, spin-off, split-up, spin-out, recapitalization, merger, consolidation, reorganization, combination or exchange of shares, the number and class of shares available for Options and grants of Restricted Stock, Performance Shares and Other Stock Based Awards and the number of Shares subject to outstanding Options, grants of Restricted Stock and Performance Shares which are not vested, and Other Stock Based Awards, and the price thereof, as applicable, shall be appropriately adjusted by the Committee.
ARTICLE IV
ELIGIBILITY
4.1
Determined By Committee. The Participants and the Benefits they receive under the Plan shall be determined solely by the Committee, or in the event the Board of Directors does not appoint a Committee, then by the Board of Directors (hereinafter the Committee or the Board, if there is no Committee appointed, is referred to as the “Committee). In making its determinations, the Committee shall consider past, present and expected future contributions of Participants and potential Participants to the Employer, including, without limitation, the performance of, or the refraining from the performance of, services.
ARTICLE V
ADMINISTRATION
5.1 Committee.
A.
The Plan shall be administered by the Board of Directors of the Company, the Stock Option Committee of the Board or another committee of the Board, all as shall be determined by the Board.
B.
If the Board appoints a Committee, the Committee shall be comprised of not less than two persons, and each member of the Committee shall be a member of the Board who during the one year period prior to service on the Committee was, and during such service is, an “outside director,” as such term is utilized in Section 162(m) of the Internal Revenue Code, and a “non-employee director,” as such term is defined and utilized in Rule 16b-3 of the Exchange Act. Subject to the foregoing, the Board may from time to time appoint members of the Committee in substitution for or in addition to members previously appointed, may fill vacancies in the Committee and may remove members of the Committee, at the sole discretion of the Board of Directors.
C.
The Committee shall select one of its members as its chairman and shall hold its meetings at such times and places as it shall deem advisable. A majority of its members shall constitute a quorum and all determinations shall be made by a majority of such quorum. Any determination reduced to writing and signed by all of the members of the Committee shall be fully as effective as if it had been made by a majority vote at a meeting duly called and held.
5.2 Powers.
A.
The Board or the Committee, if so determined by the Board, shall have full power and authority, subject to such orders or resolutions not inconsistent with the provisions of the Plan as may from time to time be issued or adopted by the Board, to grant eligible persons Benefits under the Plan, to determine the restrictions, terms and conditions (which need not be identical) of all Benefits so granted, to interpret the provisions of the Plan and any Agreements relating to Benefits granted under the Plan, and to supervise the administration of the Plan.
B.
The Board or the Committee, if the Board shall so determine, shall have sole authority in the selection of directors, officers and employees of the Company or a Subsidiary, and any consultant, advisor or independent contractor to the Company or a Subsidiary, to whom Awards may be granted under the Plan and in the determination of the timing, pricing, terms, conditions, restrictions and amount of any such Award, subject only to the express provisions of the Plan.
C.
Without limiting the generality of the above Sections, the Board or the Committee shall have the authority to condition any Award, in whole or in part, on performance or other criteria established by the Board or the Committee at the time of grant. In making determinations hereunder, the Board or the Committee may take into account the nature of the services rendered by the respective directors, officers, employees, consultants, advisors or independent contractors, their present and potential contributions to the success of the Company and its Subsidiaries and such other factors as the Board or the Committee in its discretion deems relevant, and may consult with, and give such consideration to the recommendations of, management of the Company as the Board or Committee deems desirable.
5.3
Interpretation. The Board or the Committee is authorized, subject to the provisions of the Plan, to establish, amend and rescind such rules and regulations as it deems necessary or advisable for the proper administration of the Plan and to take such other action in connection with or in relation to the Plan as it deems necessary or advisable. Each action and determination made or taken pursuant to the Plan by the Board or the Committee, including any interpretation or construction of the Plan, shall be final and conclusive for all purposes and upon all persons. No member of the Board or the Committee shall be liable for any action or determination made or taken by him or the Board or the Committee in good faith with respect to the Plan.
ARTICLE VI
AMENDMENT
6.1
Power of Board. Except as hereinafter provided, the Board shall have the sole right and power to amend the Plan at any time and from time to time.
ARTICLE VII
TERM AND TERMINATION
7.1
Term. The Plan shall commence as of the Effective Date, and, subject to the terms of the Plan, including those limiting the period over which Benefits may be granted, shall continue in full force and effect until terminated.
7.2
Termination. The Plan may be terminated at any time by the Board.
ARTICLE VIII
MODIFICATION OR TERMINATION OF BENEFITS
8.1
General. Subject to the provisions of Section 8.2, the amendment or termination of the Plan shall not adversely affect a Participant's right to any Benefit granted prior to such amendment or termination.
8.2
Committee's Right. Any Benefit granted may be converted, modified, forfeited or canceled, in whole or in part, by the Committee if and to the extent permitted in the Plan or applicable Agreement, or in the grant of the benefit, or with the consent of the Participant to whom such Benefit was granted.
ARTICLE IX
AGREEMENTS AND CERTAIN BENEFITS
9.1
Grant Evidenced by Agreement. The grant of any Benefit under the Plan may be evidenced by an Agreement which shall describe the specific Benefit granted and the terms and conditions of the Benefit or may be evidenced by adoption of a Board Resolution. The granting of any Benefit shall be subject to, and conditioned upon, the recipient's execution of any Agreement required by the Committee. Except as otherwise provided in an Agreement, all capitalized terms used in the Agreement shall have the same meaning as in the Plan and theAgreement shall be subject to all of the terms of the Plan.
9.2
Provisions of Agreement. Any Agreement shall contain such provisions that the Committee shall determine to be necessary, desirable and appropriate for the Benefit granted which may include, but not be limited to, the following with respect to any Benefit: description of the type of Benefit; the Benefit's duration;
its transferability; if an Option, the exercise price, the exercise period and the person or persons who may exercise the Option; the effect upon such Benefit of the Participant's death or termination of employment; the Benefit's conditions; when, if, and how any Benefit may be forfeited, converted into another Benefit, modified, exchanged for another Benefit or replaced; and the restrictions on any Shares purchased or granted under the Plan.
9.3
Certain Benefits. Any Benefit granted to an individual who is subject to Section 16 of the Exchange Act shall be not transferable other than by will or the laws of descent and distribution and shall be exercisable during his lifetime only by him, his guardian or his legal representative.
ARTICLE X
REPLACEMENT AND TANDEM AWARDS
10.1
Replacement. The Committee may permit a Participant to elect to surrender a Benefit in exchange for a new Benefit.
10.2
Tandem Awards. Awards may be granted by the Committee in tandem.
ARTICLE XI
PAYMENT, DIVIDENDS, DEFERRAL AND WITHHOLDING
11.1
Payment. Upon the exercise of an Option or in the case of any other Benefit that requires a payment to the Company, the amount due the Company is to be paid:
A.
in cash;
B.
by the tender to the Company of Shares owned by the optionee and registered in his name having a Fair Market Value equal to the amount due to the Company;
C.
by credit by the receipt for a Retainer due and payable under a contract executed by the Company;
D.
in other property, rights and credits, including the Participant's promissory
E.
note; or
F.
by any combination of the payment methods specified in (a), (b) and (c) above.
Notwithstanding the foregoing, any method of payment other than (a) may be used only with the consent of the Committee (or if and to the extent so provided in an Agreement). The proceeds of the Sale of Common Stock purchased pursuant to an Option and any payment to the Company for other Benefits shall be added to the general funds of the Company or to the Shares held in treasury, as the case may be, and used for the corporate purposes of the Company as the Board shall determine.
11.2
Dividend Equivalents. Grants of Benefits in Shares or Share equivalents may include dividend equivalent payments or dividend credit rights.
11.3
Deferral. The right to receive any Benefit under the Plan may, at the request of the Participant, be deferred for such period and upon such terms as the Committee shall determine, which may include crediting of interest on deferrals of cash and crediting of dividends on deferrals denominated in Shares.
11.4
Withholding. The Company, at the time any distribution is made under the Plan, whether in cash or in Shares, may at its discretion withhold from such distribution any amount necessary to satisfy federal, state and local income tax withholding requirements with respect to such distribution. Such withholding shall be in cash or, in the Committee's sole discretion, Shares.
ARTICLE XII
OPTIONS
12.1
Determination by Committee. The terms of all Options shall be determined by the Committee.
ARTICLE XIII
RESTRICTED STOCK
13.1
Description. The Committee may grant Benefits in Shares available under ARTICLE III of the Plan as Restricted Stock. Shares of Restricted Stock shall be issued and delivered at the time of the grant. Each certificate representing Shares of Restricted Stock shall bear a restrictive legend stating that such Shares are nontransferable until all restrictions have been satisfied (and such other legend as may be required in connection with any Agreement relating to the issuance under the Plan). The grantee shall be entitled to full voting and dividend rights with respect to all shares of Restricted Stock from the date of grant.
13.2
Non-Transferability. Shares of Restricted Stock shall not be transferable until after the removal of the legend with respect to such Shares.
ARTICLE XIV
PERFORMANCE SHARES
14.1
Description. Performance Shares are the right of an individual to whom a grant of such Shares is made to receive Shares or cash equal to the Fair Market Value of such Shares at a future date in accordance with the terms of such grant. Generally, such right shall be based upon the attainment of targeted profit and/or performance objectives.
14.2
Grant. The Committee may grant an award of Performance Shares. The number of Performance Shares and the terms and conditions of the grant shall be set forth in an applicable Agreement.
ARTICLE XV
FORM S-8 REGISTERED STOCK
15.1
Description. The Committee may grant Benefits in the form of the issuance of Shares available under ARTICLE III of the Plan, to be issued after filing and effectiveness of an S-8 Registration Statement filed under the Securities Act of 1933 registering such shares, either specifically or as part of a Plan wide registration of shares. The issuance of all such shares shall be in accord with the rules and regulations associated with the use of an S-8 Registration Statement adopted by the Securities and Exchange Commission as amended, and the terms set forth in the S-8 Registration as filed.
ARTICLE XVI
OTHER STOCK BASED AWARDS AND OTHER BENEFITS
16.1
Other Stock Based Awards. The Committee shall have the right to grant Other Stock Based Awards which may include, without limitation, the grant of Shares based on certain conditions, the payment of cash based on the performance of the Common Stock, and the grant of securities convertible into Shares.
16.2
Other Benefits. The Committee shall have the right to provide types of Benefits under the Plan in addition to those specifically listed, if the Committee believes that such Benefits would further the purposes for which the Plan was established.
ARTICLE XVII
MISCELLANEOUS PROVISIONS
17.1
Underscored References. The underscored references contained in the Plan are included only for convenience, and they shall not be construed as a part of the Plan or in any respect affecting or modifying its provisions.
17.2
Number and Gender. The masculine and neuter, wherever used in the Plan, shall refer to either the masculine, neuter or feminine; and, unless the context otherwise requires, the singular shall include the plural and the plural the singular.
17.3
Governing Law. This Plan shall be construed and administered in accordance with the laws of the State of Florida.
17.4
Purchase for Investment. The Committee may require each person purchasing Shares pursuant to an Option, or receiving shares under an award under the Plan to represent to and agree with the Company in writing that such person is acquiring the Shares for investment and without a view to distribution or resale. The certificates for such Shares may include any legend which the Committee deems appropriate to reflect any restrictions on transfer. All certificates for Shares delivered under the Plan shall be subject to such stock-transfer orders and other restrictions as the Committee may deem advisable under all applicable laws, rules and regulations, and the Committee may cause a legend or legends to be put on any such certificates to make appropriate references to such restrictions.
17.5
No Employment Contract. The adoption of the Plan shall not confer upon any Employee any right to continued employment nor shall it interfere in any way with the right of the Employer to terminate the employment of any of its Employees at any time.
17.6
No Effect on Other Benefits. The receipt of Benefits under the Plan shall have no effect on any benefits to which a Participant may be entitled from the Employer, under another plan or otherwise, or preclude a Participant from receiving any such benefits.
Undersigned, the Secretary of Cord Blood America, Inc., hereby certifies that this Cord Blood America, Inc 2010 Flexible Stock Plan was duly adopted by the Board of Directors of the Corporation, effective as of December 30, 2010.
Date: December 30, 2009
/s/ Matthew L. Schissler
Matthew L. Schissler, Chief Executive Officer
EX-5.1
EX 5.1
DAVIS & ASSOCIATES
(A PROFESSIONAL LAW CORPORATION)
-SECURITIES, BUSINESS & INTERNATIONAL LAWYERS-
LOS ANGELES
Ritz Carlton Annex
(310) 823-8300/fax (310) 301-3370 NEWPORT BEACH
Balboa Bay Club Annex
(949) 631-1142
Respond To:
P.O. Box 12009
Marina Del Rey, CA
90295-3009
December 30, 2009
Cord Blood America, Inc.
501 Santa Monica Blvd, Suite 700
Santa Monica, CA 90401
We have acted as counsel to Cord Blood America, Inc., a Florida corporation (the “Company”), in connection with the registration under the Securities Act of 1933, as amended, on Form S-8 (the
Ladies and Gentlemen,
“Registration Statement”) of an aggregate of 80,000,000 shares of Common Stock of the Company, for issuance in the future; all such shares to be issued pursuant to the Company’s 2010 Flexible Stock Plan (the “Plan”). Such shares issuable pursuant to the Plan are referred to herein as the “Shares”.
As such counsel, we have examined and relied upon originals or copies, certified or otherwise, identified to our satisfaction, of such corporate records, agreements, documents, instruments and certificates of law, as we deemed necessary or appropriate in order to enable us to render the opinion expressed below.
Based upon the foregoing and in reliance thereon, we are of the opinion that the Shares, upon issuance by action by the Company’s Board of Directors, and when issued in accord
with the terms and provisions of the Plan, will be duly and validly authorized, and validly issued, fully paid and non-assessable Shares of the Common Stock of the Company..
We are admitted to practice in the State of California, and are not admitted to practice in the State of Florida. However, for the limited purposes of our opinion set forth above, we are generally familiar with the General Corporation Law of the State of Florida as presently in effect and have made such inquiries as we consider necessary to render this opinion with respect to a Florida corporation. This opinion letter is limited to the laws of the State of California and, to the extent set forth above, Florida Corporate Law, as such laws presently exist and to the facts as they presently exist. We express no opinion with respect to the effect or applicability of the laws in any other jurisdiction.
The opinion stated herein is as of the date hereof, and we assume no obligation to update or supplement this legal opinion to reflect any facts or circumstances that may hereafter come to our attention or any changes in laws that may hereafter occur. This legal opinion is limited to the matters stated herein and no opinion is implied or may be inferred beyond the matters expressly stated.
We consent to the filing of this Opinion as an exhibit to the Form S-8 Registration Statement, and to the use of our name wherever it appears in said Registration Statement. In giving our consent, we do not consider that we are “experts” within the meaning of such term as used in the Securities Act of 1933, as amended (the “Act”), or the rules and regulations of the SEC issued there under with respect to the Registration Statement, or with respect to this Opinion as an Exhibit or otherwise, nor do we consider ourselves within the category of persons whose “consent” is required by Section 7 of said Act.
We consent to the filing of this Opinion as an exhibit to the Registration Statement.
Very truly yours,
/s/ Donald G. Davis
DAVIS & ASSOCIATES
EX-23.1
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation by reference, in this Registration Statement on Form S-8, of our report dated April 14, 2009, with respect to the financial statements of Cord Blood America, Inc., and Subsidiaries appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2008.
/s/ Rose, Snyder & Jacobs
Rose, Snyder & Jacobs
A Corporation of Certified Public Accountants
Encino, California
December 28, 2009
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
———————
FORM S-8
———————
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
———————
Cord Blood America, Inc.
(Exact name of registrant as specified in its charter)
———————
Florida
65-1078768
(State or other jurisdiction
of incorporation or organization)
(I.R.S. Employer
Identification No.)
1857 Helm Drive
Las Vegas, NV 89119
(Address of Principal Executive Offices and Zip Code)
Cord Blood America, Inc. 2010 Flexible Stock Plan
(Full title of the plan)
Donald G. Davis, Esq., P.O. Box 12009, Marina del Rey, CA 90295
(Name and address of agent for service)
310-823-8300
(Telephone number, including area code, of agent for service)
CALCULATION OF REGISTRATION FEE
Title of Securities
to be Registered (1)
Amount to be
Registered (3)
Proposed Maximum
Offering Price Per
Share (2)
Proposed Maximum
Aggregate Offering
Price (2)
Amount of
Registration Fee
Common Stock
$0.0001 par value
80,000,000
Shares
$0.0117
Per Share
$936,000
$66.74
———————
(1)
This registration statement covers common stock issuable under our plan titled “Cord Blood America, Inc. 2010 Flexible Stock Plan” (the “Stock Plan”)
(2)
Estimated solely for the purpose of calculating the registration fee. Pursuant to Rule 457(c) under the Securities Act, the proposed maximum offering price per share and the proposed maximum aggregate offering price have been determined on the basis of the average of the bid and asked price as of a specified date within five business days prior to the date of filing the registration statement.
(3)
This Registration Statement registers 80,000,000 shares of the Common Stock (the “Common Stock”), par value $0.0001 per share, of Cord Blood America, Inc. (the “Company”), for future issuance under the Cord Blood America, Inc. 2010 Flexible Stock Plan. to such persons as are designated by the Company from time to time under the terms of its the Plan.
Copies to:
Donald G. Davis
Davis & Associates
P.O. Box 12009
Marina del Rey, CA 90295
(310) 823-8300
INFORMATION REQUIRED IN SECTION 10(a) PROSPECTUS
Item 1.
Plan Information.*
Item 2.
Registrant Information and Employee Plan Annual Information.*
Information required by Part I to be contained in Section 10(a) prospectus is omitted from the Registration Statement in accordance with Rule 428 under the Securities Act of 1933, and Note to Part I of Form S-8.
PART II
Item 3.
Incorporation of Documents by Reference.
The following documents filed by Cord Blood America, Inc. (the “Company”), with the Securities and Exchange Commission are incorporated by reference into this Registration Statement:
(1)
The Company’s Annual Report on Form 10-K, for the year ended December 31, 2008;
(2)
All other reports filed by the Company pursuant to Sections 13(a) or 15(d) of the Exchange Act subsequent to the filing of the Company’s Annual Report for the year ended December 31, 2008 with the Securities and Exchange Commission;
(3)
The description of the Company’s Common Stock which is contained in the Company’s Registration Statement on Form S-1, filed as amended with the Securities and Exchange Commission on August 3, 2009.
All reports and other documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which de-registers all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be a part of this Registration Statement from the date of the filing of such reports and documents.
Any statement contained in an Incorporated Document shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed Incorporated Document modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.
Item 4.
Description of Securities.
The class of securities to be offered is registered under Section 12 of the Exchange Act. Therefore, a description of the Common Stock required by Item 202 of Regulation S-K is not required.
Item 5.
Interests of Named Experts and Counsel.
Donald G. Davis, Esq., of the Law Firm of Davis & Associates, Inc., has provided legal advice to the Registrant in connection with the Company’s preparation of this Registration Statement, and has also through his professional law corporation, rendered a legal opinion attached hereto as an Exhibit, as to the validity and due issuance of the shares of the Company’s Common Stock to be issued and registered hereby. At the same time, Donald G. Davis has been issued shares of the Company’s Common Stock in the past under a prior Company Flexible Stock Plan, and additional shares will be issued to Mr. Davis in the future, in payment of retainers for future legal services to be rendered pursuant to the terms of written Agreements for Legal Services with the Company. Neither Donald G. Davis, nor the law firm of Davis & Associates has been employed on a contingent basis. Neither Mr. Davis nor Davis & Associates has or is to receive a substantial interest direct or indirect in Registrant, nor are either of them connected with Registrant other than in their role as outside special legal counsel for the Company.
Item 6.
Indemnification of Directors and Officers.
The officers and directors of the Company are indemnified as provided by Florida Statutes: Title XXXVI, Chapter 607-Corporations and the Articles and bylaws of the Company.
The Company’s Articles of Incorporation and by-laws include an indemnification provision under which the Company agreed to indemnify all directors and officers to the fullest extent permitted by the laws of the State of Florida.
Item 7.
Exemption from Registration Claimed.
Not applicable.
Item 8.
Exhibits.
Exhibit
Number
Description
4.1
Cord Blood America, Inc. 2010 Flexible Stock Plan
5.1
Opinion of Davis & Associates regarding validity of securities, with “Consent to Use”
23.1
Consent of Rose, Snyder & Jacobs, A Corporation of Certified Public Accountants,, filed herewith.
23.2
Consent of Donald G. Davis, Esq., included in the opinion filed as Exhibit 5.1 hereto.
Item 9.
Undertakings.
The Company hereby undertakes:
A.
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration:
(1)
To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;
(2)
To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement; and
(3)
To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement;
Provided however, that paragraphs (a) (1) and (2) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed by the Company pursuant to section 13 or section 15(d) of the Exchange Act that are incorporated by reference herein.
B.
That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new Registration Statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
C.
To remove from registration by means of post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
(1)
The Company hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the Company’s annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 that is incorporated by reference in the Registration Statement shall be deemed to be a new Registration Statement relating to the securities offered therein, and the offering of such securities at the time shall be deemed to be the initial bona fide offering thereof.
(2)
Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Company pursuant to the foregoing provisions, or otherwise, the Company has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Company of expenses incurred or paid by the director, officer or controlling person of the Company in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Company will, unless in the opinion of the counsel the matter has been settled by controlling precedent, submit to the appropriate jurisdiction the question of whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant, Cord Blood America, Inc., certifies that it has reasonable grounds to believe that it meets all of the requirements for filing a Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of West Hollywood, State of California, on December 30, 2009.
Cord Blood America, Inc.
December 30, 2009
By:
/s/ Matthew L. Schissler
Matthew L. Schissler
Chairman of the Board and Chief Executive Officer
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the date indicated.
Signature
Title
Date
/s/ Matthew L. Schissler
Chief Executive Officer and Director
December 30, 2009
Matthew L. Schissler
/s/ Joseph Vicente
Director
December 30, 2009
Joseph Vicente
EXHIBIT INDEX
Exhibit
Number
Description
4.1
Cord Blood America, Inc. 2010 Flexible Stock Plan
5.1
Opinion of Davis & Associates regarding validity of securities, with “Consent to Use”
23.1
Consent of Rose, Snyder & Jacobs, A Corporation of Certified Public Accountants,, filed herewith.
23.2
Consent of Donald G. Davis, Esq., included in the opinion filed as Exhibit 5.1 hereto.
EX-4.1
EXHIBIT 4.1
CORD BLOOD AMERICA, INC. 2010 FLEXIBLE STOCK PLAN
ARTICLE I
NAME AND PURPOSE
1.1
Name. The name of the Plan is the "Cord Blood America, Inc. 2010 Flexible Stock Plan."
1.2
Purpose. The Company has established the Plan to attract, retain, motivate and reward Employees and other individuals, to encourage ownership of the Company's Common Stock by Employees and other individuals, and to promote and further the best interests of the Company.
ARTICLE II
DEFINITIONS OF TERMS AND RULES OF CONSTRUCTION
2.1
General Definitions. The following words and phrases, when used in the Plan, unless otherwise specifically defined or unless the context clearly otherwise requires, shall have the following respective meanings:
A.
Agreement. The document which evidences the grant of any Benefit under the Plan and which sets forth the Benefit and the terms, conditions and provisions of, and restrictions relating to, such Benefit.
B.
Benefit. Any benefit granted to a Participant under the Plan.
C.
Board. The Board of Directors of the Company.
D.
Company. Cord Blood America, Inc., a Florida Corporation
E.
Committee. The Committee described in Section 5.1, or in the event that the Board of Directors does not appoint a Committee, then the Board of Directors.
F.
Common Stock. The Company's Common Stock, $0.0001 par value.
G.
Effective Date. The date that the Plan is adopted by the Board of Directors.
H.
Employee. Any person, consultant or professional employed by the Employer.
I.
Employer. The Company and all Subsidiaries.
J.
Exchange Act. The Securities Exchange Act of 1934, as amended.
K.
Fair Market Value. The last reported sale price, regular way, of the Shares on any day or, in case no such reported sale takes place on such day, the average of the reported closing bid and asked prices, regular way, in either case on the principal national securities exchange on which the Shares are listed or if the Shares are not listed on a national securities exchange and are listed on the NASDAQ Stock Market, the sale price determined in the same fashion or, if the Shares are not so listed on any of the foregoing, the average of the bid and asked prices on such day as furnished by dealers in the Shares in the over-the-counter market. All calculations of the current market price shall be made to the nearest cent.
L.
Option. An option to purchase Shares granted under the Plan.
M.
Other Stock Based Award. An award under the Plan that is valued in whole or in part by reference to, or is otherwise based on, Common Stock.
N.
Participant. A person who is granted a Benefit under the Plan. Benefits may be granted only to Employees, employees and owners of entities which are not Subsidiaries but which have a direct or indirect ownership interest in an Employer or in which an Employer has a direct or indirect ownership interest, persons who, and employees and owners of entities which, are customers and suppliers of an Employer, persons who, and employees and owners of entities which, render services to an Employer, and persons who, and employees and owners of entities, which have ownership or business affiliations with any persons or entity previously described.
O.
Performance Share. A Share awarded to a Participant under ARTICLE XIV of the Plan.
P.
Plan. The Cord Blood America, Inc. 2010 Flexible Stock Plan, and all amendments and supplements to it.
Q.
Restricted Stock. Shares issued under ARTICLE XIII of the Plan.
R.
Share. A share of Common Stock.
S.
Subsidiary. Any corporation in an unbroken chain of corporations beginning with the Company if, at the time of grant of an Option or other Benefit, each of the corporations, other than the last corporation in the unbroken chain, owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.
2.2
Other Definitions. In addition to the above definitions, certain words and phrases used in the Plan and any Agreement may be defined in other portions of the Plan or in such Agreement.
2.3
Conflicts in Plan. In the case of any conflict in the terms of the Plan relating to a Benefit, the provisions in the ARTICLE of the Plan which specifically permits the grant of such Benefit shall control those in a different ARTICLE.
ARTICLE III
COMMON STOCK
3.1
Number of Shares. The number of Shares which may be issued or sold or for which Options or Performance Shares may be granted under the Plan is fixed at 80,000,000 Shares. At this date there are no shares issued and outstanding under this 2010 Flexible Stock Plan. Such Shares may be authorized but unissued Shares, or Shares held in the treasury, or both.
3.2
Reusage. If an Option expires or is terminated, surrendered, or canceled without having been fully exercised, if Restricted Shares or Performance Shares are forfeited, or if any other grant results in any Shares not being issued, the Shares covered by such Option, grant of Restricted Shares, Performance Shares or other grant, as the case may be, shall again be available for use under the Plan, to the fullest extent permitted under applicable law.
3.3
Adjustments. If there is any change in the Common Stock of the Company by reason of any stock dividend, spin-off, split-up, spin-out, recapitalization, merger, consolidation, reorganization, combination or exchange of shares, the number and class of shares available for Options and grants of Restricted Stock, Performance Shares and Other Stock Based Awards and the number of Shares subject to outstanding Options, grants of Restricted Stock and Performance Shares which are not vested, and Other Stock Based Awards, and the price thereof, as applicable, shall be appropriately adjusted by the Committee.
ARTICLE IV
ELIGIBILITY
4.1
Determined By Committee. The Participants and the Benefits they receive under the Plan shall be determined solely by the Committee, or in the event the Board of Directors does not appoint a Committee, then by the Board of Directors (hereinafter the Committee or the Board, if there is no Committee appointed, is referred to as the “Committee). In making its determinations, the Committee shall consider past, present and expected future contributions of Participants and potential Participants to the Employer, including, without limitation, the performance of, or the refraining from the performance of, services.
ARTICLE V
ADMINISTRATION
5.1 Committee.
A.
The Plan shall be administered by the Board of Directors of the Company, the Stock Option Committee of the Board or another committee of the Board, all as shall be determined by the Board.
B.
If the Board appoints a Committee, the Committee shall be comprised of not less than two persons, and each member of the Committee shall be a member of the Board who during the one year period prior to service on the Committee was, and during such service is, an “outside director,” as such term is utilized in Section 162(m) of the Internal Revenue Code, and a “non-employee director,” as such term is defined and utilized in Rule 16b-3 of the Exchange Act. Subject to the foregoing, the Board may from time to time appoint members of the Committee in substitution for or in addition to members previously appointed, may fill vacancies in the Committee and may remove members of the Committee, at the sole discretion of the Board of Directors.
C.
The Committee shall select one of its members as its chairman and shall hold its meetings at such times and places as it shall deem advisable. A majority of its members shall constitute a quorum and all determinations shall be made by a majority of such quorum. Any determination reduced to writing and signed by all of the members of the Committee shall be fully as effective as if it had been made by a majority vote at a meeting duly called and held.
5.2 Powers.
A.
The Board or the Committee, if so determined by the Board, shall have full power and authority, subject to such orders or resolutions not inconsistent with the provisions of the Plan as may from time to time be issued or adopted by the Board, to grant eligible persons Benefits under the Plan, to determine the restrictions, terms and conditions (which need not be identical) of all Benefits so granted, to interpret the provisions of the Plan and any Agreements relating to Benefits granted under the Plan, and to supervise the administration of the Plan.
B.
The Board or the Committee, if the Board shall so determine, shall have sole authority in the selection of directors, officers and employees of the Company or a Subsidiary, and any consultant, advisor or independent contractor to the Company or a Subsidiary, to whom Awards may be granted under the Plan and in the determination of the timing, pricing, terms, conditions, restrictions and amount of any such Award, subject only to the express provisions of the Plan.
C.
Without limiting the generality of the above Sections, the Board or the Committee shall have the authority to condition any Award, in whole or in part, on performance or other criteria established by the Board or the Committee at the time of grant. In making determinations hereunder, the Board or the Committee may take into account the nature of the services rendered by the respective directors, officers, employees, consultants, advisors or independent contractors, their present and potential contributions to the success of the Company and its Subsidiaries and such other factors as the Board or the Committee in its discretion deems relevant, and may consult with, and give such consideration to the recommendations of, management of the Company as the Board or Committee deems desirable.
5.3
Interpretation. The Board or the Committee is authorized, subject to the provisions of the Plan, to establish, amend and rescind such rules and regulations as it deems necessary or advisable for the proper administration of the Plan and to take such other action in connection with or in relation to the Plan as it deems necessary or advisable. Each action and determination made or taken pursuant to the Plan by the Board or the Committee, including any interpretation or construction of the Plan, shall be final and conclusive for all purposes and upon all persons. No member of the Board or the Committee shall be liable for any action or determination made or taken by him or the Board or the Committee in good faith with respect to the Plan.
ARTICLE VI
AMENDMENT
6.1
Power of Board. Except as hereinafter provided, the Board shall have the sole right and power to amend the Plan at any time and from time to time.
ARTICLE VII
TERM AND TERMINATION
7.1
Term. The Plan shall commence as of the Effective Date, and, subject to the terms of the Plan, including those limiting the period over which Benefits may be granted, shall continue in full force and effect until terminated.
7.2
Termination. The Plan may be terminated at any time by the Board.
ARTICLE VIII
MODIFICATION OR TERMINATION OF BENEFITS
8.1
General. Subject to the provisions of Section 8.2, the amendment or termination of the Plan shall not adversely affect a Participant's right to any Benefit granted prior to such amendment or termination.
8.2
Committee's Right. Any Benefit granted may be converted, modified, forfeited or canceled, in whole or in part, by the Committee if and to the extent permitted in the Plan or applicable Agreement, or in the grant of the benefit, or with the consent of the Participant to whom such Benefit was granted.
ARTICLE IX
AGREEMENTS AND CERTAIN BENEFITS
9.1
Grant Evidenced by Agreement. The grant of any Benefit under the Plan may be evidenced by an Agreement which shall describe the specific Benefit granted and the terms and conditions of the Benefit or may be evidenced by adoption of a Board Resolution. The granting of any Benefit shall be subject to, and conditioned upon, the recipient's execution of any Agreement required by the Committee. Except as otherwise provided in an Agreement, all capitalized terms used in the Agreement shall have the same meaning as in the Plan and theAgreement shall be subject to all of the terms of the Plan.
9.2
Provisions of Agreement. Any Agreement shall contain such provisions that the Committee shall determine to be necessary, desirable and appropriate for the Benefit granted which may include, but not be limited to, the following with respect to any Benefit: description of the type of Benefit; the Benefit's duration;
its transferability; if an Option, the exercise price, the exercise period and the person or persons who may exercise the Option; the effect upon such Benefit of the Participant's death or termination of employment; the Benefit's conditions; when, if, and how any Benefit may be forfeited, converted into another Benefit, modified, exchanged for another Benefit or replaced; and the restrictions on any Shares purchased or granted under the Plan.
9.3
Certain Benefits. Any Benefit granted to an individual who is subject to Section 16 of the Exchange Act shall be not transferable other than by will or the laws of descent and distribution and shall be exercisable during his lifetime only by him, his guardian or his legal representative.
ARTICLE X
REPLACEMENT AND TANDEM AWARDS
10.1
Replacement. The Committee may permit a Participant to elect to surrender a Benefit in exchange for a new Benefit.
10.2
Tandem Awards. Awards may be granted by the Committee in tandem.
ARTICLE XI
PAYMENT, DIVIDENDS, DEFERRAL AND WITHHOLDING
11.1
Payment. Upon the exercise of an Option or in the case of any other Benefit that requires a payment to the Company, the amount due the Company is to be paid:
A.
in cash;
B.
by the tender to the Company of Shares owned by the optionee and registered in his name having a Fair Market Value equal to the amount due to the Company;
C.
by credit by the receipt for a Retainer due and payable under a contract executed by the Company;
D.
in other property, rights and credits, including the Participant's promissory
E.
note; or
F.
by any combination of the payment methods specified in (a), (b) and (c) above.
Notwithstanding the foregoing, any method of payment other than (a) may be used only with the consent of the Committee (or if and to the extent so provided in an Agreement). The proceeds of the Sale of Common Stock purchased pursuant to an Option and any payment to the Company for other Benefits shall be added to the general funds of the Company or to the Shares held in treasury, as the case may be, and used for the corporate purposes of the Company as the Board shall determine.
11.2
Dividend Equivalents. Grants of Benefits in Shares or Share equivalents may include dividend equivalent payments or dividend credit rights.
11.3
Deferral. The right to receive any Benefit under the Plan may, at the request of the Participant, be deferred for such period and upon such terms as the Committee shall determine, which may include crediting of interest on deferrals of cash and crediting of dividends on deferrals denominated in Shares.
11.4
Withholding. The Company, at the time any distribution is made under the Plan, whether in cash or in Shares, may at its discretion withhold from such distribution any amount necessary to satisfy federal, state and local income tax withholding requirements with respect to such distribution. Such withholding shall be in cash or, in the Committee's sole discretion, Shares.
ARTICLE XII
OPTIONS
12.1
Determination by Committee. The terms of all Options shall be determined by the Committee.
ARTICLE XIII
RESTRICTED STOCK
13.1
Description. The Committee may grant Benefits in Shares available under ARTICLE III of the Plan as Restricted Stock. Shares of Restricted Stock shall be issued and delivered at the time of the grant. Each certificate representing Shares of Restricted Stock shall bear a restrictive legend stating that such Shares are nontransferable until all restrictions have been satisfied (and such other legend as may be required in connection with any Agreement relating to the issuance under the Plan). The grantee shall be entitled to full voting and dividend rights with respect to all shares of Restricted Stock from the date of grant.
13.2
Non-Transferability. Shares of Restricted Stock shall not be transferable until after the removal of the legend with respect to such Shares.
ARTICLE XIV
PERFORMANCE SHARES
14.1
Description. Performance Shares are the right of an individual to whom a grant of such Shares is made to receive Shares or cash equal to the Fair Market Value of such Shares at a future date in accordance with the terms of such grant. Generally, such right shall be based upon the attainment of targeted profit and/or performance objectives.
14.2
Grant. The Committee may grant an award of Performance Shares. The number of Performance Shares and the terms and conditions of the grant shall be set forth in an applicable Agreement.
ARTICLE XV
FORM S-8 REGISTERED STOCK
15.1
Description. The Committee may grant Benefits in the form of the issuance of Shares available under ARTICLE III of the Plan, to be issued after filing and effectiveness of an S-8 Registration Statement filed under the Securities Act of 1933 registering such shares, either specifically or as part of a Plan wide registration of shares. The issuance of all such shares shall be in accord with the rules and regulations associated with the use of an S-8 Registration Statement adopted by the Securities and Exchange Commission as amended, and the terms set forth in the S-8 Registration as filed.
ARTICLE XVI
OTHER STOCK BASED AWARDS AND OTHER BENEFITS
16.1
Other Stock Based Awards. The Committee shall have the right to grant Other Stock Based Awards which may include, without limitation, the grant of Shares based on certain conditions, the payment of cash based on the performance of the Common Stock, and the grant of securities convertible into Shares.
16.2
Other Benefits. The Committee shall have the right to provide types of Benefits under the Plan in addition to those specifically listed, if the Committee believes that such Benefits would further the purposes for which the Plan was established.
ARTICLE XVII
MISCELLANEOUS PROVISIONS
17.1
Underscored References. The underscored references contained in the Plan are included only for convenience, and they shall not be construed as a part of the Plan or in any respect affecting or modifying its provisions.
17.2
Number and Gender. The masculine and neuter, wherever used in the Plan, shall refer to either the masculine, neuter or feminine; and, unless the context otherwise requires, the singular shall include the plural and the plural the singular.
17.3
Governing Law. This Plan shall be construed and administered in accordance with the laws of the State of Florida.
17.4
Purchase for Investment. The Committee may require each person purchasing Shares pursuant to an Option, or receiving shares under an award under the Plan to represent to and agree with the Company in writing that such person is acquiring the Shares for investment and without a view to distribution or resale. The certificates for such Shares may include any legend which the Committee deems appropriate to reflect any restrictions on transfer. All certificates for Shares delivered under the Plan shall be subject to such stock-transfer orders and other restrictions as the Committee may deem advisable under all applicable laws, rules and regulations, and the Committee may cause a legend or legends to be put on any such certificates to make appropriate references to such restrictions.
17.5
No Employment Contract. The adoption of the Plan shall not confer upon any Employee any right to continued employment nor shall it interfere in any way with the right of the Employer to terminate the employment of any of its Employees at any time.
17.6
No Effect on Other Benefits. The receipt of Benefits under the Plan shall have no effect on any benefits to which a Participant may be entitled from the Employer, under another plan or otherwise, or preclude a Participant from receiving any such benefits.
Undersigned, the Secretary of Cord Blood America, Inc., hereby certifies that this Cord Blood America, Inc 2010 Flexible Stock Plan was duly adopted by the Board of Directors of the Corporation, effective as of December 30, 2010.
Date: December 30, 2009
/s/ Matthew L. Schissler
Matthew L. Schissler, Chief Executive Officer
EX-5.1
EX 5.1
DAVIS & ASSOCIATES
(A PROFESSIONAL LAW CORPORATION)
-SECURITIES, BUSINESS & INTERNATIONAL LAWYERS-
LOS ANGELES
Ritz Carlton Annex
(310) 823-8300/fax (310) 301-3370 NEWPORT BEACH
Balboa Bay Club Annex
(949) 631-1142
Respond To:
P.O. Box 12009
Marina Del Rey, CA
90295-3009
December 30, 2009
Cord Blood America, Inc.
501 Santa Monica Blvd, Suite 700
Santa Monica, CA 90401
We have acted as counsel to Cord Blood America, Inc., a Florida corporation (the “Company”), in connection with the registration under the Securities Act of 1933, as amended, on Form S-8 (the
Ladies and Gentlemen,
“Registration Statement”) of an aggregate of 80,000,000 shares of Common Stock of the Company, for issuance in the future; all such shares to be issued pursuant to the Company’s 2010 Flexible Stock Plan (the “Plan”). Such shares issuable pursuant to the Plan are referred to herein as the “Shares”.
As such counsel, we have examined and relied upon originals or copies, certified or otherwise, identified to our satisfaction, of such corporate records, agreements, documents, instruments and certificates of law, as we deemed necessary or appropriate in order to enable us to render the opinion expressed below.
Based upon the foregoing and in reliance thereon, we are of the opinion that the Shares, upon issuance by action by the Company’s Board of Directors, and when issued in accord
with the terms and provisions of the Plan, will be duly and validly authorized, and validly issued, fully paid and non-assessable Shares of the Common Stock of the Company..
We are admitted to practice in the State of California, and are not admitted to practice in the State of Florida. However, for the limited purposes of our opinion set forth above, we are generally familiar with the General Corporation Law of the State of Florida as presently in effect and have made such inquiries as we consider necessary to render this opinion with respect to a Florida corporation. This opinion letter is limited to the laws of the State of California and, to the extent set forth above, Florida Corporate Law, as such laws presently exist and to the facts as they presently exist. We express no opinion with respect to the effect or applicability of the laws in any other jurisdiction.
The opinion stated herein is as of the date hereof, and we assume no obligation to update or supplement this legal opinion to reflect any facts or circumstances that may hereafter come to our attention or any changes in laws that may hereafter occur. This legal opinion is limited to the matters stated herein and no opinion is implied or may be inferred beyond the matters expressly stated.
We consent to the filing of this Opinion as an exhibit to the Form S-8 Registration Statement, and to the use of our name wherever it appears in said Registration Statement. In giving our consent, we do not consider that we are “experts” within the meaning of such term as used in the Securities Act of 1933, as amended (the “Act”), or the rules and regulations of the SEC issued there under with respect to the Registration Statement, or with respect to this Opinion as an Exhibit or otherwise, nor do we consider ourselves within the category of persons whose “consent” is required by Section 7 of said Act.
We consent to the filing of this Opinion as an exhibit to the Registration Statement.
Very truly yours,
/s/ Donald G. Davis
DAVIS & ASSOCIATES
EX-23.1
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation by reference, in this Registration Statement on Form S-8, of our report dated April 14, 2009, with respect to the financial statements of Cord Blood America, Inc., and Subsidiaries appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2008.
/s/ Rose, Snyder & Jacobs
Rose, Snyder & Jacobs
A Corporation of Certified Public Accountants
Encino, California
December 28, 2009
Sapperlot - war ne Weile nicht online...bin überrascht- den Bericht muss ich mir erst durchlesen...hätte auch ein Link gereicht - so kann das kein Mensch lesen
Antwort auf Beitrag Nr.: 38.649.103 von fuerza_hercuela am 30.12.09 19:44:22Junger Vater " NITE ist
Knight Capital Group (NITE) Research
ein Makler - nicht mehr und nicht weniger
Knight Capital Group (NITE) Research
ein Makler - nicht mehr und nicht weniger
Müsste heute einen SK knapp an die 0,014 US$ reichen so wie ich das sehe...der Bericht ist ja genial...jetzt steigen die richtigen dort ein...bin aber noch nicht fertig mit der Analyse
super bericht jetzt kanns losgehen
3 Monatshoch ....6 Monatshoch geknackt...nun kommt das 1 Jahreshoch dran...liegt bei 0,0159 US$...danach weiß kein Mensch was so passieren kann...denke Anfang Januar packen wir das 1 Jahreshoch
Antwort auf Beitrag Nr.: 38.649.180 von oski am 30.12.09 19:56:2680 Millionen Shares an den Investor gegangen zu 0,0117....jetzt heißt es nur geduldig sein
Antwort auf Beitrag Nr.: 38.649.103 von fuerza_hercuela am 30.12.09 19:44:22http://www.otcbb.com/asp/Info_Center.asp
nächste kaufwelle kommt
Antwort auf Beitrag Nr.: 38.649.432 von oski am 30.12.09 21:18:04yeah; sieht gut aus !!
Antwort auf Beitrag Nr.: 38.649.445 von itsSHOWTIME am 30.12.09 21:22:200.0129 vol.400,000,000
Wird ein guter Jahresausklang!!
Antwort auf Beitrag Nr.: 38.649.493 von Stimmungskanone am 30.12.09 21:35:19morgen vielleicht noch ein kleiner kursanstieg
+ dann wäre der euro-cent am montag in d machbar.
+ dann wäre der euro-cent am montag in d machbar.
Auf gehts jetzt ich will schon 2 Std. in die Kneipe....FINALE
SK 0,0125 US$..sauber ...Applaus..Prost - bin weg
Antwort auf Beitrag Nr.: 38.649.582 von Expertchen007 am 30.12.09 22:00:43na denn prost - und `nen guten rutsch !!
Denke eher, dass es morgen zu erheblichen Gewinnmitnahmen in den Staaten kommen wird. Grundsätzlich sehe ich in CBAI allerdings ein ordentliches Potential !
starke letzte stunde
morgen gehts weiter UP
bis denne
morgen gehts weiter UP
bis denne
Antwort auf Beitrag Nr.: 38.649.674 von fuerza_hercuela am 30.12.09 22:25:57fuerza da gebe ich dir recht, es gibt selten nur eine Richtung und zum
Jahresende wollen mit Sicherheit einige die Gewinne mitnehmen.
Potential gut, aber vorher gehts nochmal kräftig rund.
could be right, could be wrong
Jahresende wollen mit Sicherheit einige die Gewinne mitnehmen.
Potential gut, aber vorher gehts nochmal kräftig rund.
could be right, could be wrong
In den USA im Bundesstaat Georgia ist es bereits ein erlassenes Gesetz: Ab July 2009 müssen alle werdenden Mütter durch Ihren Arzt über die Möglichkeit der Speicherung der Blutzellen aufgeklärt werden!
http://www.savingthecure.com
http://www.legis.ga.gov/legis/2007_08/sum/sb148.htm
...The bill provides that, after July 1, 2009, every expectant Georgia mother will be given information by her doctor on the full range of options with regard to postnatal tissue and fluid, including private storage and public donation. Every Georgia mother will be given the opportunity to “save the cure.”...
http://www.savingthecure.com
http://www.legis.ga.gov/legis/2007_08/sum/sb148.htm
...The bill provides that, after July 1, 2009, every expectant Georgia mother will be given information by her doctor on the full range of options with regard to postnatal tissue and fluid, including private storage and public donation. Every Georgia mother will be given the opportunity to “save the cure.”...
Wie gesagt, gehe für die nächsten Wochen noch von erheblichen Schwankungen aus, die aus meiner Sicht gute Tradingchancen darstellen. Jahresziel aus meiner Sicht sehe ich bei ca. 0,05 € (als Etappe).
Meine persönliche Meinung - keine Handelsaufforderung !
Meine persönliche Meinung - keine Handelsaufforderung !
Das war doch ein schöner Verlauf die letzten Tage. Schaun mer mal auf 2010. Bis zur Eröffnung am 22.1.2010 wird es - bei anhaltender Euphorie - wohl auch keine großen Kursrückschläge mehr geben.
Ich halte kleinere Kursrückschläge jedoch durchaus für möglich - aber wenn, enden die dann bereits weit über dem heutigen Niveau.
Einsteigen könnte somit von Tag zu Tag teurer werden...
(Meine Meinung - keine Empfehlung)
In freudiger Erwartung auf 2010
allen einen "Guten Rutsch" und für 2010 ein
Glück auf!
Antwort auf Beitrag Nr.: 38.650.576 von Skrollein am 31.12.09 12:01:04hallo
das volumen ist zu hoch das es einen markanten rücksetzer geben wird
heute schluss bei 0.015
nur meine meinung
das volumen ist zu hoch das es einen markanten rücksetzer geben wird
heute schluss bei 0.015
nur meine meinung
Mir wird es langsam schwindelig wenn das so weiter geht.
Ist den die MK überhaupt noch gerechtfertigt?
Ist den die MK überhaupt noch gerechtfertigt?
Heute fast nur Verkäufe!
Antwort auf Beitrag Nr.: 38.651.393 von Stimmungskanone am 31.12.09 15:45:20War Gestern auch so, schaun mer mal.
Lasst Börse..Börse sein heute....wünsche guten Rutsch
und ja die MK ist gerade mal bei knapp 60 Mio. und ein R/S wird irgendwann kommen...nur wann....
Als Musiker muss ich heute arbeiten ( aber die Gage ist lecker )....und alles gratis dazu...
SEE you in 2010
und ja die MK ist gerade mal bei knapp 60 Mio. und ein R/S wird irgendwann kommen...nur wann....
Als Musiker muss ich heute arbeiten ( aber die Gage ist lecker )....und alles gratis dazu...
SEE you in 2010
Antwort auf Beitrag Nr.: 38.651.438 von Expertchen007 am 31.12.09 15:51:54All together,
a HAPPY NEW YEAR!!!
Greatings and all wishes from Hamburg
a HAPPY NEW YEAR!!!
Greatings and all wishes from Hamburg
Einen guten Rutsch ins Neue Jahr und alle Gute für 2010
wünscht vom Bodensee
Stimmungskanone
wünscht vom Bodensee
Stimmungskanone
Happy New Year in Venice
guten rutsch und ein gesundes 2010
Heute gibt es wohl keine Jahres-Endrally mehr!!!!
Antwort auf Beitrag Nr.: 38.651.932 von Stimmungskanone am 31.12.09 17:31:07abwarten
Ich denke es wird so verlaufen wie gestern, gegen Ende wirds wieder aufwärts gehen.
Mein SK-Tipp: 0,0135
Einen guten Rutsch ins Jahr 2010 euch Allen
Cleffy
Mein SK-Tipp: 0,0135
Einen guten Rutsch ins Jahr 2010 euch Allen
Cleffy
Antwort auf Beitrag Nr.: 38.652.066 von oski am 31.12.09 18:10:41Soll das heissen, dass wieder neue Aktien raus gegeben werden?
0.0115 -0.0010 (-8.00%)
Delayed: 3:43PM EST
Vielleicht klappt es ja dann in der ersten Januarwoche mit meinem günstigen Reinvest bei CBAI !
__________________________________________________________________
Allen einen guten Rutsch und alles GUTE für 2010 !
Delayed: 3:43PM EST
Vielleicht klappt es ja dann in der ersten Januarwoche mit meinem günstigen Reinvest bei CBAI !
__________________________________________________________________
Allen einen guten Rutsch und alles GUTE für 2010 !
Antwort auf Beitrag Nr.: 38.652.248 von Scania01 am 31.12.09 19:50:34das ist eine reduktion der warrants/shares von 1.4Mi.zu 840M. ein guter deal für die shareholders
meiner meinung
meiner meinung
Antwort auf Beitrag Nr.: 38.655.748 von oski am 03.01.10 00:32:03müsste sich doch Positiv auf den Kurs auswirken
Antwort auf Beitrag Nr.: 38.656.163 von kunokuhn am 03.01.10 11:55:27Wenn noch mehr Aktien auf den Markt kommen und den Kurs verwässern.
Sollte mich wundern.
Sollte mich wundern.
....werde gleich morgen Früh eine Order zu 0,006 € aufgeben !
Antwort auf Beitrag Nr.: 38.656.163 von kunokuhn am 03.01.10 11:55:27bis zum 23.januar und darüber hinaus
Antwort auf Beitrag Nr.: 38.656.228 von fuerza_hercuela am 03.01.10 12:17:31Wer soll deine Order den bedienen ?
Total nette Menschen ?
Wenn du noch welche bei 0,008€ bekommst kannst du glaub ich froh sein.
Soll weder kauf- noch verkaufsempfehlung sein.
Aber bei 0,006 nehme ich auch welche.
Total nette Menschen ?
Wenn du noch welche bei 0,008€ bekommst kannst du glaub ich froh sein.
Soll weder kauf- noch verkaufsempfehlung sein.
Aber bei 0,006 nehme ich auch welche.
Antwort auf Beitrag Nr.: 38.656.924 von Blade99 am 03.01.10 17:08:57Könnte nochmals günstig werden.
http://americanbulls.com/StockPage.asp?CompanyTicker=CBAI&Ma…
http://americanbulls.com/StockPage.asp?CompanyTicker=CBAI&Ma…
Antwort auf Beitrag Nr.: 38.657.031 von Scania01 am 03.01.10 17:55:23Ich denke unter 0,01$ geht es nie wieder!
Cleffy
Cleffy
Antwort auf Beitrag Nr.: 38.657.084 von Cleffy am 03.01.10 18:13:33Na dann schau dir mal die Chartanalyse an.
http://timelesswealth.net/ta/cbai.html
http://timelesswealth.net/ta/cbai.html
Antwort auf Beitrag Nr.: 38.657.127 von Cleffy am 03.01.10 18:32:51Lach ruhig, das soll die schmerzen lindern.
montag gehts erst richtig los
Antwort auf Beitrag Nr.: 38.657.210 von oski am 03.01.10 18:59:11Und wie hoch, denkst du geht es noch nach deiner Meinung.
Antwort auf Beitrag Nr.: 38.657.408 von Scania01 am 03.01.10 20:09:0609:13:05 0,005 2750000
is das echt wahr?!?!
versteh ich nicht! hätt ich nur ne order heute morgen rein!
is das echt wahr?!?!
versteh ich nicht! hätt ich nur ne order heute morgen rein!
guten morgen zusammen
ein wunderschönes fröhliches neues jahr wünsche ich,
an die cord investierten!
möge unser cord dieses jahr eine rakete werden
wenn die 0,01 in amerika hält könnten wir nach meiner meinung,
die 0,02 angreifen
bis ende dieses monats bin ich davon überzeugt
natürlich nur meine meinung!
wenn die ersten umsätze erst reinkommen,
dann sehen wir hier andere kurse
ein wunderschönes fröhliches neues jahr wünsche ich,
an die cord investierten!
möge unser cord dieses jahr eine rakete werden
wenn die 0,01 in amerika hält könnten wir nach meiner meinung,
die 0,02 angreifen
bis ende dieses monats bin ich davon überzeugt
natürlich nur meine meinung!
wenn die ersten umsätze erst reinkommen,
dann sehen wir hier andere kurse
Frohes neues Jahr ,
gebt dem Wert nun einfach etws Zeit sich zu entwickeln...er wird es uns danken - da bin ich mir sicher - dieses Unternehmen sitzt erst auf der Startrampe - ....................und mit reduziertem Aktienanteil kanns nur " noch " besser werden
gebt dem Wert nun einfach etws Zeit sich zu entwickeln...er wird es uns danken - da bin ich mir sicher - dieses Unternehmen sitzt erst auf der Startrampe - ....................und mit reduziertem Aktienanteil kanns nur " noch " besser werden
Antwort auf Beitrag Nr.: 38.658.679 von lilie31 am 04.01.10 10:30:00sehr großen optimismus prägst du da
aber ich will hoffen das du zu 200% recht behälst
generell mal eine frage, wie steht den cord blood derzeit da fürs neue jahr, rein finanziell und technisch/entwicklungsführend?
aber ich will hoffen das du zu 200% recht behälst
generell mal eine frage, wie steht den cord blood derzeit da fürs neue jahr, rein finanziell und technisch/entwicklungsführend?
Antwort auf Beitrag Nr.: 38.656.228 von fuerza_hercuela am 03.01.10 12:17:31frohes neues jahr @ all !!
jetzt schreib` nicht, dass du heute morgen die stücke zu 5 bekommen hast. das wäre ja der hammer!!
jetzt schreib` nicht, dass du heute morgen die stücke zu 5 bekommen hast. das wäre ja der hammer!!
Antwort auf Beitrag Nr.: 38.659.331 von itsSHOWTIME am 04.01.10 12:07:08Kann mir nicht vorstellen das der Deal auf der 0,005 von uns jemand was bekommen hat,......denn da steh ich schon ewig drauf.....war wohl ein interner Wechsel der Shares....na ja ich steh mal auf der 0,007 an...aber auch noch nix bedient worden...obwohl einiges gelaufen ist dort ...USA Pari wäre ja genau 0,008
eine lächerliche 35 K Auführung hab ich in Stutgart bekommen bis jetzt auf der 7
We've gotten e-mails from investors saying that there are forces trying to shake loose some shares of Cord Blood America Inc. (OTC:CBAI) even as most traders are to looking forward to riding the stock price up towards the company's big forward-looking news event.
After re-examining the company's recent filings and reading carefully through the press-releases about the upcoming grand opening of their new Las Vegas facilities, it is hard to understand what some of these bears are seeing.
kann mir jemand sagen was das zu bedeuten hat ,Bitte
After re-examining the company's recent filings and reading carefully through the press-releases about the upcoming grand opening of their new Las Vegas facilities, it is hard to understand what some of these bears are seeing.
kann mir jemand sagen was das zu bedeuten hat ,Bitte
Vollständige Nachricht zu dem Hier:http://biomedreports.com/articles/most-popular/23186-shaking…
Antwort auf Beitrag Nr.: 38.659.060 von Expertchen007 am 04.01.10 11:23:31ist das schon beschlossene Sache, dass die shares durch einen split reduziert werden?
Stammt aus dem Artikel...immer cool bleiben ...es geht bald los
**********************************************************
http://biomedreports.com/articles/most-popular/23186-shaking…
Shaking loose shares of potential multi-bagger Cord Blood America (OTC:CBAI)? PDF | Print | E-mail
Written by Peter DePalma
Monday, 04 January 2010 04:48
We've gotten several e-mails from investors saying that there are forces trying to shake loose some shares of Cord Blood America Inc. (OTC:CBAI) even as most traders are to looking forward to riding the stock price up, ahead of the company's big forward-looking news event.
After re-examining the company's recent filings and reading carefully through the press-releases about the upcoming grand opening of their new Las Vegas facilities, it is hard to understand what some of these bears are seeing.
Quotes delayed at least 20 mins.
We dug up the most recent filings and examined them for hours as a team. It's become quite clear to our various in-house analysts and writers that despite fears of dilution:
1) The stock just emerged from sub-penny levels on incredible volume, but it appears that shares of CBAI are "priced" at a minimum of $.03 and could move to $.05 on this upcoming news event.
2) The compay has announced recent debt reduction of over $10 million and may be positioned to reduce even more debt.
3) The company now has an improved business model to work from
4) Last quarter Gross Profit increased from 54.3% to 62.7%.
And finally, there is the very important grand opening of their new lab and corporate offices- set to take place later this month on January 22, 2010. That even is a very positive event and major milestone for the company.
We're scheduled to interview the CEO of the company within the next 24-48 hours and should have an update straight from the source.
In the meantime, please be very careful of listening to bloggers and self-anointed experts and do your own due dillegence.
We warned people to stay away from this play last year, but now it could be setting up a "multi-bagger" type move from current levels.
Of course, that's just our opinion as well.
Stay tuned for solid news.
Disclosure: Long CBAI
**********************************************************
http://biomedreports.com/articles/most-popular/23186-shaking…
Shaking loose shares of potential multi-bagger Cord Blood America (OTC:CBAI)? PDF | Print | E-mail
Written by Peter DePalma
Monday, 04 January 2010 04:48
We've gotten several e-mails from investors saying that there are forces trying to shake loose some shares of Cord Blood America Inc. (OTC:CBAI) even as most traders are to looking forward to riding the stock price up, ahead of the company's big forward-looking news event.
After re-examining the company's recent filings and reading carefully through the press-releases about the upcoming grand opening of their new Las Vegas facilities, it is hard to understand what some of these bears are seeing.
Quotes delayed at least 20 mins.
We dug up the most recent filings and examined them for hours as a team. It's become quite clear to our various in-house analysts and writers that despite fears of dilution:
1) The stock just emerged from sub-penny levels on incredible volume, but it appears that shares of CBAI are "priced" at a minimum of $.03 and could move to $.05 on this upcoming news event.
2) The compay has announced recent debt reduction of over $10 million and may be positioned to reduce even more debt.
3) The company now has an improved business model to work from
4) Last quarter Gross Profit increased from 54.3% to 62.7%.
And finally, there is the very important grand opening of their new lab and corporate offices- set to take place later this month on January 22, 2010. That even is a very positive event and major milestone for the company.
We're scheduled to interview the CEO of the company within the next 24-48 hours and should have an update straight from the source.
In the meantime, please be very careful of listening to bloggers and self-anointed experts and do your own due dillegence.
We warned people to stay away from this play last year, but now it could be setting up a "multi-bagger" type move from current levels.
Of course, that's just our opinion as well.
Stay tuned for solid news.
Disclosure: Long CBAI
Antwort auf Beitrag Nr.: 38.660.394 von jebbatch am 04.01.10 14:42:47Musst du im ganzen lesen...siehe mein letztes Posting....alles wunderbar und noch besser
Antwort auf Beitrag Nr.: 38.660.429 von Tom06 am 04.01.10 14:46:57Nein !!! Sie wurden reduziert durchs Unternehmen - indem Aktien zurückgekauft wurden und diese jetzt auch nicht mehr am Markt sind....alles mal abwarten...hier sind mehr als ein paar % drin
Antwort auf Beitrag Nr.: 38.660.443 von Expertchen007 am 04.01.10 14:48:02hey :-) viel erfolg im neuen jahr. vielleicht ist CBAI ja der überflieger.
@ jebbatch
das ist die meinung eines einzelnen, der "nicht verstehen kann woher die bären ihr futter nehmen". er persönlich sieht CBAI aufgrund der aktuellen situation bei 0.03$, mit guten news bei 0.05$
@ jebbatch
das ist die meinung eines einzelnen, der "nicht verstehen kann woher die bären ihr futter nehmen". er persönlich sieht CBAI aufgrund der aktuellen situation bei 0.03$, mit guten news bei 0.05$
Antwort auf Beitrag Nr.: 38.660.447 von Expertchen007 am 04.01.10 14:48:53den hinteren teil hab ich schon verstanden,aber das mit dem splitten nicht ... hab auch nicht grad nicht das beste übersetzungsprogramm und für so ne nachricht ist mein englisch zu schlecht
Antwort auf Beitrag Nr.: 38.660.476 von Expertchen007 am 04.01.10 14:52:03weisst du um wieviele es sich dabei handelt? die werden sicherlich früher oder später zur finanzierung diverser projekte wieder neu eingesetzt. das war sehr schlau.
Antwort auf Beitrag Nr.: 38.660.476 von Expertchen007 am 04.01.10 14:52:03ups - hatte ich gar nicht mitbekommen
...... wann hat CBAI welche Anzahl von Aktien zurückgekauft?
...... wann hat CBAI welche Anzahl von Aktien zurückgekauft?
und es gibt NEWS....bereits übersetzt....
original hier
http://ih.advfn.com/p.php?pid=nmona&cb=1262613420&article=40…
Cord Blood America kündigt Nabelschnurblut-Stammzellen Verarbeitung und Lagerung Abkommen mit BioCells, eine südamerikanische Unternehmen
LAS VEGAS, Jan. 4 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com/)" target="_blank" rel="nofollow ugc noopener">http://www.cordblood-america.com/) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has signed a Letter of Intent to process and store cord blood specimens for BioCells, Inc., headquartered in Argentina, and its affiliates in Peru, Colombia, Bolivia, Panama and Puerto Rico
"Dies ist ein ausgezeichnetes Beispiel dafür, wie unser neues Labor-und Lagerhalle in Las Vegas erlaubt es uns, unser Geschäftsmodell deutlich zu diversifizieren", sagte Matthew Schissler, Mitbegründer und CEO. "BioCells ist bereits der zweitgrößte Stammzell-Lagerung Unternehmen in Argentinien mit einem Jahresumsatz von 1,5 (USD). Das Unternehmen verfügt über 12 Standorte im ganzen Land und hat kürzlich international sowohl Uruguay und Paraguay erweitert. Wir sind zuversichtlich, dass dies eine hervorragende Zusammenarbeit, von Vorteil für beide Unternehmen. Wir werden die Verarbeitung und Speicherung für Partner BioCells "in Peru, Kolumbien, Bolivien, Panama und Puerto Rico."laboratory and storage facility in Las Vegas allows us to significantly diversify our business model," said Matthew Schissler, co-founder and CEO. "BioCells is already the second largest stem cell storage company in Argentina with annual revenues of 1.5M (USD). The company has 12 locations throughout the country and has recently expanded internationally to both Uruguay and Paraguay. We are confident this will be an excellent working relationship, beneficial to both companies. We will be processing and storing for BioCells' affiliates in Peru, Colombia, Bolivia, Panama and Puerto Rico."
"Es ist eine Einnahmen-Generator haben wir nicht in der Vergangenheit hatte. Nicht nur, dass wir unser eigenes organisches Umsatzwachstum Motor haben, kann unser neues Labor erzeugt nun der Bruttogewinn um Verarbeitung und Speicherung von Vereinbarungen mit anderen erfolgreichen Stammzellen-Unternehmen", kommentierte Herr Schissler . "BioCells hat sich als eine enorme Unternehmen und wir haben das Glück, in diese Absichtserklärung eingegeben haben."generator we have not had in the past. Not only do we have our own organic sales engine, our new lab can now generate gross profit by processing and storage agreements with other successful stem cell companies," Mr. Schissler commented. "BioCells has proven to be a tremendous company and we are fortunate to have entered into this letter of intent."
Cord Blood America kündigte vor kurzem eine festliche Eröffnung des 17.000 Quadratmeter Labor-und Stammzellen-Hauptquartier ist in Las Vegas, nahe dem internationalen Flughafen der Stadt, am 22. Januar 2010international airport, on January 22, 2010
Die Vereinbarung zwischen Amerika und Cord Blood BioCells anhängig ist Due Diligence, und wenn es erfolgreich abgeschlossen ist, erwartet das Closing des Vertrags im ersten Quartal 2010
Über Cord Blood Amerika
Cord Blood America (OTC: CBAI) (OTC Bulletin Board: CBAI) ist die Muttergesellschaft von CorCell, die Nabelschnurblut-Stammzellen Erhaltung für werdende Eltern und ihre Kinder erleichtert. Seine Aufgabe ist es, das angesehenste Stammzellen Erhaltung Unternehmen in der Branche. Über eine sichere und nicht-invasive Verfahren Collected bieten Stammzellen aus Nabelschnurblut eine starke und potenziell lebensrettende Ressource für die Behandlung einer wachsenden Zahl von Krankheiten, darunter Krebs, Leukämie, Blut-und Immunerkrankungen. Sie möchten mehr wissen über Cord Blood America, Inc. (OTC: CBAI) (OTC Bulletin Board: CBAI), besuchen Sie unsere Website unter http://www.corcell.com/. Bei Investor-Informationen finden Sie unter http://www.cordblood-america.com/cancer," target="_blank" rel="nofollow ugc noopener">http://www.cordblood-america.com/cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC:CBAI) (BULLETIN BOARD: CBAI) , visit our website at http://www.corcell.com/. For investor information, visit http://www.cordblood-america.com/
Kontakt: Paul Knopick E & E Communications 949/707-5365
Forward-Looking Statements
original hier
http://ih.advfn.com/p.php?pid=nmona&cb=1262613420&article=40…
Cord Blood America kündigt Nabelschnurblut-Stammzellen Verarbeitung und Lagerung Abkommen mit BioCells, eine südamerikanische Unternehmen
LAS VEGAS, Jan. 4 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com/)" target="_blank" rel="nofollow ugc noopener">http://www.cordblood-america.com/) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has signed a Letter of Intent to process and store cord blood specimens for BioCells, Inc., headquartered in Argentina, and its affiliates in Peru, Colombia, Bolivia, Panama and Puerto Rico
"Dies ist ein ausgezeichnetes Beispiel dafür, wie unser neues Labor-und Lagerhalle in Las Vegas erlaubt es uns, unser Geschäftsmodell deutlich zu diversifizieren", sagte Matthew Schissler, Mitbegründer und CEO. "BioCells ist bereits der zweitgrößte Stammzell-Lagerung Unternehmen in Argentinien mit einem Jahresumsatz von 1,5 (USD). Das Unternehmen verfügt über 12 Standorte im ganzen Land und hat kürzlich international sowohl Uruguay und Paraguay erweitert. Wir sind zuversichtlich, dass dies eine hervorragende Zusammenarbeit, von Vorteil für beide Unternehmen. Wir werden die Verarbeitung und Speicherung für Partner BioCells "in Peru, Kolumbien, Bolivien, Panama und Puerto Rico."laboratory and storage facility in Las Vegas allows us to significantly diversify our business model," said Matthew Schissler, co-founder and CEO. "BioCells is already the second largest stem cell storage company in Argentina with annual revenues of 1.5M (USD). The company has 12 locations throughout the country and has recently expanded internationally to both Uruguay and Paraguay. We are confident this will be an excellent working relationship, beneficial to both companies. We will be processing and storing for BioCells' affiliates in Peru, Colombia, Bolivia, Panama and Puerto Rico."
"Es ist eine Einnahmen-Generator haben wir nicht in der Vergangenheit hatte. Nicht nur, dass wir unser eigenes organisches Umsatzwachstum Motor haben, kann unser neues Labor erzeugt nun der Bruttogewinn um Verarbeitung und Speicherung von Vereinbarungen mit anderen erfolgreichen Stammzellen-Unternehmen", kommentierte Herr Schissler . "BioCells hat sich als eine enorme Unternehmen und wir haben das Glück, in diese Absichtserklärung eingegeben haben."generator we have not had in the past. Not only do we have our own organic sales engine, our new lab can now generate gross profit by processing and storage agreements with other successful stem cell companies," Mr. Schissler commented. "BioCells has proven to be a tremendous company and we are fortunate to have entered into this letter of intent."
Cord Blood America kündigte vor kurzem eine festliche Eröffnung des 17.000 Quadratmeter Labor-und Stammzellen-Hauptquartier ist in Las Vegas, nahe dem internationalen Flughafen der Stadt, am 22. Januar 2010international airport, on January 22, 2010
Die Vereinbarung zwischen Amerika und Cord Blood BioCells anhängig ist Due Diligence, und wenn es erfolgreich abgeschlossen ist, erwartet das Closing des Vertrags im ersten Quartal 2010
Über Cord Blood Amerika
Cord Blood America (OTC: CBAI) (OTC Bulletin Board: CBAI) ist die Muttergesellschaft von CorCell, die Nabelschnurblut-Stammzellen Erhaltung für werdende Eltern und ihre Kinder erleichtert. Seine Aufgabe ist es, das angesehenste Stammzellen Erhaltung Unternehmen in der Branche. Über eine sichere und nicht-invasive Verfahren Collected bieten Stammzellen aus Nabelschnurblut eine starke und potenziell lebensrettende Ressource für die Behandlung einer wachsenden Zahl von Krankheiten, darunter Krebs, Leukämie, Blut-und Immunerkrankungen. Sie möchten mehr wissen über Cord Blood America, Inc. (OTC: CBAI) (OTC Bulletin Board: CBAI), besuchen Sie unsere Website unter http://www.corcell.com/. Bei Investor-Informationen finden Sie unter http://www.cordblood-america.com/cancer," target="_blank" rel="nofollow ugc noopener">http://www.cordblood-america.com/cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC:CBAI) (BULLETIN BOARD: CBAI) , visit our website at http://www.corcell.com/. For investor information, visit http://www.cordblood-america.com/
Kontakt: Paul Knopick E & E Communications 949/707-5365
Forward-Looking Statements
Dies ist ein Vertrag von vielen die hoffentlich alle auch noch folgen werden
Antwort auf Beitrag Nr.: 38.660.550 von Tom06 am 04.01.10 14:59:442-3 Seiten einfach zurückblättern....oder zuviel verlangt ??? ...da müsste es stehen...hatte jemand eingestellt
Antwort auf Beitrag Nr.: 38.660.593 von Expertchen007 am 04.01.10 15:06:43hab es rausgesucht, es handelt sich um 840 Mio Stück:
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=6673…
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=6673…
Antwort auf Beitrag Nr.: 38.660.593 von Expertchen007 am 04.01.10 15:06:43nein - nicht zu viel verlangt - Danke
Antwort auf Beitrag Nr.: 38.660.726 von kleingeldjaeger am 04.01.10 15:21:08Die waren aber ganz schön teuer .......... gut das war der Kurs am 30.12.2009 ......... hätte sie die Aktien ein paar Wochen vorher zurückgekauft wären sie billiger gewesen
...los mal raus...mit meiner Restbestellung
Antwort auf Beitrag Nr.: 38.660.798 von Tom06 am 04.01.10 15:28:06ja, aber wenn man bedenkt das die shares innerhalb der nächsten monate das doppelte kosten "könnten" war das vielleicht noch ein guter deal.
Super weitere Teile 10 129 bekommen...da lohnt ja die Gebühr fast nicht.....
Antwort auf Beitrag Nr.: 38.660.964 von Expertchen007 am 04.01.10 15:44:05zahlst du auch für jede teilausführung? echt ätzend. sei froh das es nicht 100er pakete sind wie manchmal @ nasdaq
Antwort auf Beitrag Nr.: 38.660.898 von kleingeldjaeger am 04.01.10 15:38:16es ist immer ein gutes Zeichen, wenn ein Unternehmen eigene Aktien aufkauft
von daher denke ich, dass die wissen was sie tun
von daher denke ich, dass die wissen was sie tun
Antwort auf Beitrag Nr.: 38.661.043 von kleingeldjaeger am 04.01.10 15:49:17da hab ich wohl den grösseren brocken bekommen,
43.670
is aber echt zum kotzen mit der teilausführung!
43.670
is aber echt zum kotzen mit der teilausführung!
Antwort auf Beitrag Nr.: 38.661.061 von MoneyDee am 04.01.10 15:50:42ach nee seh gerade hab nur 6330 bekommen!!
Antwort auf Beitrag Nr.: 38.661.043 von kleingeldjaeger am 04.01.10 15:49:17zahlst du auch für jede teilausführung?
Kommt auf den Broker an -bei Cortal 1 Trade 9,90...danach 4,95 / Trade / Teilausführung...allerdings wenn ich die 12 % unter Pari USA rechne passt es wieder ...nur bei 10 000 Stücken....natürlich nicht mehr....na ja wird schon werden
Kommt auf den Broker an -bei Cortal 1 Trade 9,90...danach 4,95 / Trade / Teilausführung...allerdings wenn ich die 12 % unter Pari USA rechne passt es wieder ...nur bei 10 000 Stücken....natürlich nicht mehr....na ja wird schon werden
Wer Aktien zurückkauft will investieren.
Dies ist ein sehr gutes Zeichen!
Cleffy
Dies ist ein sehr gutes Zeichen!
Cleffy
Antwort auf Beitrag Nr.: 38.661.660 von Cleffy am 04.01.10 17:00:29Ach nee, und woher nehmen sie das Geld her zum investieren wenn schon
Aktien zurück gekauft wurden sind ?
Und wo steht das überhaupt, das Aktien zurück gekauf wurden, und
welchen Sinn macht das, wenn man erst vor kurzem an die
2 Milliarden neue Aktien aus gegeben hat???
Aktien zurück gekauft wurden sind ?
Und wo steht das überhaupt, das Aktien zurück gekauf wurden, und
welchen Sinn macht das, wenn man erst vor kurzem an die
2 Milliarden neue Aktien aus gegeben hat???
Antwort auf Beitrag Nr.: 38.661.996 von Scania01 am 04.01.10 17:36:34Das wurde heute und letzte Woche alles bereits besprochen...solltest mal biscchen lesen...dann die F*** aufreissen ...bist ein sehr schlechter Basher...bzw. ich hoffe nur Du hast keine Anteile
So nächste Posi wurde ausgelöst,diesmal wenigsten über 40 K..hoffe mal die ghet noch etwas runter vor dem 22.01.2010..hab unten noch paar Orders drin...dann sind die X XXX K voll..und ich lasse die Zeit arbeiten
So nächste Posi wurde ausgelöst,diesmal wenigsten über 40 K..hoffe mal die ghet noch etwas runter vor dem 22.01.2010..hab unten noch paar Orders drin...dann sind die X XXX K voll..und ich lasse die Zeit arbeiten
Antwort auf Beitrag Nr.: 38.662.702 von Expertchen007 am 04.01.10 18:48:15Mach dir doch kein Kopf über Skania, Expertchen!
Macht eh keinen Sinn.
Wir konzentrieren uns auf Fakten, alles Andere ist Schwachsinn!
Cleffy
Macht eh keinen Sinn.
Wir konzentrieren uns auf Fakten, alles Andere ist Schwachsinn!
Cleffy
Antwort auf Beitrag Nr.: 38.662.702 von Expertchen007 am 04.01.10 18:48:15Ich kann den Text nicht finden, vom Aktienrückkaufprogramm.
Stell den doch bitte noch mal hie rein, oder verweise auf den
Text.
Danke
Stell den doch bitte noch mal hie rein, oder verweise auf den
Text.
Danke
Antwort auf Beitrag Nr.: 38.662.810 von Scania01 am 04.01.10 18:58:59einfach zurückblättern..glaubst doch nicht das ich auch noch für Dich arbeite...kannste vergessen...so aus für heute...langt
Antwort auf Beitrag Nr.: 38.662.931 von Expertchen007 am 04.01.10 19:12:42Och schade ich wollt mich noch ein wenig amüsieren.
Antwort auf Beitrag Nr.: 38.662.931 von Expertchen007 am 04.01.10 19:12:42lass scania doch für dich arbeiten willst ja auch noch welche zum kleinen preis oder nicht?
heute steht ja das ding bei 0,009
müsste eigentlich 0,007stehen!
für 0,006 hätte ich noch welche gehabt
müsste eigentlich 0,007stehen!
für 0,006 hätte ich noch welche gehabt
Antwort auf Beitrag Nr.: 38.666.292 von lilie31 am 05.01.10 11:21:56sag mal hast Du keinen Währungsrechner...niemals 0,007 und schon gar nicht 0,006
schaun wir mal, ob die börse zumindest heute die gestrige news - mit einem kursaufschlag - honoriert:
zitate aus der gestrigen nachricht:
It is a revenue generator we have not had in the past.
.
.
.
BioCells is already the second largest stem cell storage company in Argentina with annual revenues of 1.5M (USD).
zitate aus der gestrigen nachricht:
It is a revenue generator we have not had in the past.
.
.
.
BioCells is already the second largest stem cell storage company in Argentina with annual revenues of 1.5M (USD).
Antwort auf Beitrag Nr.: 38.666.925 von itsSHOWTIME am 05.01.10 12:41:52Sind doch erst am Anfang...lass mal die Fertigung öffnen und die ersten und zweiten Q. Zahlen abwarten...dann werden wir erfahren was wirklich läuft oder auch nicht...alles andere ist Nonsens....der Kurs von heute oder nächster Woche ist nebensächlich ( nun gut tiefe Kurse dienen auch einem Zweck - Einkaufen )
In diesem Sinne wünsch ich uns erst mal einen guten Tag
In diesem Sinne wünsch ich uns erst mal einen guten Tag
Cord Blood America News
--------------------------------------------------------------------------------
Cord Blood America Announces Cord Blood Stem Cell Processing and Storage Agreement With BioCells, a South American Company
Posted: 04 Jan 2010 12:55 PM PST
LAS VEGAS, Jan. 4, 2010- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (www.cordblood-america.com ) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has signed a Letter of Intent to process and store cord blood specimens for BioCells, Inc., headquartered in Argentina, and its affiliates in Peru, Colombia, Bolivia, Panama and Puerto Rico.
"This is an excellent example of how our new laboratory and storage facility in Las Vegas allows us to significantly diversify our business model," said Matthew Schissler, co-founder and CEO. "BioCells is already the second largest stem cell storage company in Argentina with annual revenues of 1.5M (USD). The company has 12 locations throughout the country and has recently expanded internationally to both Uruguay and Paraguay. We are confident this will be an excellent working relationship, beneficial to both companies. We will be processing and storing for BioCells' affiliates in Peru, Colombia, Bolivia, Panama and Puerto Rico."
"It is a revenue generator we have not had in the past. Not only do we have our own organic sales engine, our new lab can now generate gross profit by processing and storage agreements with other successful stem cell companies," Mr. Schissler commented. "BioCells has proven to be a tremendous company and we are fortunate to have entered into this letter of intent."
Cord Blood America recently announced a grand opening of its 17,000 square foot stem cell laboratory and headquarters in Las Vegas, near the city's international airport, on January 22, 2010.
The deal between Cord Blood America and BioCells is pending due diligence, and if it is completed successfully, anticipates the contract closing in the first quarter of 2010.
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.
Forward-Looking Statements
Some statements made in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as ``anticipate,'' ``believe,'' ``expect,'' ``future,'' ``intend,'' ``plan,'' and similar expressions to identify forward-looking statements. These statements including those related to the growth of the industry, new stem cell treatments, and the Company’s performance, are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.
CONTACT:
Paul Knopick
E & E Communications
949-707-5365
pknopick@eandecommunications.com
--------------------------------------------------------------------------------
Cord Blood America Announces Cord Blood Stem Cell Processing and Storage Agreement With BioCells, a South American Company
Posted: 04 Jan 2010 12:55 PM PST
LAS VEGAS, Jan. 4, 2010- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (www.cordblood-america.com ) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has signed a Letter of Intent to process and store cord blood specimens for BioCells, Inc., headquartered in Argentina, and its affiliates in Peru, Colombia, Bolivia, Panama and Puerto Rico.
"This is an excellent example of how our new laboratory and storage facility in Las Vegas allows us to significantly diversify our business model," said Matthew Schissler, co-founder and CEO. "BioCells is already the second largest stem cell storage company in Argentina with annual revenues of 1.5M (USD). The company has 12 locations throughout the country and has recently expanded internationally to both Uruguay and Paraguay. We are confident this will be an excellent working relationship, beneficial to both companies. We will be processing and storing for BioCells' affiliates in Peru, Colombia, Bolivia, Panama and Puerto Rico."
"It is a revenue generator we have not had in the past. Not only do we have our own organic sales engine, our new lab can now generate gross profit by processing and storage agreements with other successful stem cell companies," Mr. Schissler commented. "BioCells has proven to be a tremendous company and we are fortunate to have entered into this letter of intent."
Cord Blood America recently announced a grand opening of its 17,000 square foot stem cell laboratory and headquarters in Las Vegas, near the city's international airport, on January 22, 2010.
The deal between Cord Blood America and BioCells is pending due diligence, and if it is completed successfully, anticipates the contract closing in the first quarter of 2010.
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.
Forward-Looking Statements
Some statements made in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as ``anticipate,'' ``believe,'' ``expect,'' ``future,'' ``intend,'' ``plan,'' and similar expressions to identify forward-looking statements. These statements including those related to the growth of the industry, new stem cell treatments, and the Company’s performance, are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.
CONTACT:
Paul Knopick
E & E Communications
949-707-5365
pknopick@eandecommunications.com
Antwort auf Beitrag Nr.: 38.667.578 von Expertchen007 am 05.01.10 14:08:55kommt bisle leben in die bude.... bin mal gespannt was sich hier alles so tummelt wenn es was werden sollte^^
Antwort auf Beitrag Nr.: 38.667.578 von Expertchen007 am 05.01.10 14:08:55Hallu expertchen,
diese news gefällt mir ausgezeichnet.
Wenn die Verträge unterzeichnet sind ("closing in the first quarter of 2010") kann man das als Teil einer seriösen Basis sehen, hoffentlich.
lg, barb
diese news gefällt mir ausgezeichnet.
Wenn die Verträge unterzeichnet sind ("closing in the first quarter of 2010") kann man das als Teil einer seriösen Basis sehen, hoffentlich.
lg, barb
Wird dann so ab 0,010 € interessant...dann ist hier wohl vorbei mit ruhig......aber vor dem 22.01.2010..glaub ich nicht das wir die sehen...nun gut geht wie gesagt erst los
Antwort auf Beitrag Nr.: 38.667.753 von barbarez69 am 05.01.10 14:31:08Servus ,
na ja ich sag ja 1. Produktion und 2. die Q Zahlen 1+ 2. Quartal 2010...dann wisen wir genau ob es ein Geschäft oder ein Flopp war...bis dahin können wir nur warten..und schauen was passiert
na ja ich sag ja 1. Produktion und 2. die Q Zahlen 1+ 2. Quartal 2010...dann wisen wir genau ob es ein Geschäft oder ein Flopp war...bis dahin können wir nur warten..und schauen was passiert
Heissa..die geht mal wieder ordentlich ab...gibts wieder ein Volumen um die 400 Mio. heute... - mal abwarten
Antwort auf Beitrag Nr.: 38.668.348 von Expertchen007 am 05.01.10 15:39:48Wo soll das nur hinführen?
Glück auf!
Glück auf!
...NEWS mit dem CEO !!!!!!!!!
CEO of Cord Blood America (OTC:CBAI) Says Company is Ready to Expand and Grow
Written by Staff and Wire Reports
Tuesday, 05 January 2010 05:49
http://biomedreports.com/articles/most-popular/23349-ceo-of-…
CEO of Cord Blood America (OTC:CBAI) Says Company is Ready to Expand and Grow
Written by Staff and Wire Reports
Tuesday, 05 January 2010 05:49
http://biomedreports.com/articles/most-popular/23349-ceo-of-…
Antwort auf Beitrag Nr.: 38.668.412 von Skrollein am 05.01.10 15:46:16Nach dem Interview von heute...gehts vorwärts...nächster Break ist die 0,0154 US$..wenn die weg ist...dann aber HALLO !!!!!
Hier das ganze...zu dem oberen Link
*********************************************************
CEO of Cord Blood America (OTC:CBAI) Says Company is Ready to Expand and Grow PDF | Print | E-mail
Written by Staff and Wire Reports
Tuesday, 05 January 2010 05:49
On Monday, Cord Blood America Inc. announced that it had signed a Letter of Intent to process and store cord blood specimens for BioCells, Inc., headquartered in Argentina, and its affiliates in Peru, Colombia, Bolivia, Panama and Puerto Rico. This is seen as one of several key developments for the company which has a big forward looking news event later this month.
We had an exclusive opportunity to speak to Matthew L. Schissler, the CEO of the company and what follows is a transcript of that conversation:
BioMedReports: Let’s start by having you tell us about your company, for those who may not be too familiar with what you do.
CEO Matthew L. Schissler: Sure. At Cord Blood America we privately bank umbilical cord blood stem cells for families. We started the company in 2003 and began trading publicly in January of 2005, so we’re celebrating almost five years of being a fully reporting company on the OTCBB. Same company since 2005, so there is a lot of history and information on Cord Blood America. Since that time, in January of 2005, we’ve raised approximately $30 million for the organization. Some of that as debt, some convertible debt, some short term equities, some long term equities and some preferred equity. In fact, just in the last 18 months, we’ve managed to raise $16.8 million, so it’s been a good experience to be able to raise that capital and with it we now have a decent organic growth story. We’ve made three acquisitions in the last three years and we’re in the process of opening our new state of the art laboratory here in Las Vegas, Nevada.
BioMedReports: Wet thought about covering your company last year, but we decided to take a wait and see approach because, honestly, we didn’t know if you were a real company.
CEO Matthew L. Schissler: (Laughs)
BioMedReports: Now it looks like you guys are turning the corner and that company is coming into it’s own with major milestones and some news events on the way. What can you tell us about what is going on with CBAI?
CEO Matthew L. Schissler: We are what we say we are. In 2009, we said we were going to focus on growth, debt reduction and by all accounts the debt reduction was wildly successful. We reduced over $10 million in 2009 and I think we entered the year with approximately $13 million in long term obligations and about $8 million in short term obligations and by reducing over $10 million in 2009, which we’ve announced so far, we’ve effectively reduced all of our short term obligations and dug in pretty hard to our long terms as well so it was a very good year for us.
BioMedReports: There has been some talk about the upcoming opening of your new state-of-the-art facility. Can you tell us about that?
CEO Matthew L. Schissler: We always try to focus on three core goals and in 2010 we are opening our new state of the art laboratory. One of those three core goals is the diversification of revenue streams. Not only will we have our own organic growth engine, by processing and storing for our own company, but we recently entered into a letter of agreement to process and store for another very successful stem cell company. That’s going to be the flavor for 2010 and onward- diversification of revenue streams by using our new facility to its full capacity. The other goal is continued growth- like we saw mention of when we announced in late 2009 when we signed an agreement with a national labor association, Blue Cross and Blue Shield Association. That’s how we’ll grow some more, through the insurance companies. And finally, we’re going to be very focused on acquisitions. In fact, I’ll tell you that in 2010 we have a voracious appetite for acquisitions. With the economy the way it is, a lot of stem cell companies are struggling and we’ve been very fortunate to have our company go in the right direction by reducing debt and raising capital. We feel it’s a very good time for us to make some acquisitions and so we’re going to be very focused on that this year.
BioMedReports: So I would imagine that these acquisitions are somehow related to the goal of increasing your revenue streams in some way?
CEO Matthew L. Schissler: The overall goal in our mission statement is to not only become the world’s number one most respected stem cell company but also to be the largest as well. As we say in our mission statement, the world’s globally dominant stem cell storage company and so, those acquisitions will be in related fields, but I can’t say too much but it’s all about cryogenic preservation of stem cells and other forms of biologics.
BioMedReports: Tell us about this new state-of-the-art facility that you’re getting ready to open.
CEO Matthew L. Schissler: It’s a seventeen thousand square foot facility and to start, it’s going to be able to process cord blood stem cells. It’s built for expansion, though. Like I said we’ll be able to process our own company’s cord blood stem cells and other company’s stem cells as well. It’s built so that we can build different laboratories within the building so that we can focus on different types of technologies that we so need. It’s also being built to become one of the largest storage facilities in the country with tremendous room for expansion, so it’s going to be a very large cryogenic preservation area with multiple labs to focus on different products.
BioMedReports: Some of the bears are claiming: 'Oh it’s just a big warehouse.' What’s your reaction to that?
CEO Matthew L. Schissler: Our address is 1857 Helm Drive. Give me a call. Come on down and take a look.
As you know, we have a very liquid stock and liquid creates volatility so it’s got a lot of bulls and a lot of bears because there’s money to be made on both sides. As much as they can, the detractors will say anything negative they can about our company to create some of that and move the stock price around. At least, that’s my belief. If they want to come see the facility, we’re having a grand opening on January 22nd. We’ll be giving tours of the facility. They’ll be able to see the expansion. They’ll be able to see our current processing, the cord blood lab and our cryogenic lab. That’s what I like to say to the bears. We’re not hiding. If you have any questions, please feel free to come down and take a look.
Note:
The second part of this interview is being transcribed and should be posted here in its entirety by 1pm EST. Investors will find that it is filled with positive sentiment. The discussion will continue to shed light on the growing company’s plans for the future as well as insight into how their business is being affected by the current trends in the sector. Look for that text in this space in a couple of hours.
*********************************************************
CEO of Cord Blood America (OTC:CBAI) Says Company is Ready to Expand and Grow PDF | Print | E-mail
Written by Staff and Wire Reports
Tuesday, 05 January 2010 05:49
On Monday, Cord Blood America Inc. announced that it had signed a Letter of Intent to process and store cord blood specimens for BioCells, Inc., headquartered in Argentina, and its affiliates in Peru, Colombia, Bolivia, Panama and Puerto Rico. This is seen as one of several key developments for the company which has a big forward looking news event later this month.
We had an exclusive opportunity to speak to Matthew L. Schissler, the CEO of the company and what follows is a transcript of that conversation:
BioMedReports: Let’s start by having you tell us about your company, for those who may not be too familiar with what you do.
CEO Matthew L. Schissler: Sure. At Cord Blood America we privately bank umbilical cord blood stem cells for families. We started the company in 2003 and began trading publicly in January of 2005, so we’re celebrating almost five years of being a fully reporting company on the OTCBB. Same company since 2005, so there is a lot of history and information on Cord Blood America. Since that time, in January of 2005, we’ve raised approximately $30 million for the organization. Some of that as debt, some convertible debt, some short term equities, some long term equities and some preferred equity. In fact, just in the last 18 months, we’ve managed to raise $16.8 million, so it’s been a good experience to be able to raise that capital and with it we now have a decent organic growth story. We’ve made three acquisitions in the last three years and we’re in the process of opening our new state of the art laboratory here in Las Vegas, Nevada.
BioMedReports: Wet thought about covering your company last year, but we decided to take a wait and see approach because, honestly, we didn’t know if you were a real company.
CEO Matthew L. Schissler: (Laughs)
BioMedReports: Now it looks like you guys are turning the corner and that company is coming into it’s own with major milestones and some news events on the way. What can you tell us about what is going on with CBAI?
CEO Matthew L. Schissler: We are what we say we are. In 2009, we said we were going to focus on growth, debt reduction and by all accounts the debt reduction was wildly successful. We reduced over $10 million in 2009 and I think we entered the year with approximately $13 million in long term obligations and about $8 million in short term obligations and by reducing over $10 million in 2009, which we’ve announced so far, we’ve effectively reduced all of our short term obligations and dug in pretty hard to our long terms as well so it was a very good year for us.
BioMedReports: There has been some talk about the upcoming opening of your new state-of-the-art facility. Can you tell us about that?
CEO Matthew L. Schissler: We always try to focus on three core goals and in 2010 we are opening our new state of the art laboratory. One of those three core goals is the diversification of revenue streams. Not only will we have our own organic growth engine, by processing and storing for our own company, but we recently entered into a letter of agreement to process and store for another very successful stem cell company. That’s going to be the flavor for 2010 and onward- diversification of revenue streams by using our new facility to its full capacity. The other goal is continued growth- like we saw mention of when we announced in late 2009 when we signed an agreement with a national labor association, Blue Cross and Blue Shield Association. That’s how we’ll grow some more, through the insurance companies. And finally, we’re going to be very focused on acquisitions. In fact, I’ll tell you that in 2010 we have a voracious appetite for acquisitions. With the economy the way it is, a lot of stem cell companies are struggling and we’ve been very fortunate to have our company go in the right direction by reducing debt and raising capital. We feel it’s a very good time for us to make some acquisitions and so we’re going to be very focused on that this year.
BioMedReports: So I would imagine that these acquisitions are somehow related to the goal of increasing your revenue streams in some way?
CEO Matthew L. Schissler: The overall goal in our mission statement is to not only become the world’s number one most respected stem cell company but also to be the largest as well. As we say in our mission statement, the world’s globally dominant stem cell storage company and so, those acquisitions will be in related fields, but I can’t say too much but it’s all about cryogenic preservation of stem cells and other forms of biologics.
BioMedReports: Tell us about this new state-of-the-art facility that you’re getting ready to open.
CEO Matthew L. Schissler: It’s a seventeen thousand square foot facility and to start, it’s going to be able to process cord blood stem cells. It’s built for expansion, though. Like I said we’ll be able to process our own company’s cord blood stem cells and other company’s stem cells as well. It’s built so that we can build different laboratories within the building so that we can focus on different types of technologies that we so need. It’s also being built to become one of the largest storage facilities in the country with tremendous room for expansion, so it’s going to be a very large cryogenic preservation area with multiple labs to focus on different products.
BioMedReports: Some of the bears are claiming: 'Oh it’s just a big warehouse.' What’s your reaction to that?
CEO Matthew L. Schissler: Our address is 1857 Helm Drive. Give me a call. Come on down and take a look.
As you know, we have a very liquid stock and liquid creates volatility so it’s got a lot of bulls and a lot of bears because there’s money to be made on both sides. As much as they can, the detractors will say anything negative they can about our company to create some of that and move the stock price around. At least, that’s my belief. If they want to come see the facility, we’re having a grand opening on January 22nd. We’ll be giving tours of the facility. They’ll be able to see the expansion. They’ll be able to see our current processing, the cord blood lab and our cryogenic lab. That’s what I like to say to the bears. We’re not hiding. If you have any questions, please feel free to come down and take a look.
Note:
The second part of this interview is being transcribed and should be posted here in its entirety by 1pm EST. Investors will find that it is filled with positive sentiment. The discussion will continue to shed light on the growing company’s plans for the future as well as insight into how their business is being affected by the current trends in the sector. Look for that text in this space in a couple of hours.
http://app.quotemedia.com/quotetools/newsStoryPopup.go?story…
January 4, 2010 - 10:34 AM EST
Jan. 4, 2010 (Baystreet.ca) --
Are the bears trying to shake loose some shares of Cord Blood America Inc. (OTC:CBAI) even as most traders are to looking forward to riding the stock price up, ahead of the company's big forward-looking news event?
After re-examining the company's recent filings and reading carefully through the press-releases about the upcoming grand opening of their new Las Vegas facilities, it is hard to understand what some of these bears are seeing.
We dug up the most recent filings and examined them for hours as a team. It's become quite clear to our various in-house analysts and writers that despite fears of dilution:
1) The stock just emerged from sub-penny levels on incredible volume, but it appears that shares of CBAI are "priced" at a minimum of $.03 and could move to $.05 on this upcoming news event.
2) The compay has announced recent debt reduction of over $10 million and may be positioned to reduce even more debt.
3) The company now has an improved business model to work from
4) Last quarter Gross Profit increased from 54.3% to 62.7%.
And finally, there is the very important grand opening of their new lab and corporate offices- set to take place later this month on January 22, 2010. That positive news item that has been in the works for some time and represents a major milestone for the company.
BioMedReports is scheduled to interview the CEO of the company within the next 24-48 hours and they should have an update straight from the source.
In the meantime, please be very careful of listening to bloggers and self-anointed experts and do your own due dillegence.
We warned people to stay away from this play last year, but now it could be setting up a "multi-bagger" type move from current levels.
Of course, that's just our opinion as well.
Stay tuned for credible, solid news.
Peter Depalma covers the healthcare and biotech sector for BioMedReports. He discloses that he is long CBAI.
Source: Baystreet.ca (January 4, 2010 - 10:34 AM EST)
News by QuoteMedia
January 4, 2010 - 10:34 AM EST
Jan. 4, 2010 (Baystreet.ca) --
Are the bears trying to shake loose some shares of Cord Blood America Inc. (OTC:CBAI) even as most traders are to looking forward to riding the stock price up, ahead of the company's big forward-looking news event?
After re-examining the company's recent filings and reading carefully through the press-releases about the upcoming grand opening of their new Las Vegas facilities, it is hard to understand what some of these bears are seeing.
We dug up the most recent filings and examined them for hours as a team. It's become quite clear to our various in-house analysts and writers that despite fears of dilution:
1) The stock just emerged from sub-penny levels on incredible volume, but it appears that shares of CBAI are "priced" at a minimum of $.03 and could move to $.05 on this upcoming news event.
2) The compay has announced recent debt reduction of over $10 million and may be positioned to reduce even more debt.
3) The company now has an improved business model to work from
4) Last quarter Gross Profit increased from 54.3% to 62.7%.
And finally, there is the very important grand opening of their new lab and corporate offices- set to take place later this month on January 22, 2010. That positive news item that has been in the works for some time and represents a major milestone for the company.
BioMedReports is scheduled to interview the CEO of the company within the next 24-48 hours and they should have an update straight from the source.
In the meantime, please be very careful of listening to bloggers and self-anointed experts and do your own due dillegence.
We warned people to stay away from this play last year, but now it could be setting up a "multi-bagger" type move from current levels.
Of course, that's just our opinion as well.
Stay tuned for credible, solid news.
Peter Depalma covers the healthcare and biotech sector for BioMedReports. He discloses that he is long CBAI.
Source: Baystreet.ca (January 4, 2010 - 10:34 AM EST)
News by QuoteMedia
und wieder mal wurde das 6 Monatshoch geknackt !!!!
6 Monate
6 Monate
Antwort auf Beitrag Nr.: 38.668.469 von obdachlos am 05.01.10 15:52:45... obdachlos ...hoffe bald nicht mehr !!!!
glaub ich kann meine Restorder auf der 0,007 € wohl bald streichen...wird nix - so wie es aussieht...kommt wohl in D eher bald die 0,010 €
Antwort auf Beitrag Nr.: 38.668.484 von Expertchen007 am 05.01.10 15:54:48Hammerhart !
Besonders schon zu diesem Zeitpunkt
Die 0,01 € läßt wohl auch nicht bis zur Eröffnung auf sich warten...
Glück auf!
Besonders schon zu diesem Zeitpunkt
Die 0,01 € läßt wohl auch nicht bis zur Eröffnung auf sich warten...
Glück auf!
muss meine bude bezahlen. kann ruhig auf $0,05 steigen. oder noch höher.
wer bald zu diesen preisen kaufen will, kann er später über $0,05 bezahlen. glaube ich.
Antwort auf Beitrag Nr.: 38.668.563 von Skrollein am 05.01.10 16:01:56Denke ich auch nicht...die 0,013 US$ ist auch so ein kritischer Punkt...denke aber die hauts heute schon weg,,,und dann wie gesagt gehts in Richtung 0,0154....fällt dann das Jahreshoch....ist viles möglich ....positive Zeichen gibts genug
0,013 US$ ist angekratzt.
Die PR Maschine funktioniert schon mal ganz gut
************************************************************
http://www.marketwire.com/press-release/BiomedreportsCom-109…
Jan 05, 2010 10:04 ETCEO of Cord Blood America (OTCBB: CBAI) Reveals His Company Has Voracious Appetite for Growth, Expansion and Acquisitions
LOS ANGELES, CA--(Marketwire - January 5, 2010) - BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, has an exclusive interview with Matthew L. Schissler, the CEO of Cord Blood America (OTCBB: CBAI), the small cap company that is preparing to open its seventeen thousand square foot state-of-the-art stem cell storage facility and laboratory in Las Vegas.
In the interview, the CEO reveals that his company is focused on three core goals for 2010.
"One of those three core goals is the diversification of revenue streams," says Schissler. "Not only will we have our own organic growth engine by processing and storing for our own company, but (yesterday) we announced that we have entered into a letter of agreement to process and store for another very successful stem cell company.
"That's going to be the flavor for 2010 and onward -- diversification of revenue streams by using our new facility to its full capacity. The other goal is continued growth and we're going to be very focused on acquisitions.
"In fact, I'll tell you that in 2010 we have a voracious appetite for acquisitions. With the economy the way it is, a lot of stem cell companies are struggling and we've been very fortunate to have our company go in the right direction by reducing debt and raising capital. We feel it's a very good time for us to make some acquisitions and so we're going to be very focused on that this year."
The interview is available now at BioMedReports.Com:
http://biomedreports.com/articles/most-popular/23349-ceo-of-…
Biotech investors interested in accessing the news portal's complete database of clinical trials and upcoming FDA decisions can access that information here:
http://biomedreports.com/fda-calendar/fda-calendar.html
About BioMedReports.Com
BioMedReports.com is a news portal covering the biomedical news and financial sector. BioMedReports is not paid or compensated to report the news and developments of publicly traded companies.
For more biomedical sector and investment news go to http://BioMedReports.com
************************************************************
http://www.marketwire.com/press-release/BiomedreportsCom-109…
Jan 05, 2010 10:04 ETCEO of Cord Blood America (OTCBB: CBAI) Reveals His Company Has Voracious Appetite for Growth, Expansion and Acquisitions
LOS ANGELES, CA--(Marketwire - January 5, 2010) - BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, has an exclusive interview with Matthew L. Schissler, the CEO of Cord Blood America (OTCBB: CBAI), the small cap company that is preparing to open its seventeen thousand square foot state-of-the-art stem cell storage facility and laboratory in Las Vegas.
In the interview, the CEO reveals that his company is focused on three core goals for 2010.
"One of those three core goals is the diversification of revenue streams," says Schissler. "Not only will we have our own organic growth engine by processing and storing for our own company, but (yesterday) we announced that we have entered into a letter of agreement to process and store for another very successful stem cell company.
"That's going to be the flavor for 2010 and onward -- diversification of revenue streams by using our new facility to its full capacity. The other goal is continued growth and we're going to be very focused on acquisitions.
"In fact, I'll tell you that in 2010 we have a voracious appetite for acquisitions. With the economy the way it is, a lot of stem cell companies are struggling and we've been very fortunate to have our company go in the right direction by reducing debt and raising capital. We feel it's a very good time for us to make some acquisitions and so we're going to be very focused on that this year."
The interview is available now at BioMedReports.Com:
http://biomedreports.com/articles/most-popular/23349-ceo-of-…
Biotech investors interested in accessing the news portal's complete database of clinical trials and upcoming FDA decisions can access that information here:
http://biomedreports.com/fda-calendar/fda-calendar.html
About BioMedReports.Com
BioMedReports.com is a news portal covering the biomedical news and financial sector. BioMedReports is not paid or compensated to report the news and developments of publicly traded companies.
For more biomedical sector and investment news go to http://BioMedReports.com
um ca 13:00 Uhr USA Time gibts einen weiteren Teil des CEO Interview ´s - man darf gespannt sein ( Info aus dem USA Board )
Antwort auf Beitrag Nr.: 38.668.700 von Expertchen007 am 05.01.10 16:16:15d.h. 19.00Uhr in Deutschland?
hallo zusammen,
bin auch mit einer kleinen Posi dabei.
ja, 19 Uhr unserer Zeit
bin auch mit einer kleinen Posi dabei.
ja, 19 Uhr unserer Zeit
scheene fette blaue balken - jetzt geht was
fällt jetzt mal die 0,01 in Stuttgart?
fällt jetzt mal die 0,01 in Stuttgart?
0.0138 plus 21% vol.125,000,000
Antwort auf Beitrag Nr.: 38.669.969 von oski am 05.01.10 18:15:41
Jetzt wird es aber massiv grün - mit vielen dicken blauen Balken
Was für ein Farbenspiel!
Glück auf!
Jetzt wird es aber massiv grün - mit vielen dicken blauen Balken
Was für ein Farbenspiel!
Glück auf!
Antwort auf Beitrag Nr.: 38.670.006 von Skrollein am 05.01.10 18:20:31Wo die damals bei VW die werbung gemacht haben "blau macht glücklich" mit ihren autos, war es anscheind auch ne anspielung auf aktienkurse
Scheint wohl bereits News zu geben...die 0,013 ist weg...jetzt kommts drauf an ob diese Woche die 0,0154 fällt
Berlin ASK 0,012 € !!!!!!!"
lt. USA Board kommt Teil 2 des CEO Interview...mit einem Hamnmer raus...siehe Kurs
Antwort auf Beitrag Nr.: 38.670.035 von Expertchen007 am 05.01.10 18:25:20http://ih.advfn.com/p.php?pid=nmona&cb=1262712516&article=40…
Jetzt gibts Action....1 Jahreshoch ( o,0154 in Sicht.) ..aber dann
0.0148 vol.157,000,000
Antwort auf Beitrag Nr.: 38.670.111 von oski am 05.01.10 18:33:59Was glaubste wo der Kurs steht wenn es wieder 400 - oder sogar 500 Mio heute werden...will gar nicht dran denken
RT Berlin 0,011€ !!!!
RT Berlin 0,011€ !!!!
Sapperlot das 1 Jahreshoch fällt wirklich noch !!!!! Ich glaubs ja nicht !!!!
Antwort auf Beitrag Nr.: 38.670.123 von Expertchen007 am 05.01.10 18:35:50geduld übt sich aus, tendenz nordisch
Antwort auf Beitrag Nr.: 38.670.133 von Expertchen007 am 05.01.10 18:37:23hätte hätte hätte, kannste dich noch vor paar wochen erinnern, verdammte sau hätte man sowas kommen sehn in kurzer zeit, man man will sich ja nicht beklagen hauptsache es hält und steigt weiter
So, kleine Steigepause. Einige nehmen jetzt schon Gewinne mit um dann teurer noch mal einzusteigen
Ist ja auch o. k. - aber ggf. viel zu früh
Glück auf!
Ist ja auch o. k. - aber ggf. viel zu früh
Glück auf!
So muss für heute weg....bleibt sauber und SK auf TH...dann passt es !!!
Hallo ihr Stammzellen -Experten !
Bin hier mit eingestiegen und schauen wir mal was ab geht.
Sieht ja sehr gut aus.
Bin hier mit eingestiegen und schauen wir mal was ab geht.
Sieht ja sehr gut aus.
Antwort auf Beitrag Nr.: 38.670.461 von noeppchen am 05.01.10 19:11:23ja am bischen spät,vin de Champagne ist am ende
Antwort auf Beitrag Nr.: 38.670.657 von 320dd am 05.01.10 19:34:28ne ne bin schon was länger drin
http://biomedreports.com/articles/most-popular/23349-ceo-of-…
das komplette interview von heute...sehr interessant.
das komplette interview von heute...sehr interessant.
ich glaub', diese woche werden wieder locker über 0,016 US$ errreichen und schließen. zwischenzeitlich wird auch wahrscheinlich gewinne mitgenommen, so dass wir einen rücksetzer zu 0,013 US$ machen werden. Ich hoffe natürlich nicht.
Antwort auf Beitrag Nr.: 38.671.221 von obdachlos am 05.01.10 20:55:23was wäre ich ohne fehlerteufel im text:
ich glaub', diese woche werden wir locker über 0,016 US$ errreichen und schließen. zwischenzeitlich wird auch wahrscheinlich gewinne mitgenommen, so dass wir einen rücksetzer zu 0,013 US$ machen werden. Ich hoffe natürlich nicht.
ich glaub', diese woche werden wir locker über 0,016 US$ errreichen und schließen. zwischenzeitlich wird auch wahrscheinlich gewinne mitgenommen, so dass wir einen rücksetzer zu 0,013 US$ machen werden. Ich hoffe natürlich nicht.
Antwort auf Beitrag Nr.: 38.671.245 von obdachlos am 05.01.10 20:58:32ok, 1 Versuch haste noch.
Antwort auf Beitrag Nr.: 38.671.333 von chicco20 am 05.01.10 21:10:48Mein Tip für Heute SK US: 0,0148 US$
Antwort auf Beitrag Nr.: 38.671.379 von obdachlos am 05.01.10 21:18:27knapp vorbei; es werden 0,0149 sein !!
Antwort auf Beitrag Nr.: 38.671.412 von itsSHOWTIME am 05.01.10 21:24:03dann tipp ich mal 0,015$
Antwort auf Beitrag Nr.: 38.671.450 von chicco20 am 05.01.10 21:28:04noch 28 min.
Wo ist eigentlich unser schwedische LKW Nulleins
Cleffy
Cleffy
Antwort auf Beitrag Nr.: 38.671.544 von Cleffy am 05.01.10 21:40:39Wo das bashende Mopped ist, will wirklich keiner wissen
CBAI kommt die letzten Minuten ggf. noch ein bißchen und hat uns so oder so einen sehr schönen Tag beschert!
Bis morgen und
Glück auf!
CBAI kommt die letzten Minuten ggf. noch ein bißchen und hat uns so oder so einen sehr schönen Tag beschert!
Bis morgen und
Glück auf!
Antwort auf Beitrag Nr.: 38.671.379 von obdachlos am 05.01.10 21:18:27sk 147 - knapp vorbei ist auch vorbei !!
guten morgen zusammen
sieht ja wunderbar aus
ich bin am überlegen ob ich gewinne mitnehmen soll
oder der run erst richtig begonnen hat!
mein tipp von0,015dollar ist schneller erreicht als ich dachte
was meint ihr ist auch 0,025us dollar drinne bis ende januar!
weil heute nochmal so ein anstieg sind wir bei 0,02 marke
sieht ja wunderbar aus
ich bin am überlegen ob ich gewinne mitnehmen soll
oder der run erst richtig begonnen hat!
mein tipp von0,015dollar ist schneller erreicht als ich dachte
was meint ihr ist auch 0,025us dollar drinne bis ende januar!
weil heute nochmal so ein anstieg sind wir bei 0,02 marke
Antwort auf Beitrag Nr.: 38.673.030 von lilie31 am 06.01.10 10:02:27moinsen geht mir ähnlich, bin bei CBAI mit 70% in grün. rückschlagpotential ist auf jeden fall vorhanden, aber im moment passt der newsflow. vermutlich werden sie irgendwann einen resplit ankündigen um schneller aus dem penny-bereich zu kommen, oder uns mit finanzierungsrunden quälen. darin sehe ich die grösste gefahr für rückschläge. mal 10 odet 15% durch gewinnmitnahmen bringen mich da nicht so aus der ruhe.
Antwort auf Beitrag Nr.: 38.673.193 von kleingeldjaeger am 06.01.10 10:23:58mit einem r/s kommen sie nicht schneller aus dem penny-bereich !!!! nur kurzfristig !!!!
das wäre worst case für alle anleger !!!
aber ich glaube nicht, dass es einen r/s geben wird. wieso auch.
das wäre worst case für alle anleger !!!
aber ich glaube nicht, dass es einen r/s geben wird. wieso auch.
mega :
CBAI IN THE NEW YORK TIME TODAY !!!
http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks…
CBAI IN THE NEW YORK TIME TODAY !!!
http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks…
Antwort auf Beitrag Nr.: 38.673.275 von itsSHOWTIME am 06.01.10 10:34:28können wir uns dann heute auf einen megarun freuen
mein ziel ist mittlerweile 0,05cent
mein ziel ist mittlerweile 0,05cent
Antwort auf Beitrag Nr.: 38.673.534 von Belu1972 am 06.01.10 11:02:19wobei einem der 5-jahreschart schon etwas zu denken gibt ;-) - gut damals waren die bedingungen anders. jetzt scheint sich ja auch die gesetzeslage zu deren gunsten zu wenden.
Antwort auf Beitrag Nr.: 38.673.702 von kleingeldjaeger am 06.01.10 11:17:11sorry, hab was behauptet ohne quelle:
Die Stammzellenforschung ist ein äußerst umstrittenes Thema. So war sie auch in den USA die vergangenen acht Jahre aus ethischen Gründen verboten. Unter Barack Obama bekommt dieser Forschungszweig nun wieder eine Chance.
http://www.handelsblatt.com/politik/international/nach-acht-…
Die Stammzellenforschung ist ein äußerst umstrittenes Thema. So war sie auch in den USA die vergangenen acht Jahre aus ethischen Gründen verboten. Unter Barack Obama bekommt dieser Forschungszweig nun wieder eine Chance.
http://www.handelsblatt.com/politik/international/nach-acht-…
Tagchen,
na läuft doch alles prima bei Cord....bisschen hin und her wirds schon noch geben....aber das Ergebniss so im Oktober 2010 zählt...denn wenn alles so wird wie angekündigt...halte ich Kurse von 0,04 - 0,05 US$ auf jeden Fall für möglich - werden wir sehen....bis jetzt darf man sehr zufrieden sein - wenigstens diejenigen die unten mit mit eingestiegen sind....dem Rest l
langst aber auch noch genug
na läuft doch alles prima bei Cord....bisschen hin und her wirds schon noch geben....aber das Ergebniss so im Oktober 2010 zählt...denn wenn alles so wird wie angekündigt...halte ich Kurse von 0,04 - 0,05 US$ auf jeden Fall für möglich - werden wir sehen....bis jetzt darf man sehr zufrieden sein - wenigstens diejenigen die unten mit mit eingestiegen sind....dem Rest l
langst aber auch noch genug
also Kurse von 0,04-0,05$ halte ich auch für sehr wahrscheinlich obwohl ich denke das da noch mehr geht!
Warten wir den 22.01. ab
Warten wir den 22.01. ab
Moin,
ich denke es geht heute mind auf die 0,0175, wenn nicht noch mehr drin ist.
Cleffy
ich denke es geht heute mind auf die 0,0175, wenn nicht noch mehr drin ist.
Cleffy
Antwort auf Beitrag Nr.: 38.674.557 von Cleffy am 06.01.10 13:00:02Na so hoch nochn nicht aber höher als gestern auf alle Fälle!!!!
Antwort auf Beitrag Nr.: 38.674.557 von Cleffy am 06.01.10 13:00:02na cleffy, dann geh schnellstens raus!
lg,
freybel
lg,
freybel
Antwort auf Beitrag Nr.: 38.674.643 von freybel am 06.01.10 13:09:11oh sorry, habe falsch gelesen. dachte - wenn du raus bist.....
verzeihung!
freybel
verzeihung!
freybel
Beacon Equity Initiates Independent Research Coverage for Cord Blood America Inc.
http://finance.yahoo.com/news/Beacon-Equity-Initiates-pz-225…
Press Release Source: Beacon Equity On Wednesday January 6, 2010, 6:50 am
DALLAS, Jan. 6, 2010 (GLOBE NEWSWIRE) -- BeaconEquity.com announces an investment report featuring Cord Blood America Inc. (OTCBB:CBAI - News). The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.
It is available at: http://www.beaconequity.com/i/CBAI
Get our alerts BEFORE the rest of the market. Follow us on Twitter: http://twitter.com/BeaconEquity
Cord Blood America Inc. (CBAI) is engaged in the business of collecting, testing, processing and preserving umbilical cord blood. The Company is primarily a holding company whose subsidiaries include Cord Partners Inc., CorCell Co. Inc., CorCell Ltd., CBA Professional Services Inc. D/B/A BodyCells Inc., CBA Properties Inc., Career Channel Inc., D/B/A Rainmakers International, and Family Marketing Inc. In addition, the Company provides private cord blood stem cell preservation services to families in the United States.
Message Board Search for CBAI: http://www.boardcentral.com/boards/CBAI
In the report, the analyst notes:
"For the three months ended September 30, 2009, total revenue decreased approximately $90,000, or 9.6% to approximately $0.8 million. . CBAI's revenues remained approximately the same in the comparative periods at $0.8 million. CBAI remains focused on strategic organic growth and accretive acquisition strategies, which management hopes will reduce or eliminate continuing losses and negative cash flow.
"CBAI recently announced that it has signed a Letter of Intent to process and store cord blood specimens for BioCells Inc.... BioCells is already the second largest stem-cell storage company in Argentina with annual revenues of 1.5M (USD)... The deal between CBAI and BioCells is pending due diligence, and if it is completed successfully, anticipates the contract closing in the first quarter of 2010."
To read the entire report visit: http://www.beaconequity.com/i/CBAI
See what investors are saying about CBAI at penny stock forum.
BeaconEquity.com is one of the industry's largest small-cap report providers. Beacon strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on Beacon Research, please visit http://www.BeaconEquity.com
Beacon Equity Disclosure
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Beacon Equity Research nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Contact:
Beacon Equity ResearchJeff Bishop(469)-252-3505press@beaconequity.com
Antwort auf Beitrag Nr.: 38.674.557 von Cleffy am 06.01.10 13:00:02ich denke es geht heute mind auf die 0,0175, wenn nicht noch mehr drin ist
Könnte in die Richtung gehen...allerdings gilt es 0,0154 und dann 0,0172 US$ erst mal zu nehmen - dort sind 2 wesentliche Hürden...aber wir werden sehen
Wo ist eigentlich der User Scania geblieben....seltsam ruhig geworden ??? Zeugt nicht von Stärke auch mal zugeben zu können das man falsch gelegen hat
Könnte in die Richtung gehen...allerdings gilt es 0,0154 und dann 0,0172 US$ erst mal zu nehmen - dort sind 2 wesentliche Hürden...aber wir werden sehen
Wo ist eigentlich der User Scania geblieben....seltsam ruhig geworden ??? Zeugt nicht von Stärke auch mal zugeben zu können das man falsch gelegen hat
Historical Prices
Date Open High Low Close Volume Adj
Close
2010/01/05 0.011 0.015 0.011 0.015 314,282,645 0.015
2010/01/04 0.011 0.012 0.011 0.011 177,003,523 0.011
2010/01/01 0.013 0.013 0.012 0.012 192,681,518 0.012
2009/12/31 0.013 0.013 0.011 0.012 192,681,518 0.012
2009/12/30 0.012 0.013 0.010 0.013 444,934,463 0.013
2009/12/29 0.0088 0.012 0.0087 0.012 530,062,247 0.012
2009/12/28 0.0081 0.0086 0.0080 0.0086 60,177,010 0.0086
2009/12/25 0.0081 0.0081 0.0080 0.0080 37,969,730 0.0080
2009/12/24 0.0081 0.0082 0.0079 0.0080 37,969,730 0.0080
2009/12/23 0.0084 0.0088 0.0080 0.0082 66,182,142 0.0082
2009/12/22 0.0084 0.0085 0.0080 0.0084 65,856,996 0.0084
2009/12/21 0.0077 0.0084 0.0076 0.0082 58,979,869 0.0082
2009/12/18 0.0076 0.0078 0.0069 0.0076 94,450,759 0.0076
2009/12/17 0.0079 0.0084 0.0073 0.0076 88,348,104 0.0076
2009/12/16 0.0081 0.0085 0.0073 0.0079 128,041,653 0.0079
2009/12/15 0.0093 0.0093 0.0075 0.0078 170,451,163 0.0078
2009/12/14 0.0077 0.0094 0.0075 0.0090 285,561,927 0.0090
2009/12/11 0.0067 0.0073 0.0066 0.0071 147,531,541 0.0071
2009/12/10 0.0058 0.0068 0.0055 0.0066 205,312,203 0.0066
2009/12/09 0.0058 0.0058 0.0054 0.0057 29,408,390 0.0057
2009/12/08 0.0051 0.0059 0.0051 0.0058 89,974,976 0.0058
2009/12/07 0.0059 0.0059 0.0052 0.0052 26,418,242 0.0052
Date Open High Low Close Volume Adj
Close
2010/01/05 0.011 0.015 0.011 0.015 314,282,645 0.015
2010/01/04 0.011 0.012 0.011 0.011 177,003,523 0.011
2010/01/01 0.013 0.013 0.012 0.012 192,681,518 0.012
2009/12/31 0.013 0.013 0.011 0.012 192,681,518 0.012
2009/12/30 0.012 0.013 0.010 0.013 444,934,463 0.013
2009/12/29 0.0088 0.012 0.0087 0.012 530,062,247 0.012
2009/12/28 0.0081 0.0086 0.0080 0.0086 60,177,010 0.0086
2009/12/25 0.0081 0.0081 0.0080 0.0080 37,969,730 0.0080
2009/12/24 0.0081 0.0082 0.0079 0.0080 37,969,730 0.0080
2009/12/23 0.0084 0.0088 0.0080 0.0082 66,182,142 0.0082
2009/12/22 0.0084 0.0085 0.0080 0.0084 65,856,996 0.0084
2009/12/21 0.0077 0.0084 0.0076 0.0082 58,979,869 0.0082
2009/12/18 0.0076 0.0078 0.0069 0.0076 94,450,759 0.0076
2009/12/17 0.0079 0.0084 0.0073 0.0076 88,348,104 0.0076
2009/12/16 0.0081 0.0085 0.0073 0.0079 128,041,653 0.0079
2009/12/15 0.0093 0.0093 0.0075 0.0078 170,451,163 0.0078
2009/12/14 0.0077 0.0094 0.0075 0.0090 285,561,927 0.0090
2009/12/11 0.0067 0.0073 0.0066 0.0071 147,531,541 0.0071
2009/12/10 0.0058 0.0068 0.0055 0.0066 205,312,203 0.0066
2009/12/09 0.0058 0.0058 0.0054 0.0057 29,408,390 0.0057
2009/12/08 0.0051 0.0059 0.0051 0.0058 89,974,976 0.0058
2009/12/07 0.0059 0.0059 0.0052 0.0052 26,418,242 0.0052
Antwort auf Beitrag Nr.: 38.675.004 von Cleffy am 06.01.10 14:00:03
Hmmmm...es gibt im US Board das " Gerücht " es könnte nach US - Time vormittags was an News kommen...lassen wir uns überraschen.....aber zuviel an News zeugt nicht immer von Qualität....
Hmmmm...es gibt im US Board das " Gerücht " es könnte nach US - Time vormittags was an News kommen...lassen wir uns überraschen.....aber zuviel an News zeugt nicht immer von Qualität....
Antwort auf Beitrag Nr.: 38.675.039 von Expertchen007 am 06.01.10 14:03:33Ein LOI kann manchmal sehr schnell realisiert werden. Kann mir es zwar nicht vorstellen, möglich ist aber alles!
Geplant ist die Vertragsunterzeichung im 1.Quartal 2010.
Falls positive News, nur her damit!
Cleffy
Geplant ist die Vertragsunterzeichung im 1.Quartal 2010.
Falls positive News, nur her damit!
Cleffy
Hallo alle zusammen!
Gibts es andere Unternehmen, die in diesem Bereich tätig sind?
Antwort auf Beitrag Nr.: 38.675.242 von obdachlos am 06.01.10 14:27:08Hast DU googel ????
und zack wieder auf der 11 in berlin :-)
1. Bid aus USA ist ja bereits auf der 0,0147 .....allerdings OTC halt..keine Vorbörse
Cord Blood America signs letter of intent with BioCell
Jan 06, 2010 (Datamonitor via COMTEX News Network) --
Cord Blood America, the umbilical cord blood stem cell preservation company, has signed a letter of intent to process and store cord blood specimens for BioCells, headquartered in Argentina, and its affiliates in Peru, Colombia, Bolivia, Panama and Puerto Rico.
Cord Blood America has recently announced opening of its 17,000sqft stem cell laboratory and headquarters in Las Vegas, near the city's international airport, on January 22, 2010.
The deal between Cord Blood America and BioCells is pending due diligence, and if it is completed successfully, anticipates the contract closing in the first quarter of 2010.
Matthew Schissler, co-founder and CEO of Cord Blood America, said: "BioCells is already the second largest stem cell storage company in Argentina with annual revenues of $1.5 million.
"The company has 12 locations throughout the country and has recently expanded internationally to both Uruguay and Paraguay. We are confident this will be an excellent working relationship, beneficial to both companies. We will be processing and storing for BioCells's affiliates in Peru, Colombia, Bolivia, Panama and Puerto Rico."
Jan 06, 2010 (Datamonitor via COMTEX News Network) --
Cord Blood America, the umbilical cord blood stem cell preservation company, has signed a letter of intent to process and store cord blood specimens for BioCells, headquartered in Argentina, and its affiliates in Peru, Colombia, Bolivia, Panama and Puerto Rico.
Cord Blood America has recently announced opening of its 17,000sqft stem cell laboratory and headquarters in Las Vegas, near the city's international airport, on January 22, 2010.
The deal between Cord Blood America and BioCells is pending due diligence, and if it is completed successfully, anticipates the contract closing in the first quarter of 2010.
Matthew Schissler, co-founder and CEO of Cord Blood America, said: "BioCells is already the second largest stem cell storage company in Argentina with annual revenues of $1.5 million.
"The company has 12 locations throughout the country and has recently expanded internationally to both Uruguay and Paraguay. We are confident this will be an excellent working relationship, beneficial to both companies. We will be processing and storing for BioCells's affiliates in Peru, Colombia, Bolivia, Panama and Puerto Rico."
NEWS
LAS VEGAS, Jan. 6 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today said that it has retired a $1.35 million note which had been provided by JMJ Financial in May of 2009.
\"We finished 2009 as we proceeded throughout the year, succeeding in a major effort to reduce debt and strengthen our balance sheet,\" said Matthew Schissler, CEO and co-founder, Cord Blood America. \"The debt reduced, over $10.5 million, is the overwhelming majority we entered the year with and effectively all the debt available for retirement in 2009. We believe the minimal long term obligations left are immaterial in terms of standing in our way of future growth. This sets the table for 2010 to allow us to execute our three pillars of success: organic growth, acquisitions and diversification of our revenue stream.\"
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.
CONTACT:
Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com
Forward-Looking Statements
Some statements made in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as \"anticipate,\'\' \"believe,\'\' \"expect,\'\' \"future,\'\' \"intend,\'\' \"plan,\'\' and similar expressions to identify forward-looking statements. These statements including those related to the growth of the industry, new stem cell treatments, and the Company\'s performance, are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company\'s public filings with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company\'s past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.
LAS VEGAS, Jan. 6 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today said that it has retired a $1.35 million note which had been provided by JMJ Financial in May of 2009.
\"We finished 2009 as we proceeded throughout the year, succeeding in a major effort to reduce debt and strengthen our balance sheet,\" said Matthew Schissler, CEO and co-founder, Cord Blood America. \"The debt reduced, over $10.5 million, is the overwhelming majority we entered the year with and effectively all the debt available for retirement in 2009. We believe the minimal long term obligations left are immaterial in terms of standing in our way of future growth. This sets the table for 2010 to allow us to execute our three pillars of success: organic growth, acquisitions and diversification of our revenue stream.\"
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.
CONTACT:
Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com
Forward-Looking Statements
Some statements made in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as \"anticipate,\'\' \"believe,\'\' \"expect,\'\' \"future,\'\' \"intend,\'\' \"plan,\'\' and similar expressions to identify forward-looking statements. These statements including those related to the growth of the industry, new stem cell treatments, and the Company\'s performance, are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company\'s public filings with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company\'s past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.
Antwort auf Beitrag Nr.: 38.675.624 von itsSHOWTIME am 06.01.10 15:12:24die schmeissen uns ja zu mit news. für 0.014€ würd ich meine schon verkaufen :P
Antwort auf Beitrag Nr.: 38.675.670 von kleingeldjaeger am 06.01.10 15:18:26Das wirste wohl bald bekommen...bin ich dann ja mal gespannt...was Du machst
Auf jeden Fall war das " Gerücht " mit News richtig !!!!
Also ich sag mal das Jahreshoch fällt heute mit der 0,0154 US$...die Drähte bei den Maklern laufen jetzt heiß....0,0151 sag ich zur Eröffnung
itsSHOWTIME
Yeah - 1 Jahreshoch gefallen....nächster Stop ist die 0,0172 US$
WOW...in D wird wohl heute die 0,012 fallen und die 0,013 € auf jeden FAll sichbar werden...jetzt gibts Feuer - Shortsquezze ist angesagt
Antwort auf Beitrag Nr.: 38.675.823 von Expertchen007 am 06.01.10 15:37:20wirklich krass, knapp 20 Mio gleich zur eröffnung weg... alter falter
heute geht es 0,02
Antwort auf Beitrag Nr.: 38.675.860 von kleingeldjaeger am 06.01.10 15:40:59Na das war doch mal ein guter Tipp von mir...gell .....und was machste jetzt wenn die 0,014 € kommen sollte ???? ...kenn Dich doch
Geht alles nun aber echt flott vorwärts und wenn der Widerstand bei der 0,0172 wirklich gebrochen wird sag ich auch min. ist dann 0,030 US....aber minimum
Geht alles nun aber echt flott vorwärts und wenn der Widerstand bei der 0,0172 wirklich gebrochen wird sag ich auch min. ist dann 0,030 US....aber minimum
Die grossen Sprünge werden nun etwas kleiner....ist auch klar...die MK nähert sich sonst der 100 Mio. Grenze.....30 % werden nun nicht jeden Tag drin sein....
Antwort auf Beitrag Nr.: 38.675.947 von Expertchen007 am 06.01.10 15:49:46Why not?? Und ob!!! Da sind noch ganz andere Srünge drin!
Antwort auf Beitrag Nr.: 38.675.904 von Expertchen007 am 06.01.10 15:45:27ja allerdings hab ne vk order zu 0.013 drin, das wären dann 125% - wenn sie weg sind, sind sie eben weg... kauf sie auch wieder ein - nur wo ist dann die frage
Antwort auf Beitrag Nr.: 38.675.983 von Stimmungskanone am 06.01.10 15:53:02Letztendlich vielleicht...aber nun muss es mal die Produktion her und die 1 + 2 Q Zahlen in 2010....man darf auch so zufrieden sein mit dem Verlauf würde ich sagen.....nun beginnt die Zeit der Trader erst mal....aber ich seh da relaxt ins Jahr 2010
Antwort auf Beitrag Nr.: 38.676.022 von kleingeldjaeger am 06.01.10 15:56:04...Gewinn ist Gewinn...stimmt auch wieder
GREAT NEWS!
1/6/09
Cbai, the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today said that it has retired a $1.35 million note which had been provided by JMJ Financial in May of 2009
1/6/09
Cbai, the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today said that it has retired a $1.35 million note which had been provided by JMJ Financial in May of 2009
Antwort auf Beitrag Nr.: 38.676.036 von Expertchen007 am 06.01.10 15:57:16hmmmm...war wohl nichts - zu gierig gewesen
Diese kleinen Kurskorrekturen sind gut für den Markt....wirkt seriös
Antwort auf Beitrag Nr.: 38.676.187 von kleingeldjaeger am 06.01.10 16:11:59Noch nicht...da mach ich mir keine Sorgen das Du den Preis nicht bekommst
SK auf Tageshoch kann ich mir gut vorstellen.
Am Anfang die Bären rausschütteln, zwischendrin konsolidieren und gegen Ende wieder Gas geben.
Cleffy
Am Anfang die Bären rausschütteln, zwischendrin konsolidieren und gegen Ende wieder Gas geben.
Cleffy
Antwort auf Beitrag Nr.: 38.676.272 von Expertchen007 am 06.01.10 16:19:49Hallo Expertchen,
schau mal bei unser alten Freundin aus Canada vorbei.
I like telephone devices...
Das mit Coord sehe ich sehr entspannt mir die nächsten Wochen an und freu mich einfach nur über mein Depot.
Gruß aus HH
schau mal bei unser alten Freundin aus Canada vorbei.
I like telephone devices...
Das mit Coord sehe ich sehr entspannt mir die nächsten Wochen an und freu mich einfach nur über mein Depot.
Gruß aus HH
0,016 durchbrochen
Unglaublich unsere "Perle!
Glück auf!
Unglaublich unsere "Perle!
Glück auf!
YES
Das macht Freude
Das macht Freude
Stuttgart 0,012 !!!!!
Achtung Fans !!!!! gleich fällt die 0,0172 US$....dann gehts richtig los....
Antwort auf Beitrag Nr.: 38.676.529 von frankashh am 06.01.10 16:42:24schau mal bei unser alten Freundin aus Canada vorbei.
Hab ich mehrere -welche meinst du ???
Hab ich mehrere -welche meinst du ???
Antwort auf Beitrag Nr.: 38.677.396 von Expertchen007 am 06.01.10 18:15:34na jetzt sollte mir aber mal einer die dinger für 0,013€ abkaufen.... her mit die monetas
yeah und passiert...@kleingeldjäger- gleich gibts Cash !!!!
Antwort auf Beitrag Nr.: 38.677.396 von Expertchen007 am 06.01.10 18:15:34Wer hätte das gedacht, dass das so schnell geht
Einfach irre
Bin gespannt was die nächsten Wochen noch so abgeht
Glück auf!
Einfach irre
Bin gespannt was die nächsten Wochen noch so abgeht
Glück auf!
Antwort auf Beitrag Nr.: 38.677.419 von Expertchen007 am 06.01.10 18:18:21ne- order immernoch offen
Antwort auf Beitrag Nr.: 38.677.457 von kleingeldjaeger am 06.01.10 18:22:52Schon klar.....hat ja auch noch kein anderer bekommen -erst muss die 0,0172 US$ durch sein -aber siehst ja erst mal abgeprallt - splange musste warten...
So neuer Angriff auf die wichtigste Marke derzeit...mal sehen obs klappt
...echt schwer die 0,0172
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Investoren beobachten auch:
Wertpapier | Perf. % |
---|---|
0,00 | |
-1,36 | |
+2,63 | |
-0,53 | |
-0,02 | |
+0,32 | |
-2,69 | |
+1,06 | |
-10,45 | |
+1,04 |
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
141 | ||
75 | ||
52 | ||
37 | ||
29 | ||
25 | ||
20 | ||
19 | ||
17 | ||
16 |